# EDGAR Filing Document

**Accession Number:** 0000312069
**File Stem:** 0001654954-23-001773
**Filing Date:** 2023-2
**Character Count:** 339654
**Document Hash:** 2d9d5cb95fac414b805409ae4aeec5a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-23-001773.hdr.sgml**: 20230215

**ACCESSION NUMBER**: 0001654954-23-001773

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230215

**FILED AS OF DATE**: 20230215

**DATE AS OF CHANGE**: 20230215

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BARCLAYS PLC
- **CENTRAL INDEX KEY:** 0000312069
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMERCIAL BANKS, NEC [6029]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09246
- **FILM NUMBER:** 23634499

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CHURCHILL PLACE
- **STREET 2:** CANARY WHARF
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** E14 5HP
- **BUSINESS PHONE:** 00442031340952

**MAIL ADDRESS:**
- **STREET 1:** 1 CHURCHILL PLACE
- **STREET 2:** CANARY WHARF
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** E14 5HP

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BARCLAYS BANK PLC
- **DATE OF NAME CHANGE:** 19850313

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BARCLAYS BANK LTD
- **DATE OF NAME CHANGE:** 19820607

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, DC 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER**

 **PURSUANT TO RULE 13A-16 OR 15D-16**

 **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

February 15, 2023

 **Barclays PLC**

(Name of Registrant)

 **1 Churchill Place**

 **London E14 5HP**

 **England**

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F

Indicate by check mark whether the registrant by furnishing the information

contained in this Form is also thereby furnishing the information to the

Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes No x

If "Yes" is marked, indicate below the file number assigned to the registrant

in connection with Rule 12g3-2(b):

This Report on Form 6-K is filed by Barclays PLC.

This Report comprises:

Information given to The London Stock Exchange and furnished pursuant to

General Instruction B to the General Instructions to Form 6-K.

__________________________________________________________________________________

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BARCLAYS PLC <br> (Registrant)

Date: February 15, 2023

---

| |
|:---|
| By: /s/ Garth Wright<br> -------------------------------- |
| Garth Wright |
| Assistant Secretary |

---

 **Barclays PLC**

 **2022 Results Announcement**

31 December 2022

---

| | |
|:---|:---|
| **Results Announcement** | **Page** |
| Notes | 1 |
| Performance Highlights | 2 |
| Group Finance Director's Review | 6 |
| **Results by Business** |  |
| Barclays UK | 8 |
| Barclays International | 11 |
| Head Office | 16 |
| Quarterly Results Summary | 17 |
| Quarterly Results by Business | 18 |
| **Performance Management** |  |
| Margins and Balances | 24 |
| Remuneration | 26 |
| **Risk Management** |  |
| Risk Management and Principal Risks | 28 |
| Credit Risk | 29 |
| Market Risk | 49 |
| Treasury and Capital Risk | 50 |
| Statement of Directors' Responsibilities | 63 |
| Condensed Consolidated Financial Statements | 64 |
| Financial Statement Notes | 69 |
| Appendix: Non-IFRS Performance Measures | 77 |
| Shareholder Information | 84 |

---

BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.

 **Notes**

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the year ended 31 December 2022 to the corresponding 12 months of 2021 and the three months ended 31 December 2022 to the corresponding three months in 2021 and balance sheet analysis as at 31 December 2022 with comparatives relating to 31 December 2021. The historical financial information used for the purposes of such analysis has been restated. Please refer to Supplementary Information contained herein for further information. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at <u>home.barclays/investor-relations</u>.

The information in this announcement, which was approved by the Board of Directors on 14 February 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at <u>www.sec.gov</u>.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 **Non-IFRS performance measures**

Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 77 to 83 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 **Forward-looking statements**

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's reputation, business or operations; the Group's ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the SEC (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2022), which are available on the SEC's website at <u>www.sec.gov</u>.

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 **Performance Highlights**

 ***In 2022 Barclays delivered a profit before tax of £7.0bn and return on tangible equity (RoTE) of 10.4%, with total capital distributions equivalent to c.13.4p per share***

 ***C. S. Venkatakrishnan, Group Chief Executive, commented***<br> *"Barclays performed strongly in 2022. Each business delivered income growth, with Group income up 14%. We achieved our RoTE target of over 10%, maintained a strong Common Equity Tier 1 (CET1) capital ratio of 13.9%, and returned capital to shareholders. We are cautious about global economic conditions, but continue to see growth opportunities across our businesses through 2023."*<br>

 **Key financial metrics:**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Income** | **Cost: income ratio** | **Profit before tax** | **Attributable profit** | **RoTE** | **EPS** | **TNAV per share** | **CET1 ratio** | **Total capital return<sup>1</sup>** |
| **FY22** | £25.0bn | 67% | £7.0bn | £5.0bn | 10.4% | 30.8p | 295p | 13.9% | c.13.4p equivalent |
| **Q422** | £5.8bn | 69% | £1.3bn | £1.0bn | 8.9% | 6.5p | 295p | 13.9% | c.13.4p equivalent |

---

 **Demonstrating execution against our three strategic priorities:**

● **Deliver next generation digitised consumer financial services:** simplifying and upgrading online banking services
- with over 10.5 million Barclays UK mobile banking app users, and
log-ins up 8% year-on-year. c.220k 'Rainy Day Saver'
accounts opened online since launch on 29 September 2022, 41% are
new or re-joining Blue Rewards customers. In the US Consumer Bank,
the Gap portfolio <sup>2</sup> integration onto our
platform doubled our US customer base to over 20
million

● **Deliver sustainable growth in the Corporate and Investment Bank (CIB):** 114bps of revenue share gain in Global Markets from
2019-2022 <sup>3</sup> ; second fastest
growth rate across the top 10 global peers. Investment in Financing
businesses delivered more stable, high returning income of
£2.9bn in 2022 reflecting a compound annual growth rate (CAGR)
of 16% since 2019

● **Capture opportunities as we transition to a low-carbon economy:** new expanded target to facilitate $1 trillion of
Sustainable and Transition Financing by the end of 2030. The
Group's Sustainable Impact Capital investment mandate is now
£500m by the end of 2027

 **2022 Performance highlights<sup>4</sup>:**

– Excluding the impact of Over-issuance of Securities in the US (Over-issuance of Securities) <sup>5</sup> , RoTE was 11.6%

– **CIB income increased by 8% ;** the best full year for both Global Markets and FICC <sup>6</sup> , and strong performance in Transaction banking, more than offsetting the impact of a reduced fee pool in Investment Banking <sup>7</sup>

– **Consumer, Cards and Payments (CC&P) income increased by 35%** supported by higher balances in US cards and Private Bank with turnover growth in Payments

– **Barclays UK income increased by 11%** primarily driven by the rising rate environment

– Group operating expenses excluding litigation and conduct were £15.1bn , up 6% year-on-year, reflecting the impact of FX and inflation

---

| | |
|:---|:---|
| *1* | *Includes total dividend for 2022 of 7.25p per share and total share buybacks announced in relation to 2022 of £1.0bn.* |
| *2* | *The Gap portfolio refers to the Gap Inc. US credit card portfolio.* |
| *3* | *Barclays' calculations using Peer reported financials.* |
| *4* | *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |
| *5* | *Denotes the Over-issuance of Securities under Barclays Bank PLC's (BBPLC) US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See page 5 for reconciliation of Barclays' performance excluding the impact of the Over-issuance of Securities.* |
| *6* | *Period covering 2014-2022. Pre 2014 data was not restated following re-segmentation in 2016.* |
| *7* | *Data source: Dealogic for the period covering 1 January to 31 December 2022.* |

---

 **Q422 Performance highlights<sup>1</sup>:**

● **Attributable profit was £1.0bn and RoTE was 8.9% with profit before impairment of £1.8bn , up 29% year-on-year with positive cost: income jaws of 6%** 

● **Group income was £5.8bn, up 12% year-on-year** including the benefit from FX, with
strong performances in Barclays UK and CC&P. Within CIB, strong
performances in Global Markets and Transaction banking were more
than offset by reduced income in Investment Banking and Corporate
Lending

● **Group operating expenses were £4.0bn, up 6% year-on-year,** reflecting the
impact of FX, inflation and investment in the
business

● **Credit impairment charges were £0.5bn with an LLR of 49bps .** The deteriorating macroeconomic forecast resulted
in an increased charge, partially offset by utilising economic
uncertainty PMAs

 **Outlook*:***

● **Returns:** targeting RoTE of
greater than 10% in 2023

● **Income:** diversified income
streams continue to position the Group well for the current
economic and market environment including higher interest rates. In
2023, Barclays UK net interest margin (NIM) is expected to be
greater than 3.20% <sup>2</sup>

● **Costs:** targeting a cost: income
ratio percentage in the low 60s in 2023, investing for growth
whilst progressing towards the Group's medium-term target of
below 60%

● **Impairment:** expect an LLR of
50-60bps in 2023, based on the current macroeconomic
outlook

● **Capital:** expect to operate
within the CET1 ratio target range of 13-14%

● **Capital returns:** capital
distribution policy incorporates a progressive ordinary dividend,
supplemented with buybacks as appropriate

---

| | |
|:---|:---|
| *1* | *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |
| *2* | *Assumes the UK bank rate peaks at 4.25% in 2023.* |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group results** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| **Barclays Group results** | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  |
|  | £m | £m | % Change | £m | £m | % Change |
| **Barclays UK** | **7259** | **6536** | **11** | **1970** | **1699** | **16** |
| Corporate and Investment Bank | 13368 | 12334 | 8 | 2576 | 2632 | (2) |
| Consumer, Cards and Payments | 4499 | 3331 | 35 | 1286 | 878 | 46 |
| **Barclays International** | **17867** | **15665** | **14** | **3862** | **3510** | **10** |
| **Head Office** | **(170)** | **(261)** | **35** | **(31)** | **(49)** | **37** |
| **Total income** | **24956** | **21940** | **14** | **5801** | **5160** | **12** |
| Operating costs | (14957) | (14092) | (6) | (3748) | (3514) | (7) |
| UK bank levy | (176) | (170) | (4) | (176) | (170) | (4) |
| Litigation and conduct | (1597) | (397) |  | (79) | (92) | 14 |
| **Total operating expenses** | **(16730)** | **(14659)** | **(14)** | **(4003)** | **(3776)** | **(6)** |
| Other net income | 6 | 260 | (98) | 10 | 13 | (23) |
| **Profit before impairment** | **8232** | **7541** | **9** | **1808** | **1397** | **29** |
| Credit impairment (charges)/releases | (1220) | 653 |  | (498) | 31 |  |
| **Profit before tax** | **7012** | **8194** | **(14)** | **1310** | **1428** | **(8)** |
| Tax (charge)/credit | (1039) | (1138) | 9 | 33 | (104) |  |
| **Profit after tax** | **5973** | **7056** | **(15)** | **1343** | **1324** | **1** |
| Non-controlling interests | (45) | (47) | 4 | (22) | (27) | 19 |
| Other equity instrument holders | (905) | (804) | (13) | (285) | (218) | (31) |
| **Attributable profit** | **5023** | **6205** | **(19)** | **1036** | **1079** | **(4)** |
| **Performance measures** |  |  |  |  |  |  |
| Return on average tangible shareholders' equity | 10.4% | 13.1% |  | 8.9% | 9.0% |  |
| Average tangible shareholders' equity (£bn) | 48.3 | 47.3 |  | 46.7 | 48.0 |  |
| Cost: income ratio | 67% | 67% |  | 69% | 73% |  |
| Loan loss rate (bps) | 30 | (18) |  | 49 | (3) |  |
| Basic earnings per share | 30.8p | 36.5p |  | 6.5p | 6.4p |  |
| Dividend per share | 7.25p | 6.0p |  |  |  |  |
| Share buyback announced (£m) | 1000 | 1500 |  |  |  |  |
| Total payout equivalent per share | c.13.4p | 15.0p |  |  |  |  |
| Basic weighted average number of shares (m) | 16333 | 16985 | (4) | 15828 | 16985 | (7) |
| Period end number of shares (m) | 15871 | 16752 | (5) | 15871 | 16752 | (5) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **As at 31.12.22** | **As at 30.09.22** | **Restated**<br> **As at 31.12.21<sup>1</sup>** |
| **Balance sheet and capital management<sup>2</sup>** | £bn | £bn | £bn |
| Loans and advances at amortised cost | 398.8 | 413.7 | 361.5 |
| Loans and advances at amortised cost impairment coverage ratio | 1.4% | 1.4% | 1.6% |
| Total assets | 1513.7 | 1726.9 | 1384.3 |
| Deposits at amortised cost | 545.8 | 574.4 | 519.4 |
| Tangible net asset value per share | 295p | 286p | 291p |
| Common equity tier 1 ratio | 13.9% | 13.8% | 15.1% |
| Common equity tier 1 capital | 46.9 | 48.6 | 47.3 |
| Risk weighted assets | 336.5 | 350.8 | 314.1 |
| UK leverage ratio | 5.3% | 5.0% | 5.2% |
| UK leverage exposure | 1130.0 | 1232.1 | 1137.9 |
| Average UK leverage ratio | 4.8% | 4.8% | 4.9% |
| Average UK leverage exposure | 1281.0 | 1259.6 | 1229.0 |
| **Funding and liquidity** |  |  |  |
| Group liquidity pool (£bn) | 318 | 326 | 291 |
| Liquidity coverage ratio | 165% | 151% | 168% |
| Net stable funding ratio<sup>3</sup> | 137% |  |  |
| Loan: deposit ratio | 73% | 72% | 70% |

---

---

| | |
|:---|:---|
| *1* | *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |
| *2* | *Refer to pages 54 to 62 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated.* |
| *3* | *Represents average of the last four spot quarter end positions.* |

---

 **Reconciliation of financial results excluding the impact of the Over-issuance of Securities**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Restated<sup>1</sup>**<br> **Year ended 31.12.21** | **Restated<sup>1</sup>**<br> **Year ended 31.12.21** | **Restated<sup>1</sup>**<br> **Year ended 31.12.21** | |
|  | **Statutory** | **Impact of the Over-issuance of Securities** | **Excluding impact of the Over-issuance of Securities** | **Statutory** | **Impact of the Over-issuance of Securities** | **Excluding impact of the Over-issuance of Securities** | |
|  | £m | £m | £m | £m | £m | £m | % Change |
| **Barclays UK** | **7259** | **—** | **7259** | **6536** | **—** | **6536** | **11** |
| Corporate and Investment Bank | 13368 | 292 | 13076 | 12334 |  | 12334 | 6 |
| Consumer, Cards and Payments | 4499 | **—** | 4499 | 3331 |  | 3331 | 35 |
| **Barclays International** | **17867** | **292** | **17575** | **15665** | **—** | **15665** | **12** |
| **Head Office** | **(170)** | **—** | **(170)** | **(261)** | **—** | **(261)** | **35** |
| **Total income** | **24956** | **292** | **24664** | **21940** | **—** | **21940** | **12** |
| Operating costs | (14957) |  | (14957) | (14092) |  | (14092) | (6) |
| UK bank levy | (176) |  | (176) | (170) |  | (170) | (4) |
| Litigation and conduct | (1597) | (966) | (631) | (397) | (220) | (177) |  |
| **Total operating expenses** | **(16730)** | **(966)** | **(15764)** | **(14659)** | **(220)** | **(14439)** | **(9)** |
| Other net income | 6 |  | 6 | 260 |  | 260 | (98) |
| **Profit before impairment** | **8232** | **(674)** | **8906** | **7541** | **(220)** | **7761** | **15** |
| Credit impairment (charges)/releases | (1220) |  | (1220) | 653 |  | 653 |  |
| **Profit before tax** | **7012** | **(674)** | **7686** | **8194** | **(220)** | **8414** | **(9)** |
| **Attributable profit** | **5023** | **(552)** | **5575** | **6205** | **(170)** | **6375** | **(13)** |
|  | £bn |  | £bn | £bn |  | £bn |  |
| Average tangible shareholders' equity | 48.3 |  | 48.3 | 47.3 |  | 47.3 |  |
| **Return on average tangible shareholders' equity** | **10.4%** |  | **11.6%** | **13.1%** |  | **13.5%** |  |
|  | **Three months ended 31.12.22** | **Three months ended 31.12.22** | **Three months ended 31.12.22** | **Restated<sup>1</sup>**<br> **Three months ended 31.12.21** | **Restated<sup>1</sup>**<br> **Three months ended 31.12.21** | **Restated<sup>1</sup>**<br> **Three months ended 31.12.21** |  |
|  | **Statutory** | **Impact of the Over-issuance of Securities** | **Excluding impact of the Over-issuance of Securities** | **Statutory** | **Impact of the Over-issuance of Securities** | **Excluding impact of the Over-issuance of Securities** |  |
|  | £m | £m | £m | £m | £m | £m | % Change |
| **Barclays UK** | **1970** | **—** | **1970** | **1699** | **—** | **1699** | **16** |
| Corporate and Investment Bank | 2576 |  | 2576 | 2632 |  | 2632 | (2) |
| Consumer, Cards and Payments | 1286 | **—** | 1286 | 878 |  | 878 | 46 |
| **Barclays International** | **3862** | **—** | **3862** | **3510** | **—** | **3510** | **10** |
| **Head Office** | **(31)** | **—** | **(31)** | **(49)** | **—** | **(49)** | **37** |
| **Total income** | **5801** | **—** | **5801** | **5160** | **—** | **5160** | **12** |
| Operating costs | (3748) |  | (3748) | (3514) |  | (3514) | (7) |
| UK bank levy | (176) |  | (176) | (170) |  | (170) | (4) |
| Litigation and conduct | (79) |  | (79) | (92) | (46) | (46) | (72) |
| **Total operating expenses** | **(4003)** | **—** | **(4003)** | **(3776)** | **(46)** | **(3730)** | **(7)** |
| Other net income | 10 |  | 10 | 13 |  | 13 | (23) |
| **Profit before impairment** | **1808** | **—** | **1808** | **1397** | **(46)** | **1443** | **25** |
| Credit impairment (charges)/releases | (498) |  | (498) | 31 |  | 31 |  |
| **Profit before tax** | **1310** | **—** | **1310** | **1428** | **(46)** | **1474** | **(11)** |
| **Attributable profit** | **1036** | **—** | **1036** | **1079** | **(38)** | **1117** | **(7)** |
|  | £bn |  | £bn | £bn |  | £bn |  |
| Average tangible shareholders' equity | 46.7 |  | 46.7 | 48.0 |  | 48.0 |  |
| **Return on average tangible shareholders' equity** | **8.9%** |  | **8.9%** | **9.0%** |  | **9.3%** |  |

---

 *1* *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

 **Group Finance Director's Review**

 **2022 Group performance<sup>1</sup>**

– Excluding the income benefit of £292m relating to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of Securities, total Group income was £24,664m, up 12% year-on-year

– Group operating expenses excluding litigation and conduct charges increased 6% to £15,133m, reflecting the impact of inflation and the appreciation of average USD against GBP

– Litigation and conduct charges were £1,597m (2021: £397m) including £966m from the Over-issuance of Securities

 **Capital distributions**

● Barclays
intends to pay a 2022 full year dividend of 5.0p per share, taking
the total dividend for 2022 to 7.25p per share (2021: 6.0p).
Barclays also intends to initiate a share buyback of up to
£0.5bn, bringing the total share buybacks announced in
relation to 2022 to £1.0bn and total capital return equivalent
to c.13.4p per share

● Barclays
is committed to maintaining an appropriate balance between
delivering attractive total cash returns to shareholders,
investment in the business and maintaining a strong capital
position. Barclays pays a progressive ordinary dividend, taking
into account these objectives and the earnings outlook of the
Group. The Board will also continue to supplement the ordinary
dividends as appropriate, including with share
buybacks

● Dividends
will continue to be paid semi-annually

 **Group capital and leverage<sup>1</sup>**

---

| | |
|:---|:---|
| ●  | The reported CET1 ratio decreased by c.120bps to 13.9% (December 2021: 15.1%) as RWAs increased by £22.4bn to £336.5bn and CET1 capital decreased by £0.4bn to £46.9bn |
| – | c.150bps increase from 2022 attributable profit |
| – | c.80bps returned to shareholders including the 2.25p half year dividend paid in September 2022, £1.5bn of share buybacks announced with FY21 and H122 results and a FY22 dividend accrual |
| – | c.80bps reduction due to the impact of regulatory change on 1 January 2022 as CET1 capital decreased £1.7bn and RWAs increased £6.6bn |
| – | c.70bps reduction from decreases in the fair value of the bond portfolio through other comprehensive income and other capital deductions |
| – | c.40bps reduction due to pension contributions, including the accelerated cash settlement to the UK Retirement Fund (UKRF) of earlier deficit reduction contributions and deficit reduction payments made in 2022 |
| – | A £14.1bn increase in RWAs as a result of foreign exchange movements was broadly offset by a £2bn increase in the currency translation reserve |
| ●  | The UK leverage ratio increased to 5.3% (December 2021: 5.2%) primarily due to a decrease in the leverage exposure of £7.9bn to £1,130.0bn and an increase in Tier 1 Capital of £0.6bn to £60.1bn |

---

 *1* *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

 **Group funding and liquidity**

● The liquidity pool was £318bn (December 2021: £291bn) and
the liquidity coverage ratio (LCR) remained significantly above the
100% regulatory requirement at 165% (December 2021: 168%),
equivalent to a surplus of £117bn (December 2021:
£116bn). The increase in the liquidity pool over the year was
driven by continued deposit growth and an increase in wholesale
funding, partly offset by an increase in business funding
consumption. An increase in net stress outflows and trapped
liquidity within Barclays' subsidiaries led to a modest
reduction in the LCR ratio. The Net Stable Funding Ratio (NSFR)
(average of last four quarter ends) was 137%, which represents a
£155bn surplus above the 100% regulatory
requirement

● Wholesale
funding outstanding, excluding repurchase agreements, was
£184.0bn (December 2021: £167.5bn). The Group issued £15.3bn equivalent of
minimum requirement for own funds and eligible liabilities (MREL)
instruments from Barclays PLC (BPLC) (the Parent company) in 2022.
The Group has a strong MREL position with a ratio of 33.5% of RWAs,
which is in excess of the 28.9% regulatory requirement excluding a
confidential, institution specific Prudential Regulation Authority
(PRA) buffer

 **Other matters**

● **Over-issuance of Securities**: Barclays recognised a net
attributable loss of £0.6 bn in 2022 (£nil in Q422,
£0.7bn total loss including 2021). This included a monetary
penalty of $200m (£165m <sup>1</sup>) following the
resolution of the SEC's investigation of BPLC and BBPLC
relating to the Over-issuance of Securities As
previously disclosed, Barclays has a contingent liability in
relation to current and potential private civil claims and other
potential enforcement actions relating to the Over-issuance of
Securities. For further details see Restatement of financial
statements (Note 1a) in the BPLC 2022 Annual Report on page
428. ● **SEC and Commodity and Futures Trading Commission (CFTC) devices investigation:** in Q322, the SEC and CFTC announced the final
settlement terms relating to their investigations of compliance
with record-keeping obligations in connection with business-related
communications over unapproved electronic messaging platforms.
Under these settlements, BBPLC and Barclays Capital Inc. paid a
combined $125m (£103m <sup>1</sup>) civil monetary
penalty to the SEC and a $75m (£62m <sup>1</sup>) civil monetary
penalty to the CFTC

● **Legacy Loan Portfolio:** a customer remediation provision of
£282m was recognised during 2022, relating to a legacy
timeshare loan portfolio brokered by Azure Services Limited and
other legacy loan portfolios

● **Financial Conduct Authority (FCA) proceedings:** a provision
of £50m was recognised in Q322 in relation to the FCA
investigation into disclosure-related matters arising out of BPLC's
June and November 2008 capital raisings

● **Gap portfolio acquisition**: in Q222, Barclays completed the
acquisition of a US credit card portfolio of $3.3bn
(£2.7bn <sup>2</sup>) of receivables, in
partnership with Gap Inc.

● **Kensington Mortgage Company (KMC) acquisition:** in Q222, BPLC
announced that Barclays Bank UK PLC had agreed to acquire UK
specialist mortgage lender KMC and a portfolio of UK mortgages.
Regulatory approval has been obtained and the transaction is now
expected to complete in Q123

● **Absa Group Limited** (**Absa) sale:** during 2022 Barclays fully disposed of its
shareholding in Absa, raising aggregate gross sale proceeds of ZAR
21.0bn (c.£1.1bn <sup>3</sup>)

● **UK Corporation Tax:** an increase in the UK Corporation Tax
rate from 19% to 25% was enacted in 2021 and a reduction in the UK
banking surcharge from 8% to 3% was enacted in 2022, both to be
effective from 1 April 2023. The future statutory tax rate applied
to UK banking profits will therefore be 28% from 1 April
2023

 **Group targets**

---

| | |
|:---|:---|
| Barclays continues to target the following over the medium-term: | Barclays continues to target the following over the medium-term: |
| ●  | Returns: RoTE of greater than 10% |
| ●  | Cost efficiency: cost: income ratio below 60% |
| ●  | Capital adequacy: CET1 ratio in the range of 13-14% |

---

 **Anna Cross, Group Finance Director**

---

| | |
|:---|:---|
| *1* | *Exchange rate GBP/USD 1.22 as at 30 June 2022.* |
| *2* | *Exchange rate GBP/USD 1.22 as at 17 June 2022.* |
| *3* | *On 21 April 2022, ZAR 10.3bn at exchange rate GBP/ZAR 20.04 and on 1 September 2022, ZAR 10.7bn at exchange rate GBP/ZAR 19.93.* |

---

 **Results by Business**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.12.22** | **31.12.21** |  | **31.12.22** | **31.12.21** |  |
| **Income statement information** | £m | £m | % Change | £m | £m | % Change |
| Net interest income | 5893 | 5202 | 13 | 1600 | 1313 | 22 |
| Net fee, commission and other income | 1366 | 1334 | 2 | 370 | 386 | (4) |
| **Total income** | **7259** | **6536** | **11** | **1970** | **1699** | **16** |
| Operating costs | (4260) | (4357) | 2 | (1108) | (1202) | 8 |
| UK bank levy | (26) | (36) | 28 | (26) | (36) | 28 |
| Litigation and conduct | (41) | (37) | (11) | (13) | (5) |  |
| **Total operating expenses** | **(4327)** | **(4430)** | **2** | **(1147)** | **(1243)** | **8** |
| Other net income/(expenses) |  |  |  | 1 | (1) |  |
| **Profit before impairment** | **2932** | **2106** | **39** | **824** | **455** | **81** |
| Credit impairment (charges)/releases | (286) | 365 |  | (157) | 59 |  |
| **Profit before tax** | **2646** | **2471** | **7** | **667** | **514** | **30** |
| Attributable profit | 1877 | 1756 | 7 | 474 | 420 | 13 |
| **Performance measures** |  |  |  |  |  |  |
| Return on average allocated tangible equity | 18.7% | 17.6% |  | 18.7% | 16.8% |  |
| Average allocated tangible equity (£bn) | 10.0 | 10.0 |  | 10.2 | 10.0 |  |
| Cost: income ratio | 60% | 68% |  | 58% | 73% |  |
| Loan loss rate (bps) | 13 | (16) |  | 27 | (10) |  |
| Net interest margin | 2.86% | 2.52% |  | 3.10% | 2.49% |  |
| **Key facts** |  |  |  |  |  |  |
| UK mortgage balances (£bn) | 162.2 | 158.1 |  |  |  |  |
| Mortgage gross lending flow (£bn) | 30.3 | 33.9 |  |  |  |  |
| Average loan to value of mortgage portfolio<sup>1</sup> | 50% | 51% |  |  |  |  |
| Average loan to value of new mortgage lending<sup>1</sup> | 68% | 70% |  |  |  |  |
| Number of branches | 481 | 666 |  |  |  |  |
| Mobile banking active customers | 10.5m | 9.7m |  |  |  |  |
| 30 day arrears rate - Barclaycard Consumer UK | 0.9% | 1.0% |  |  |  |  |
| **Balance sheet information** | £bn | £bn |  |  |  |  |
| Loans and advances to customers at amortised cost | 205.1 | 208.8 |  |  |  |  |
| Total assets | 313.2 | 321.2 |  |  |  |  |
| Customer deposits at amortised cost | 258.0 | 260.6 |  |  |  |  |
| Loan: deposit ratio | 87% | 85% |  |  |  |  |
| Risk weighted assets | 73.1 | 72.3 |  |  |  |  |
| Period end allocated tangible equity | 10.1 | 10.0 |  |  |  |  |

---

 *1* *Average loan to value (LTV) of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans portfolio.*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays UK** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| **Analysis of Barclays UK** | **31.12.22** | **31.12.21** |  | **31.12.22** | **31.12.21** |  |
| **Analysis of total income** | £m | £m | % Change | £m | £m | % Change |
| Personal Banking | 4540 | 3883 | 17 | 1229 | 983 | 25 |
| Barclaycard Consumer UK | 1093 | 1250 | (13) | 269 | 352 | (24) |
| Business Banking | 1626 | 1403 | 16 | 472 | 364 | 30 |
| **Total income** | **7259** | **6536** | **11** | **1970** | **1699** | **16** |
| **Analysis of credit impairment (charges)/releases** |  |  |  |  |  |  |
| Personal Banking | (167) | 28 |  | (120) | 8 |  |
| Barclaycard Consumer UK | 30 | 404 | (93) | (12) | 114 |  |
| Business Banking | (149) | (67) |  | (25) | (63) | 60 |
| **Total credit impairment (charges)/releases** | **(286)** | **365** |  | **(157)** | **59** |  |
| **Analysis of loans and advances to customers at amortised cost** | £bn | £bn |  |  |  |  |
| Personal Banking | 169.7 | 165.4 |  |  |  |  |
| Barclaycard Consumer UK | 9.2 | 8.7 |  |  |  |  |
| Business Banking | 26.2 | 34.7 |  |  |  |  |
| **Total loans and advances to customers at amortised cost** | **205.1** | **208.8** |  |  |  |  |
| **Analysis of customer deposits at amortised cost** |  |  |  |  |  |  |
| Personal Banking | 195.6 | 196.4 |  |  |  |  |
| Barclaycard Consumer UK |  |  |  |  |  |  |
| Business Banking | 62.4 | 64.2 |  |  |  |  |
| **Total customer deposits at amortised cost** | **258.0** | **260.6** |  |  |  |  |

---

 **Barclays UK delivered a RoTE of 18.7% (2021: 17.6%)** as the transformation into a next generation, digitised consumer bank drove strong returns and cost efficiencies, which combined with rising interest rates contributed to a cost: income ratio of 60% (2021: 68%). Barclays UK continues to support customers through affordability pressures.

 **2022 compared to 2021**

 **Income statement**

– Personal Banking income increased 17% to £4,540m, driven by rising interest rates, partially offset by mortgage margin compression

– Barclaycard Consumer UK income decreased 13% to £1,093m as higher customer spend volumes were more than offset by lower interest earning lending (IEL) balances following repayments and ongoing prudent risk management

– Business Banking income increased 16% to £1,626m driven by rising interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending income as repayments continue

 **Balance sheet**

● **Loans and advances to customers at amortised cost decreased 2% to £205.1bn** as £4.1bn of mortgage growth was
more than offset by a £8.5bn decrease in Business Banking
balances due to the repayment of government scheme lending and the
yield curve impact from rising interest rates on the Education,
Social Housing and Local Authority portfolio carrying
value

● **Customer deposits at amortised cost remained broadly stable at £258.0bn (December 2021: £260.6bn)**, maintaining a strong loan: deposit ratio of 87%
(December 2021: 85%)

● **RWAs remained broadly stable at £73.1bn (December 2021: £72.3bn)** 

---

| | |
|:---|:---|
| *1* | *As at 31 December 2019, UK cards 30 and 90 day arrears were 1.7% and 0.8% respectively.* |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Barclays International** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  |
| **Income statement information** | £m | £m | % Change | £m | £m | % Change |
| Net interest income | 4927 | 3263 | 51 | 1465 | 955 | 53 |
| Net trading income | 7709 | 5693 | 35 | 1169 | 789 | 48 |
| Net fee, commission and other income | 5231 | 6709 | (22) | 1228 | 1766 | (30) |
| **Total income** | **17867** | **15665** | **14** | **3862** | **3510** | **10** |
| Operating costs | (10361) | (9076) | (14) | (2543) | (2160) | (18) |
| UK bank levy | (133) | (134) | 1 | (133) | (134) | 1 |
| Litigation and conduct | (1503) | (345) |  | (67) | (84) | 20 |
| **Total operating expenses** | **(11997)** | **(9555)** | **(26)** | **(2743)** | **(2378)** | **(15)** |
| Other net income | 28 | 40 | (30) | 5 | 3 | 67 |
| **Profit before impairment** | **5898** | **6150** | **(4)** | **1124** | **1135** | **(1)** |
| Credit impairment (charges)/releases | (933) | 288 |  | (328) | (23) |  |
| **Profit before tax** | **4965** | **6438** | **(23)** | **796** | **1112** | **(28)** |
| Attributable profit | 3844 | 4647 | (17) | 625 | 818 | (24) |
| **Performance measures** |  |  |  |  |  |  |
| Return on average allocated tangible equity | 10.2% | 14.4% |  | 6.4% | 9.9% |  |
| Average allocated tangible equity (£bn) | 37.6 | 32.4 |  | 38.9 | 32.9 |  |
| Cost: income ratio | 67% | 61% |  | 71% | 68% |  |
| Loan loss rate (bps) | 54 | (21) |  | 75 | 7 |  |
| Net interest margin | 5.02% | 4.01% |  | 5.71% | 4.14% |  |
| **Balance sheet information** | £bn | £bn |  |  |  |  |
| Loans and advances to customers at amortised cost | 133.7 | 106.4 |  |  |  |  |
| Loans and advances to banks at amortised cost | 8.7 | 8.4 |  |  |  |  |
| Debt securities at amortised cost | 27.2 | 19.0 |  |  |  |  |
| **Loans and advances at amortised cost** | **169.6** | **133.8** |  |  |  |  |
| Trading portfolio assets | 133.8 | 146.9 |  |  |  |  |
| Derivative financial instrument assets | 301.7 | 261.5 |  |  |  |  |
| Financial assets at fair value through the income statement | 210.5 | 188.2 |  |  |  |  |
| Cash collateral and settlement balances | 107.7 | 88.1 |  |  |  |  |
| Other assets | 258.0 | 225.6 |  |  |  |  |
| **Total assets** | **1181.3** | **1044.1** |  |  |  |  |
| Deposits at amortised cost | 287.6 | 258.8 |  |  |  |  |
| Derivative financial instrument liabilities | 288.9 | 256.4 |  |  |  |  |
| Loan: deposit ratio | 59% | 52% |  |  |  |  |
| Risk weighted assets | 254.8 | 230.9 |  |  |  |  |
| Period end allocated tangible equity | 36.8 | 33.2 |  |  |  |  |

---

 *1* *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays International** | **Analysis of Barclays International** |  |  |  |  |  |
| **Corporate and Investment Bank** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  | **31.12.22** | **Restated<sup>1</sup>**<br> **31.12.21** |  |
| **Income statement information** | £m | £m | % Change | £m | £m | % Change |
| Net interest income | 1949 | 1351 | 44 | 548 | 432 | 27 |
| Net trading income | 7733 | 5652 | 37 | 1201 | 774 | 55 |
| Net fee, commission and other income | 3686 | 5331 | (31) | 827 | 1426 | (42) |
| **Total income** | **13368** | **12334** | **8** | **2576** | **2632** | **(2)** |
| Operating costs | (7630) | (6818) | (12) | (1796) | (1562) | (15) |
| UK bank levy | (126) | (128) | 2 | (126) | (128) | 2 |
| Litigation and conduct | (1189) | (237) |  | (55) | (59) | 7 |
| **Total operating expenses** | **(8945)** | **(7183)** | **(25)** | **(1977)** | **(1749)** | **(13)** |
| Other net income | 2 | 2 |  | 2 | 1 |  |
| **Profit before impairment** | **4425** | **5153** | **(14)** | **601** | **884** | **(32)** |
| Credit impairment (charges)/releases | (119) | 473 |  | (41) | 73 |  |
| **Profit before tax** | **4306** | **5626** | **(23)** | **560** | **957** | **(41)** |
| Attributable profit | 3364 | 4032 | (17) | 454 | 695 | (35) |
| **Performance measures** |  |  |  |  |  |  |
| Return on average allocated tangible equity | 10.2% | 14.3% |  | 5.4% | 9.7% |  |
| Average allocated tangible equity (£bn) | 32.8 | 28.3 |  | 33.7 | 28.7 |  |
| Cost: income ratio | 67% | 58% |  | 77% | 66% |  |
| Loan loss rate (bps) | 9 | (47) |  | 13 | (29) |  |
| **Balance sheet information** | £bn | £bn |  |  |  |  |
| Loans and advances to customers at amortised cost | 90.5 | 73.4 |  |  |  |  |
| Loans and advances to banks at amortised cost | 8.1 | 7.6 |  |  |  |  |
| Debt securities at amortised cost | 27.2 | 19.0 |  |  |  |  |
| **Loans and advances at amortised cost** | **125.8** | **100.0** |  |  |  |  |
| Trading portfolio assets | 133.7 | 146.7 |  |  |  |  |
| Derivative financial instrument assets | 301.6 | 261.5 |  |  |  |  |
| Financial assets at fair value through the income statement | 210.5 | 188.1 |  |  |  |  |
| Cash collateral and settlement balances | 106.9 | 87.2 |  |  |  |  |
| Other assets | 222.6 | 195.8 |  |  |  |  |
| **Total assets** | **1101.1** | **979.3** |  |  |  |  |
| Deposits at amortised cost | 205.8 | 189.4 |  |  |  |  |
| Derivative financial instrument liabilities | 288.9 | 256.4 |  |  |  |  |
| Risk weighted assets | 215.9 | 200.7 |  |  |  |  |
| **Analysis of total income** | £m | £m | % Change | £m | £m | % Change |
| FICC | 5695 | 3448 | 65 | 976 | 546 | 79 |
| Equities | 3149 | 2967 | 6 | 440 | 501 | (12) |
| **Global Markets** | **8844** | **6415** | **38** | **1416** | **1047** | **35** |
| Advisory | 768 | 921 | (17) | 197 | 287 | (31) |
| Equity capital markets | 166 | 813 | (80) | 40 | 158 | (75) |
| Debt capital markets | 1281 | 1925 | (33) | 243 | 511 | (52) |
| **Investment Banking fees** | **2215** | **3659** | **(39)** | **480** | **956** | **(50)** |
| Corporate lending | (231) | 588 |  | (128) | 176 |  |
| Transaction banking | 2540 | 1672 | 52 | 808 | 453 | 78 |
| **Corporate** | **2309** | **2260** | **2** | **680** | **629** | **8** |
| **Total income** | **13368** | **12334** | **8** | **2576** | **2632** | **(2)** |

---

 *1* *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays International** | **Analysis of Barclays International** |  |  |  |  |  |
| **Consumer, Cards and Payments** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.12.22** | **31.12.21** |  | **31.12.22** | **31.12.21** |  |
| **Income statement information** | £m | £m | % Change | £m | £m | % Change |
| Net interest income | 2979 | 1912 | 56 | 918 | 522 | 76 |
| Net fee, commission, trading and other income | 1520 | 1419 | 7 | 368 | 356 | 3 |
| **Total income** | **4499** | **3331** | **35** | **1286** | **878** | **46** |
| Operating costs | (2731) | (2258) | (21) | (747) | (598) | (25) |
| UK bank levy | (7) | (6) | (17) | (7) | (6) | (17) |
| Litigation and conduct | (314) | (108) |  | (12) | (25) | 52 |
| **Total operating expenses** | **(3052)** | **(2372)** | **(29)** | **(766)** | **(629)** | **(22)** |
| Other net income | 26 | 38 | (32) | 3 | 2 | 50 |
| **Profit before impairment** | **1473** | **997** | **48** | **523** | **251** |  |
| Credit impairment charges | (814) | (185) |  | (287) | (96) |  |
| **Profit before tax** | **659** | **812** | **(19)** | **236** | **155** | **52** |
| Attributable profit | 480 | 615 | (22) | 171 | 123 | 39 |
| **Performance measures** |  |  |  |  |  |  |
| Return on average allocated tangible equity | 10.0% | 15.0% |  | 13.0% | 11.7% |  |
| Average allocated tangible equity (£bn) | 4.8 | 4.1 |  | 5.2 | 4.2 |  |
| Cost: income ratio | 68% | 71% |  | 60% | 72% |  |
| Loan loss rate (bps) | 175 | 51 |  | 245 | 105 |  |
| **Key facts** |  |  |  |  |  |  |
| US cards 30 day arrears rate | 2.2% | 1.6% |  |  |  |  |
| US cards customer FICO score distribution |  |  |  |  |  |  |
| <660 | 11% | 10% |  |  |  |  |
| >660 | 89% | 90% |  |  |  |  |
| Total number of payments clients | 395k | 380k |  |  |  |  |
| Value of payments processed (£bn)<sup>1</sup> | 307 | 277 |  |  |  |  |
| **Balance sheet information** | £bn | £bn |  |  |  |  |
| Loans and advances to customers at amortised cost | 43.2 | 33.0 |  |  |  |  |
| Total assets | 80.2 | 64.8 |  |  |  |  |
| Deposits at amortised cost | 81.8 | 69.4 |  |  |  |  |
| Risk weighted assets | 38.9 | 30.2 |  |  |  |  |
| **Analysis of total income** | £m | £m | % Change | £m | £m | % Change |
| International Cards and Consumer Bank | 2913 | 2092 | 39 | 860 | 552 | 56 |
| Private Bank | 1014 | 781 | 30 | 285 | 200 | 43 |
| Payments | 572 | 458 | 25 | 141 | 126 | 12 |
| **Total income** | **4499** | **3331** | **35** | **1286** | **878** | **46** |

---

---

| | |
|:---|:---|
| *1* | *Includes £296bn (2021: £270bn) of merchant acquiring payments.* |

---

 **Barclays International delivered a RoTE of 10.2% (2021: 14.4%)** reflecting the benefits of income diversification and continued investment in sustainable growth, partially offset by the net impact of the Over-issuance of Securities in the CIB. CC&P performance reflected continued income momentum, investment for growth and a provision for customer remediation costs relating to legacy loan portfolios.

 **2022 compared to 2021**

 **Income statement<sup>1</sup>**

– Excluding the impact of the Over-issuance of Securities, CIB RoTE was 12.0%

– CIB income increased 8% to £13,368m

– CC&P income increased 35% to £4,499m

– CIB total operating expenses increased 25% to £8,945m. Operating expenses excluding litigation and conduct charges increased 12% to £7,756m driven by continued investment in talent and technology, and the impact of inflation. Litigation and conduct charges were £1,189m (2021: £237m) including £966m from the Over-issuance of Securities and £165m relating to the Devices Settlements <sup>4</sup>

– CC&P total operating expenses increased 29% to £3,052m. Operating expenses excluding litigation and conduct charges increased 21% to £2,738m, including higher investment spend reflecting an increase in marketing and partnership costs. Litigation and conduct charges were £314m (2021: £108m) mainly driven by customer remediation costs relating to legacy loan portfolios

– CIB credit impairment charges of £119m (2021: £473m net release) were driven by a net increase in modelled impairment and single name charges partially offset by the benefit of credit protection

– CC&P credit impairment charges increased to £814m (2021: £185m), driven by higher balances in US cards, including the day one impact of acquiring the Gap portfolio, macroeconomic deterioration and a gradual increase in delinquencies, partially offset by the utilisation of economic uncertainty PMAs and the release of COVID-19 related adjustments informed by refreshed macroeconomic scenarios. As at 31 December 2022, US cards 30 and 90 day arrears remain below pre-pandemic levels at 2.2% (Q421: 1.6%) and 1.2% (Q421: 0.8%) respectively <sup>5</sup> . The US cards business is supported by a total coverage ratio of 8.1% (December 2021: 10.6%)

---

| | |
|:---|:---|
| *1* | *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |
| *2* | *Period covering 2014-2016. Pre 2014 data was not restated following re-segmentation in 2016.* |
| *3* | *Data source: Dealogic for the period covering 1 January to 31 December 2022.* |
| *4* | *Refers to the settlements with the SEC and CFTC in connection with their investigations of the use of unauthorised devices for business communications. See Other matters on page 7.* |
| *5* | *As at 31 December 2019, US cards 30 and 90 days arrears were 2.7% and 1.4% respectively.* |

---

 **Balance sheet**

● **Loans and advances at amortised cost increased £35.8bn to £169.6bn** due to increased
lending to customers across CIB and CC&P, inclusive of the Gap
portfolio acquisition and appreciation of USD against GBP, and
increased investment in debt securities

● **Trading portfolio assets decreased £13.1bn to £133.8bn** due to a
reduction in equity securities as clients repositioned their
demand, partially offset by increased trading activity in debt
securities

● **Derivative assets and liabilities increased £40.2bn and £32.5bn respectively to £301.7bn and £288.9bn** driven by
market volatility and increased activity

● **Financial assets at fair value through the income statement increased £22.3bn to £210.5bn** driven by increased reverse repurchase
activity

● **Deposits at amortised cost increased £28.8bn to £287.6bn** primarily due to
growth in Corporate deposits and an increase in short-term money
market deposits

● **RWAs increased to £254.8bn (December 2021: £230.9bn)** mainly resulting
from the impact of the appreciation of USD against GBP, regulatory
changes and higher CC&P balances including the Gap
portfolio

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Head Office** | **Year ended** | **Year ended** | **Year ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.12.22** | **31.12.21** |  | **31.12.22** | **31.12.21** |  |
| **Income statement information** | £m | £m | % Change | £m | £m | % Change |
| Net interest income | (248) | (392) | 37 | (324) | (38) |  |
| Net fee, commission and other income | 78 | 131 | (40) | 293 | (11) |  |
| **Total income** | **(170)** | **(261)** | **35** | **(31)** | **(49)** | **37** |
| Operating costs | (336) | (659) | 49 | (97) | (152) | 36 |
| UK bank levy | (17) |  |  | (17) |  |  |
| Litigation and conduct | (53) | (15) |  | 1 | (3) |  |
| **Total operating expenses** | **(406)** | **(674)** | **40** | **(113)** | **(155)** | **27** |
| Other net (expenses)/income | (22) | 220 |  | 4 | 11 | (64) |
| **Loss before impairment** | **(598)** | **(715)** | **16** | **(140)** | **(193)** | **27** |
| Credit impairment charges | (1) |  |  | (13) | (5) |  |
| **Loss before tax** | **(599)** | **(715)** | **16** | **(153)** | **(198)** | **23** |
| Attributable loss | (698) | (198) |  | (63) | (159) | 60 |
| **Performance measures<sup>1</sup>** |  |  |  |  |  |  |
| Average allocated tangible equity (£bn) | 0.7 | 5.0 |  | (2.4) | 5.1 |  |
| **Balance sheet information<sup>1</sup>** | £bn | £bn |  |  |  |  |
| Total assets | 19.2 | 19.0 |  |  |  |  |
| Risk weighted assets | 8.6 | 11.0 |  |  |  |  |
| Period end allocated tangible equity | (0.2) | 5.5 |  |  |  |  |

---

 **2022 compared to 2021**

 **Income statement**

● **Loss before tax was £599m (2021: £715m)** 

● **Total income was an expense of £170m (2021: £261m)** primarily reflecting treasury items,
funding costs on legacy capital instruments and mark-to-market
losses on legacy investments, partially offset by hedge accounting
gains. Additionally, there was a £74m loss on sale arising
from disposals of Barclays' equity stake in Absa, and a
£72m interest expense that became payable to a US tax
authority upon the resolution of historical tax issues. This was
partially offset by a gain of £86m from the sale and leaseback
of UK data centres and the receipt of £30m of dividends from
Absa prior to disposal

● **Total operating expenses reduced to £406m (2021: £674m)** reflecting the
non-recurrence of the £266m structural cost action charge
taken as part of the real estate review in June
2021

● **Other net income was an expense of £22m (2021: £220m income)** driven by a fair value
loss on investments held by the Business Growth Fund in which
Barclays has an associate interest

 **Balance sheet**

● **RWAs reduced to £8.6bn (December 2021: £11.0bn)** reflecting the disposals of Barclays'
equity stake in Absa in April 2022 and September
2022

 *1* *2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

 **Quarterly Results Summary**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group** |  |  |  |  |  |  |  |  |
|  | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 2741 | 3068 | 2422 | 2341 | 2230 | 1940 | 2052 | 1851 |
| Net fee, commission and other income | 3060 | 2883 | 4286 | 4155 | 2930 | 3525 | 3363 | 4049 |
| **Total income** | **5801** | **5951** | **6708** | **6496** | **5160** | **5465** | **5415** | **5900** |
| Operating costs | (3748) | (3939) | (3682) | (3588) | (3514) | (3446) | (3587) | (3545) |
| UK bank levy | (176) |  |  |  | (170) |  |  |  |
| Litigation and conduct | (79) | 339 | (1334) | (523) | (92) | (129) | (143) | (33) |
| **Total operating expenses** | **(4003)** | **(3600)** | **(5016)** | **(4111)** | **(3776)** | **(3575)** | **(3730)** | **(3578)** |
| Other net income/(expenses) | 10 | (1) | 7 | (10) | 13 | 94 | 21 | 132 |
| **Profit before impairment** | **1808** | **2350** | **1699** | **2375** | **1397** | **1984** | **1706** | **2454** |
| Credit impairment (charges)/releases | (498) | (381) | (200) | (141) | 31 | (120) | 797 | (55) |
| **Profit before tax** | **1310** | **1969** | **1499** | **2234** | **1428** | **1864** | **2503** | **2399** |
| Tax credit/(charge) | 33 | (249) | (209) | (614) | (104) | (292) | (246) | (496) |
| **Profit after tax** | **1343** | **1720** | **1290** | **1620** | **1324** | **1572** | **2257** | **1903** |
| Non-controlling interests | (22) | (2) | (20) | (1) | (27) | (1) | (15) | (4) |
| Other equity instrument holders | (285) | (206) | (199) | (215) | (218) | (197) | (194) | (195) |
| **Attributable profit** | **1036** | **1512** | **1071** | **1404** | **1079** | **1374** | **2048** | **1704** |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average tangible shareholders' equity | 8.9% | 12.5% | 8.7% | 11.5% | 9.0% | 11.4% | 17.6% | 14.7% |
| Average tangible shareholders' equity (£bn) | 46.7 | 48.6 | 49.0 | 48.8 | 48.0 | 48.3 | 46.5 | 46.5 |
| Cost: income ratio | 69% | 60% | 75% | 63% | 73% | 65% | 69% | 61% |
| Loan loss rate (bps) | 49 | 36 | 20 | 15 | (3) | 13 | (90) | 6 |
| Basic earnings per share | 6.5p | 9.4p | 6.4p | 8.4p | 6.4p | 8.0p | 11.9p | 9.9p |
| Basic weighted average number of shares (m) | 15828 | 16148 | 16684 | 16682 | 16985 | 17062 | 17140 | 17293 |
| Period end number of shares (m) | 15871 | 15888 | 16531 | 16762 | 16752 | 16851 | 16998 | 17223 |
| **Balance sheet and capital management<sup>2</sup>** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 343.3 | 346.3 | 337.2 | 325.8 | 319.9 | 313.5 | 309.2 | 306.9 |
| Loans and advances to banks at amortised cost | 10.0 | 12.5 | 12.5 | 11.4 | 9.7 | 10.6 | 11.0 | 12.9 |
| Debt securities at amortised cost | 45.5 | 54.8 | 46.1 | 34.5 | 31.8 | 28.9 | 28.3 | 25.9 |
| **Loans and advances at amortised cost** | **398.8** | **413.7** | **395.8** | **371.7** | **361.5** | **353.0** | **348.5** | **345.8** |
| Loans and advances at amortised cost impairment coverage ratio | 1.4% | 1.4% | 1.4% | 1.5% | 1.6% | 1.7% | 1.8% | 2.2% |
| Total assets | 1513.7 | 1726.9 | 1589.2 | 1496.1 | 1384.3 | 1406.5 | 1376.3 | 1379.7 |
| Deposits at amortised cost | 545.8 | 574.4 | 568.7 | 546.5 | 519.4 | 510.2 | 500.9 | 498.8 |
| Tangible net asset value per share | 295p | 286p | 297p | 294p | 291p | 286p | 280p | 267p |
| Common equity tier 1 ratio | 13.9% | 13.8% | 13.6% | 13.8% | 15.1% | 15.3% | 15.0% | 14.6% |
| Common equity tier 1 capital | 46.9 | 48.6 | 46.7 | 45.3 | 47.3 | 47.2 | 46.2 | 45.9 |
| Risk weighted assets | 336.5 | 350.8 | 344.5 | 328.8 | 314.1 | 307.7 | 307.4 | 313.4 |
| UK leverage ratio | 5.3% | 5.0% | 5.1% | 5.0% | 5.2% | 5.1% | 5.0% | 5.0% |
| UK leverage exposure | 1130.0 | 1232.1 | 1151.2 | 1123.5 | 1137.9 | 1162.7 | 1154.9 | 1145.4 |
| Average UK leverage ratio | 4.8% | 4.8% | 4.7% | 4.8% | 4.9% | 4.9% | 4.8% | 4.9% |
| Average UK leverage exposure | 1281.0 | 1259.6 | 1233.5 | 1179.4 | 1229.0 | 1201.1 | 1192.7 | 1174.9 |
| **Funding and liquidity** |  |  |  |  |  |  |  |  |
| Group liquidity pool (£bn) | 318 | 326 | 343 | 320 | 291 | 293 | 291 | 290 |
| Liquidity coverage ratio | 165% | 151% | 156% | 159% | 168% | 161% | 162% | 161% |
| Net stable funding ratio<sup>3</sup> | 137% |  |  |  |  |  |  |  |
| Loan: deposit ratio | 73% | 72% | 70% | 68% | 70% | 69% | 70% | 69% |

---

---

| | |
|:---|:---|
| *1* | *The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |
| *2* | *Refer to pages 54 to 62 for further information on how capital, RWAs and leverage are calculated.* |
| *3* | *Represents average of the last four spot quarter end positions.* |

---

 **Quarterly Results by Business**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** |  |  |  |  |  |  |  |  |
|  | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 1600 | 1561 | 1393 | 1339 | 1313 | 1303 | 1305 | 1281 |
| Net fee, commission and other income | 370 | 355 | 331 | 310 | 386 | 335 | 318 | 295 |
| **Total income** | **1970** | **1916** | **1724** | **1649** | **1699** | **1638** | **1623** | **1576** |
| Operating costs | (1108) | (1069) | (1085) | (998) | (1202) | (1041) | (1078) | (1036) |
| UK bank levy | (26) |  |  |  | (36) |  |  |  |
| Litigation and conduct | (13) | (3) | (16) | (9) | (5) | (10) | (19) | (3) |
| **Total operating expenses** | **(1147)** | **(1072)** | **(1101)** | **(1007)** | **(1243)** | **(1051)** | **(1097)** | **(1039)** |
| Other net income/(expenses) | 1 | (1) |  |  | (1) | 1 |  |  |
| **Profit before impairment** | **824** | **843** | **623** | **642** | **455** | **588** | **526** | **537** |
| Credit impairment (charges)/releases | (157) | (81) |  | (48) | 59 | (137) | 520 | (77) |
| **Profit before tax** | **667** | **762** | **623** | **594** | **514** | **451** | **1046** | **460** |
| Attributable profit | 474 | 549 | 458 | 396 | 420 | 317 | 721 | 298 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 205.1 | 205.1 | 205.9 | 207.3 | 208.8 | 208.6 | 207.8 | 205.7 |
| Total assets | 313.2 | 316.8 | 318.8 | 317.2 | 321.2 | 312.1 | 311.2 | 309.1 |
| Customer deposits at amortised cost | 258.0 | 261.0 | 261.5 | 260.3 | 260.6 | 256.8 | 255.5 | 247.5 |
| Loan: deposit ratio | 87% | 86% | 85% | 85% | 85% | 86% | 87% | 88% |
| Risk weighted assets | 73.1 | 73.2 | 72.2 | 72.7 | 72.3 | 73.2 | 72.2 | 72.7 |
| Period end allocated tangible equity | 10.1 | 10.1 | 9.9 | 10.1 | 10.0 | 10.0 | 9.9 | 10.0 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 18.7% | 22.1% | 18.4% | 15.6% | 16.8% | 12.7% | 29.1% | 12.0% |
| Average allocated tangible equity (£bn) | 10.2 | 9.9 | 10.0 | 10.1 | 10.0 | 10.0 | 9.9 | 9.9 |
| Cost: income ratio | 58% | 56% | 64% | 61% | 73% | 64% | 68% | 66% |
| Loan loss rate (bps) | 27 | 14 |  | 9 | (10) | 24 | (93) | 14 |
| Net interest margin | 3.10% | 3.01% | 2.71% | 2.62% | 2.49% | 2.49% | 2.55% | 2.54% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays UK** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| Personal Banking | 1229 | 1212 | 1077 | 1022 | 983 | 990 | 987 | 923 |
| Barclaycard Consumer UK | 269 | 283 | 265 | 276 | 352 | 293 | 290 | 315 |
| Business Banking | 472 | 421 | 382 | 351 | 364 | 355 | 346 | 338 |
| **Total income** | **1970** | **1916** | **1724** | **1649** | **1699** | **1638** | **1623** | **1576** |
| **Analysis of credit impairment (charges)/releases** |  |  |  |  |  |  |  |  |
| Personal Banking | (120) | (26) | (42) | 21 | 8 | (30) | 72 | (22) |
| Barclaycard Consumer UK | (12) | 2 | 84 | (44) | 114 | (108) | 434 | (36) |
| Business Banking | (25) | (57) | (42) | (25) | (63) | 1 | 14 | (19) |
| **Total credit impairment (charges)/releases** | **(157)** | **(81)** | **—** | **(48)** | **59** | **(137)** | **520** | **(77)** |
| **Analysis of loans and advances to customers at amortised cost** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Personal Banking | 169.7 | 168.7 | 167.1 | 166.5 | 165.4 | 164.6 | 162.4 | 160.4 |
| Barclaycard Consumer UK | 9.2 | 9.0 | 8.8 | 8.4 | 8.7 | 8.6 | 8.8 | 8.7 |
| Business Banking | 26.2 | 27.4 | 30.0 | 32.4 | 34.7 | 35.4 | 36.6 | 36.6 |
| **Total loans and advances to customers at amortised cost** | **205.1** | **205.1** | **205.9** | **207.3** | **208.8** | **208.6** | **207.8** | **205.7** |
| **Analysis of customer deposits at amortised cost** |  |  |  |  |  |  |  |  |
| Personal Banking | 195.6 | 197.3 | 197.0 | 196.6 | 196.4 | 193.3 | 191.0 | 186.0 |
| Barclaycard Consumer UK |  |  |  |  |  |  | 0.1 | 0.1 |
| Business Banking | 62.4 | 63.7 | 64.5 | 63.7 | 64.2 | 63.5 | 64.4 | 61.4 |
| **Total customer deposits at amortised cost** | **258.0** | **261.0** | **261.5** | **260.3** | **260.6** | **256.8** | **255.5** | **247.5** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays International** |  |  |  |  |  |  |  |  |
|  | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 1465 | 1497 | 1029 | 936 | 955 | 749 | 811 | 748 |
| Net trading income | 1169 | 1328 | 2766 | 2446 | 789 | 1515 | 1455 | 1934 |
| Net fee, commission and other income | 1228 | 1240 | 1321 | 1442 | 1766 | 1673 | 1553 | 1717 |
| **Total income** | **3862** | **4065** | **5116** | **4824** | **3510** | **3937** | **3819** | **4399** |
| Operating costs | (2543) | (2776) | (2537) | (2505) | (2160) | (2310) | (2168) | (2438) |
| UK bank levy | (133) |  |  |  | (134) |  |  |  |
| Litigation and conduct | (67) | 396 | (1319) | (513) | (84) | (100) | (140) | (21) |
| **Total operating expenses** | **(2743)** | **(2380)** | **(3856)** | **(3018)** | **(2378)** | **(2410)** | **(2308)** | **(2459)** |
| Other net income | 5 | 10 | 5 | 8 | 3 | 15 | 13 | 9 |
| **Profit before impairment** | **1124** | **1695** | **1265** | **1814** | **1135** | **1542** | **1524** | **1949** |
| Credit impairment (charges)/releases | (328) | (295) | (209) | (101) | (23) | 18 | 271 | 22 |
| **Profit before tax** | **796** | **1400** | **1056** | **1713** | **1112** | **1560** | **1795** | **1971** |
| Attributable profit | 625 | 1136 | 783 | 1300 | 818 | 1191 | 1207 | 1431 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 133.7 | 137.0 | 126.7 | 113.9 | 106.4 | 99.9 | 96.3 | 97.1 |
| Loans and advances to banks at amortised cost | 8.7 | 11.0 | 11.3 | 10.2 | 8.4 | 9.4 | 9.9 | 12.0 |
| Debt securities at amortised cost | 27.2 | 36.2 | 29.3 | 20.7 | 19.0 | 16.6 | 15.7 | 14.4 |
| **Loans and advances at amortised cost** | **169.6** | **184.2** | **167.3** | **144.8** | **133.8** | **125.9** | **121.9** | **123.5** |
| Trading portfolio assets | 133.8 | 126.3 | 126.9 | 134.1 | 146.9 | 144.8 | 147.1 | 131.1 |
| Derivative financial instrument assets | 301.7 | 415.7 | 343.5 | 288.8 | 261.5 | 257.0 | 255.4 | 269.4 |
| Financial assets at fair value through the income statement | 210.5 | 244.7 | 209.3 | 203.8 | 188.2 | 200.5 | 190.4 | 197.5 |
| Cash collateral and settlement balances | 107.7 | 163.3 | 128.5 | 132.0 | 88.1 | 115.9 | 108.5 | 109.7 |
| Other assets | 258.0 | 257.2 | 275.1 | 255.5 | 225.6 | 231.8 | 223.5 | 221.7 |
| **Total assets** | **1181.3** | **1391.4** | **1250.6** | **1159.0** | **1044.1** | **1075.9** | **1046.8** | **1052.9** |
| Deposits at amortised cost | 287.6 | 313.2 | 307.4 | 286.1 | 258.8 | 253.3 | 245.4 | 251.2 |
| Derivative financial instrument liabilities | 288.9 | 394.2 | 321.2 | 277.2 | 256.4 | 252.3 | 246.9 | 260.2 |
| Loan: deposit ratio | 59% | 59% | 54% | 51% | 52% | 50% | 50% | 49% |
| Risk weighted assets | 254.8 | 269.3 | 263.8 | 245.1 | 230.9 | 222.7 | 223.2 | 230.0 |
| Period end allocated tangible equity | 36.8 | 38.8 | 38.0 | 35.6 | 33.2 | 31.8 | 31.8 | 32.7 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 6.4% | 11.6% | 8.4% | 14.8% | 9.9% | 14.9% | 14.9% | 17.7% |
| Average allocated tangible equity (£bn) | 38.9 | 39.1 | 37.3 | 35.1 | 32.9 | 31.8 | 32.4 | 32.3 |
| Cost: income ratio | 71% | 59% | 75% | 63% | 68% | 61% | 60% | 56% |
| Loan loss rate (bps) | 75 | 62 | 49 | 28 | 7 | (6) | (87) | (7) |
| Net interest margin | 5.71% | 5.58% | 4.52% | 4.15% | 4.14% | 4.02% | 3.96% | 3.92% |

---

---

| | |
|:---|:---|
| *1* | *The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays International** |  |  |  |  |  |  |  |  |
| **Corporate and Investment Bank** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 548 | 606 | 410 | 385 | 432 | 279 | 370 | 270 |
| Net trading income | 1201 | 1344 | 2738 | 2450 | 774 | 1467 | 1494 | 1917 |
| Net fee, commission and other income | 827 | 871 | 885 | 1103 | 1426 | 1383 | 1115 | 1407 |
| **Total income** | **2576** | **2821** | **4033** | **3938** | **2632** | **3129** | **2979** | **3594** |
| Operating costs | (1796) | (2043) | (1870) | (1921) | (1562) | (1747) | (1623) | (1886) |
| UK bank levy | (126) |  |  |  | (128) |  |  |  |
| Litigation and conduct | (55) | 498 | (1314) | (318) | (59) | (99) | (78) | (1) |
| **Total operating expenses** | **(1977)** | **(1545)** | **(3184)** | **(2239)** | **(1749)** | **(1846)** | **(1701)** | **(1887)** |
| Other net income | 2 |  |  |  | 1 |  |  | 1 |
| **Profit before impairment** | **601** | **1276** | **849** | **1699** | **884** | **1283** | **1278** | **1708** |
| Credit impairment (charges)/releases | (41) | (46) | (65) | 33 | 73 | 128 | 229 | 43 |
| **Profit before tax** | **560** | **1230** | **784** | **1732** | **957** | **1411** | **1507** | **1751** |
| Attributable profit | 454 | 1015 | 579 | 1316 | 695 | 1085 | 989 | 1263 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 90.5 | 93.6 | 86.5 | 79.5 | 73.4 | 68.3 | 66.3 | 68.5 |
| Loans and advances to banks at amortised cost | 8.1 | 10.2 | 10.0 | 9.4 | 7.6 | 8.9 | 9.0 | 11.4 |
| Debt securities at amortised cost | 27.2 | 36.2 | 29.3 | 20.7 | 19.0 | 16.6 | 15.7 | 14.4 |
| **Loans and advances at amortised cost** | **125.8** | **140.0** | **125.8** | **109.6** | **100.0** | **93.8** | **91.0** | **94.3** |
| Trading portfolio assets | 133.7 | 126.1 | 126.7 | 134.0 | 146.7 | 144.7 | 147.0 | 130.9 |
| Derivative financial instruments assets | 301.6 | 415.5 | 343.4 | 288.7 | 261.5 | 256.9 | 255.3 | 269.4 |
| Financial assets at fair value through the income statement | 210.5 | 244.6 | 209.2 | 203.8 | 188.1 | 200.4 | 190.3 | 197.3 |
| Cash collateral and settlement balances | 106.9 | 162.6 | 127.7 | 131.2 | 87.2 | 115.1 | 107.7 | 108.8 |
| Other assets | 222.6 | 220.6 | 237.2 | 222.5 | 195.8 | 200.4 | 192.5 | 190.8 |
| **Total assets** | **1101.1** | **1309.4** | **1170.0** | **1089.8** | **979.3** | **1011.3** | **983.8** | **991.5** |
| Deposits at amortised cost | 205.8 | 229.5 | 229.5 | 214.7 | 189.4 | 185.8 | 178.2 | 185.2 |
| Derivative financial instrument liabilities | 288.9 | 394.2 | 321.2 | 277.1 | 256.4 | 252.2 | 246.8 | 260.2 |
| Risk weighted assets | 215.9 | 230.6 | 227.6 | 213.5 | 200.7 | 192.5 | 194.3 | 201.3 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 5.4% | 11.9% | 7.1% | 17.1% | 9.7% | 15.6% | 14.0% | 17.9% |
| Average allocated tangible equity (£bn) | 33.7 | 34.0 | 32.7 | 30.8 | 28.7 | 27.8 | 28.4 | 28.2 |
| Cost: income ratio | 77% | 55% | 79% | 57% | 66% | 59% | 57% | 53% |
| Loan loss rate (bps) | 13 | 13 | 20 | (12) | (29) | (54) | (100) | (18) |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| FICC | 976 | 1546 | 1529 | 1644 | 546 | 803 | 895 | 1204 |
| Equities | 440 | 246 | 1411 | 1052 | 501 | 757 | 777 | 932 |
| **Global Markets** | **1416** | **1792** | **2940** | **2696** | **1047** | **1560** | **1672** | **2136** |
| Advisory | 197 | 150 | 236 | 185 | 287 | 253 | 218 | 163 |
| Equity capital markets | 40 | 42 | 37 | 47 | 158 | 186 | 226 | 243 |
| Debt capital markets | 243 | 341 | 281 | 416 | 511 | 532 | 429 | 453 |
| **Investment Banking fees** | **480** | **533** | **554** | **648** | **956** | **971** | **873** | **859** |
| Corporate lending | (128) | (181) | (47) | 125 | 176 | 168 | 38 | 206 |
| Transaction banking | 808 | 677 | 586 | 469 | 453 | 430 | 396 | 393 |
| **Corporate** | **680** | **496** | **539** | **594** | **629** | **598** | **434** | **599** |
| **Total income** | **2576** | **2821** | **4033** | **3938** | **2632** | **3129** | **2979** | **3594** |

---

---

| | |
|:---|:---|
| *1* | *The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays International** |  |  |  |  |  |  |  |  |
| **Consumer, Cards and Payments** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 918 | 891 | 619 | 551 | 522 | 471 | 441 | 478 |
| Net fee, commission, trading and other income | 368 | 353 | 464 | 335 | 356 | 337 | 399 | 327 |
| **Total income** | **1286** | **1244** | **1083** | **886** | **878** | **808** | **840** | **805** |
| Operating costs | (747) | (733) | (667) | (584) | (598) | (563) | (545) | (552) |
| UK bank levy | (7) |  |  |  | (6) |  |  |  |
| Litigation and conduct | (12) | (102) | (5) | (195) | (25) | (1) | (62) | (20) |
| **Total operating expenses** | **(766)** | **(835)** | **(672)** | **(779)** | **(629)** | **(564)** | **(607)** | **(572)** |
| Other net income | 3 | 10 | 5 | 8 | 2 | 15 | 13 | 8 |
| **Profit before impairment** | **523** | **419** | **416** | **115** | **251** | **259** | **246** | **241** |
| Credit impairment (charges)/releases | (287) | (249) | (144) | (134) | (96) | (110) | 42 | (21) |
| **Profit/(loss) before tax** | **236** | **170** | **272** | **(19)** | **155** | **149** | **288** | **220** |
| Attributable profit/(loss) | 171 | 121 | 204 | (16) | 123 | 106 | 218 | 168 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 43.2 | 43.4 | 40.2 | 34.4 | 33.0 | 31.6 | 30.0 | 28.6 |
| Total assets | 80.2 | 82.0 | 80.6 | 69.2 | 64.8 | 64.6 | 63.0 | 61.4 |
| Deposits at amortised cost | 81.8 | 83.7 | 77.9 | 71.4 | 69.4 | 67.5 | 67.2 | 66.0 |
| Risk weighted assets | 38.9 | 38.7 | 36.2 | 31.6 | 30.2 | 30.2 | 29.0 | 28.8 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 13.0% | 9.5% | 17.8% | (1.5)% | 11.7% | 10.5% | 21.8% | 16.5% |
| Average allocated tangible equity (£bn) | 5.2 | 5.1 | 4.6 | 4.3 | 4.2 | 4.0 | 4.0 | 4.1 |
| Cost: income ratio | 60% | 67% | 62% | 88% | 72% | 70% | 72% | 71% |
| Loan loss rate (bps) | 245 | 211 | 132 | 145 | 105 | 127 | (49) | 27 |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| International Cards and Consumer Bank | 860 | 824 | 691 | 538 | 552 | 490 | 517 | 533 |
| Private Bank | 285 | 270 | 245 | 214 | 200 | 188 | 214 | 179 |
| Payments | 141 | 150 | 147 | 134 | 126 | 130 | 109 | 93 |
| **Total income** | **1286** | **1244** | **1083** | **886** | **878** | **808** | **840** | **805** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Head Office** |  |  |  |  |  |  |  |  |
|  | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | (324) | 10 |  | 66 | (38) | (112) | (64) | (178) |
| Net fee, commission and other income | 293 | (40) | (132) | (43) | (11) | 2 | 37 | 103 |
| **Total income** | **(31)** | **(30)** | **(132)** | **23** | **(49)** | **(110)** | **(27)** | **(75)** |
| Operating costs | (97) | (94) | (60) | (85) | (152) | (95) | (341) | (71) |
| UK bank levy | (17) |  |  |  |  |  |  |  |
| Litigation and conduct | 1 | (54) | 1 | (1) | (3) | (19) | 16 | (9) |
| **Total operating expenses** | **(113)** | **(148)** | **(59)** | **(86)** | **(155)** | **(114)** | **(325)** | **(80)** |
| Other net income/(expenses) | 4 | (10) | 2 | (18) | 11 | 78 | 8 | 123 |
| **Loss before impairment** | **(140)** | **(188)** | **(189)** | **(81)** | **(193)** | **(146)** | **(344)** | **(32)** |
| Credit impairment (charges)/releases | (13) | (5) | 9 | 8 | (5) | (1) | 6 |  |
| **Loss before tax** | **(153)** | **(193)** | **(180)** | **(73)** | **(198)** | **(147)** | **(338)** | **(32)** |
| Attributable (loss)/profit | (63) | (173) | (170) | (292) | (159) | (134) | 120 | (25) |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Total assets | 19.2 | 18.7 | 19.8 | 19.9 | 19.0 | 18.5 | 18.3 | 17.7 |
| Risk weighted assets<sup>1</sup> | 8.6 | 8.2 | 8.6 | 11.0 | 11.0 | 11.8 | 12.0 | 10.7 |
| Period end allocated tangible equity<sup>1</sup> | (0.2) | (3.5) | 1.1 | 3.6 | 5.5 | 6.3 | 5.9 | 3.3 |
| **Performance measures<sup>1</sup>** |  |  |  |  |  |  |  |  |
| Average allocated tangible equity (£bn) | (2.4) | (0.4) | 1.7 | 3.6 | 5.1 | 6.5 | 4.2 | 4.3 |

---

---

| | |
|:---|:---|
| *1* | *The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.* |

---

 **Performance Management**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Margins and balances** | **Margins and balances** | **Margins and balances** | **Margins and balances** | **Margins and balances** | **Margins and balances** | **Margins and balances** |
|  | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.21** | **Year ended 31.12.21** | **Year ended 31.12.21** |
|  | **Net interest income** | **Average customer assets** | **Net interest margin** | **Net interest income** | **Average customer assets** | **Net interest margin** |
|  | £m | £m | % | £m | £m | % |
| Barclays UK | 5893 | 205972 | 2.86 | 5202 | 206628 | 2.52 |
| Corporate and Investment Bank<sup>1</sup> | 1796 | 56008 | 3.21 | 1238 | 47725 | 2.59 |
| Consumer, Cards and Payments | 2979 | 39193 | 7.60 | 1911 | 30805 | 6.21 |
| Barclays International<sup>1</sup> | 4775 | 95201 | 5.02 | 3149 | 78530 | 4.01 |
| **Total Barclays UK and Barclays International** | **10668** | **301173** | **3.54** | **8351** | **285158** | **2.93** |
| Other<sup>2</sup> | (96) |  |  | (278) |  |  |
| **Total Barclays Group** | **10572** |  |  | **8073** |  |  |

---

---

| | |
|:---|:---|
| *1* | *CIB and Barclays International margins include the lending related investment bank business.* |
| *2* | *Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.* |

---

The Group NIM increased 61bps to 3.54%. Barclays UK NIM increased 34bps to 2.86%, reflecting the impact of higher UK interest rates. Barclays International NIM increased 101bps to 5.02%. CIB NIM increased 62bps to 3.21% and CC&P NIM increased 139bps to 7.60%, reflecting the impact of balance growth and higher interest rates.

The Group's combined product and equity structural hedge notional as at 31 December 2022 was £263bn (31 December 2021: £228bn), with an average duration of approximately 2.5 years (2021: average duration close to 3 years). Gross structural hedge contributions of £2,196m (2021: £1,415m) and net structural hedge contributions of £(1,544)m (2021: £1,187m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.

---

| | | | |
|:---|:---|:---|:---|
| **Quarterly analysis for Barclays UK and Barclays International** | **Net interest income** | <br> **Average customer assets** | **Net interest margin** |
| **Three months ended 31.12.22** | £m | £m | % |
| Barclays UK | 1600 | 204941 | 3.10 |
| Corporate and Investment Bank | 556 | 59146 | 3.73 |
| Consumer, Cards and Payments | 918 | 43319 | 8.40 |
| Barclays International<sup>1</sup> | 1474 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102465 | 5.71 |
| **Total Barclays UK and Barclays International** | **3074** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **307406** | **3.97** |
| **Three months ended 30.09.22** |  |  |  |
| Barclays UK | 1561 | 205881 | 3.01 |
| Corporate and Investment Bank | 529 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58891 | 3.56 |
| Consumer, Cards and Payments | 891 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42019 | 8.41 |
| Barclays International<sup>1</sup> | 1420 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100910 | 5.58 |
| **Total Barclays UK and Barclays International** | **2981** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **306791** | **3.85** |
| **Three months ended 30.06.22** |  |  |  |
| Barclays UK | 1393 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 205834 | 2.71 |
| Corporate and Investment Bank | 397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 55181 | 2.88 |
| Consumer, Cards and Payments | 619 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37190 | 6.68 |
| Barclays International<sup>1</sup> | 1016 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 92371 | 4.41 |
| **Total Barclays UK and Barclays International** | **2409** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **298205** | **3.24** |
| **Three months ended 31.03.22** |  |  |  |
| Barclays UK | 1339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 207607 | 2.62 |
| Corporate and Investment Bank | 316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50798 | 2.52 |
| Consumer, Cards and Payments | 551 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34040 | 6.56 |
| Barclays International<sup>1</sup> | 867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 84838 | 4.15 |
| **Total Barclays UK and Barclays International** | **2206** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **292445** | **3.06** |
| **Three months ended 31.12.21** |  |  |  |
| Barclays UK | 1313 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 209064 | 2.49 |
| Corporate and Investment Bank | 326 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48310 | 2.67 |
| Consumer, Cards and Payments | 522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32934 | 6.29 |
| Barclays International<sup>1</sup> | 848 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81244 | 4.14 |
| **Total Barclays UK and Barclays International** | **2161** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **290308** | **2.95** |

---

 *1* *Barclays International margins include the lending related investment bank business.*

 **Remuneration**

Deferred bonuses are payable only once an employee meets certain conditions, including a specified period of future service. This creates a timing difference between the communication of the bonus pool and the charges that are recognised in the income statement which are reconciled in the table below to show the charge for performance costs. Refer to the Remuneration Report on pages 197 to 245 of the Barclays PLC Annual Report 2022 for further detail on remuneration. The table below includes the other elements of compensation and staff costs.

---

| | | | |
|:---|:---|:---|:---|
|  | **Year ended 31.12.22**<br>£m | **Year ended 31.12.21**<br>£m | % Change |
| **Incentive awards granted:** |  |  |  |
| Current year bonus | 1241 | 1278 | 3 |
| Deferred bonus | 549 | 667 | 18 |
| **Total incentive awards granted** | **1790** | **1945** | **8** |
| **Reconciliation of incentive awards granted to income statement charge:** |  |  |  |
| Less: deferred bonuses granted but not charged in current year | (388) | (457) | 15 |
| Add: current year charges for deferred bonuses from previous years | 399 | 280 | (43) |
| Other differences between incentive awards granted and income statement charge | 35 | (23) | 252 |
| **Income statement charge for performance costs** | **1836** | **1745** | **(5)** |
| **Other income statement charges:** |  |  |  |
| Salaries | 4732 | 4290 | (10) |
| Social security costs | 714 | 619 | (15) |
| Post-retirement benefits<sup>1</sup> | 563 | 539 | (4) |
| Other compensation costs | 504 | 431 | (17) |
| **Total compensation costs<sup>2</sup>** | **8349** | **7624** | **(10)** |
| **Other resourcing costs** |  |  |  |
| Outsourcing | 607 | 357 | (70) |
| Redundancy and restructuring | (7) | 296 | 102 |
| Temporary staff costs | 113 | 109 | (4) |
| Other | 190 | 125 | (52) |
| **Total other resourcing costs** | **903** | **887** | **(2)** |
| **Total staff costs** | **9252** | **8511** | **(9)** |
| **Group compensation costs as a % of total income** | **33.5** | **34.7** |  |
| **Group staff costs as a % of total income** | **37.1** | **38.8** |  |

---

One of the primary considerations for performance costs are Group and business level returns, alongside other financial and non-financial measures, including strategic delivery, risk and conduct, aligning colleague, shareholder and wider stakeholder interests.

---

| | |
|:---|:---|
| *1* | *Post-retirement benefits charge includes £313m (2021: £289m) in respect of defined contribution schemes and £250m (2021: £250m) in respect of defined benefit schemes.* |
| *2* | *£604m (2021: £484m) of Group compensation was capitalised as internally generated software and excluded from the Staff cost disclosed above.* |

---

Deferred bonuses have been awarded and are expected to be charged to the income statement in the years outlined in the table that follows:

 **Year in which income statement charge is expected to be taken for deferred bonuses awarded to date<sup>1</sup>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Actual** | **Actual** | **Expected<sup>1, 2</sup>** | **Expected<sup>1, 2</sup>** |
|  | | | **Year ended** | **2024 and** |
|  | | | **31.12.23** | **beyond** |
|  | **Year ended**<br>**31.12.21**<br>£m | **Year ended**<br>**31.12.22**<br>£m | £m | £m |
| **Deferred bonuses from 2019 and earlier bonus pools** | 141 | 52 | 50 |  |
| Deferred bonuses from 2020 bonus pool | 139 | 133 | 55 | 10 |
| Deferred bonuses from 2021 bonus pool | 210 | 214 | 165 | 102 |
| Deferred bonuses from 2022 bonus pool |  | 161 | 152 | 177 |
| **Income statement charge for deferred bonuses** | **490** | **560** | **422** | **289** |

---

---

| | |
|:---|:---|
| *1* | *The actual amount charged depends upon whether conditions have been met and may vary compared with the above expectation.* |
| *2* | *Does not include the impact of grants which will be made in 2023 and beyond.* |

---

 **Charging of deferred bonus profile<sup>1</sup>**

---

| | | | |
|:---|:---|:---|:---|
| **Grant date** | **Expected payment date(s)<sup>2</sup> and percentage of the deferred bonus paid** | **Year** | **Income statement charge % profile of 2022 onwards<sup>3,4</sup>** |
| March 2023 |  | 2022 | 33% |
|  |  | 2023 | 31% |
|  | March 2024 (33.3%) | 2024 | 21% |
|  | March 2025 (33.3%) | 2025 | 13% |
|  | March 2026 (33.3%) | 2026 | 2% |

---

---

| | |
|:---|:---|
| *1* | *Represents a typical vesting schedule for deferred awards. Certain awards may be subject to a 3, 4, 5 or 7 year deferral in line with regulatory requirements.* |
| *2* | *Share awards may be subject to an additional holding period.* |
| *3* | *The income statement charge is based on the period over which conditions are met.* |
| *4* | *Income statement charge profile % disclosed as a percentage of the award excluding lapse. The percentages have changed from last year due to introduction of 4 year awards.* |

---

 **Risk Management**

 **Risk management and principal risks**

The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking.

The framework identifies nine principal risks: credit risk, market risk, treasury and capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Further detail on the Group's principal risks and previously identified material existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual Report 2022, or online at home.barclays/annualreport.

The following section gives an overview of credit risk, market risk, and treasury and capital risk for the period.

 **Credit Risk**

 **Loans and advances at amortised cost by stage**

The table below presents a stage allocation and business segment analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio as at 31 December 2022. Also included are stage allocation of off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage as at 31 December 2022.

Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Net exposure** |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Net exposure** |
| **As at 31.12.22** | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| Barclays UK | 160424 | 24837 | 2711 | 187972 | 232 | 718 | 485 | 1435 | 186537 |
| Barclays International | 33735 | 4399 | 1793 | 39927 | 392 | 1200 | 949 | 2541 | 37386 |
| Head Office | 3644 | 252 | 661 | 4557 | 3 | 24 | 359 | 386 | 4171 |
| **Total Barclays Group retail** | **197803** | **29488** | **5165** | **232456** | **627** | **1942** | **1793** | **4362** | **228094** |
| Barclays UK | 34858 | 2954 | 805 | 38617 | 129 | 109 | 96 | 334 | 38283 |
| Barclays International | 117692 | 14298 | 1098 | 133088 | 301 | 265 | 312 | 878 | 132210 |
| Head Office | 192 |  | 18 | 210 |  |  | 18 | 18 | 192 |
| **Total Barclays Group wholesale<sup>1</sup>** | **152742** | **17252** | **1921** | **171915** | **430** | **374** | **426** | **1230** | **170685** |
| **Total loans and advances at amortised cost** | **350545** | **46740** | **7086** | **404371** | **1057** | **2316** | **2219** | **5592** | **398779** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 372945 | 30694 | 1180 | 404819 | 245 | 315 | 23 | 583 | 404236 |
| **Total<sup>3</sup>** | **723490** | **77434** | **8266** | **809190** | **1302** | **2631** | **2242** | **6175** | **803015** |
|  | **As at 31.12.22** | **As at 31.12.22** | **As at 31.12.22** | **As at 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** |  |
|  | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** |  |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Loan impairment charge/(release)** | **Loan impairment charge/(release)** | **Loan loss rate** | **Loan loss rate** |  |
|  | % | % | % | % | £m | £m | bps | bps |  |
| Barclays UK | 0.1 | 2.9 | 17.9 | 0.8 |  | 169 |  | 9 |  |
| Barclays International | 1.2 | 27.3 | 52.9 | 6.4 |  | 763 |  | 191 |  |
| Head Office | 0.1 | 9.5 | 54.3 | 8.5 |  |  |  |  |  |
| **Total Barclays Group retail** | **0.3** | **6.6** | **34.7** | **1.9** |  | **932** |  | **40** |  |
| Barclays UK | 0.4 | 3.7 | 11.9 | 0.9 |  | 106 |  | 27 |  |
| Barclays International | 0.3 | 1.9 | 28.4 | 0.7 |  | 127 |  | 10 |  |
| Head Office |  |  | 100 | 8.6 |  |  |  |  |  |
| **Total Barclays Group wholesale<sup>1</sup>** | **0.3** | **2.2** | **22.2** | **0.7** |  | **233** |  | **14** |  |
| **Total loans and advances at amortised cost** | **0.3** | **5.0** | **31.3** | **1.4** |  | **1165** |  | **29** |  |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 0.1 | 1.0 | 1.9 | 0.1 |  | 18 |  |  |  |
| Other financial assets subject to impairment<sup>3</sup> |  |  |  |  |  | 37 |  |  |  |
| **Total<sup>4</sup>** | **0.2** | **3.4** | **27.1** | **0.8** |  | **1220** |  |  |  |

---

---

| | |
|:---|:---|
| *1* | *Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6.6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.8bn of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure.* |
| *2* | *Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.* |
| *3* | *Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises £10m ECL on £178.4bn Stage 1 assets, £9m on £1.5bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £144m on £149m Stage 3 other assets.* |
| *4* | *The loan loss rate is 30bps after applying the total impairment charge of £1,220m.* |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Net exposure** |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Net exposure** |
| **As at 31.12.21** | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| Barclays UK | 160695 | 22779 | 2915 | 186389 | 261 | 949 | 728 | 1938 | 184451 |
| Barclays International | 25981 | 2691 | 1566 | 30238 | 603 | 795 | 858 | 2256 | 27982 |
| Head Office | 3735 | 429 | 705 | 4869 | 2 | 36 | 347 | 385 | 4484 |
| **Total Barclays Group retail** | **190411** | **25899** | **5186** | **221496** | **866** | **1780** | **1933** | **4579** | **216917** |
| Barclays UK | 35571 | 1917 | 969 | 38457 | 153 | 43 | 111 | 307 | 38150 |
| Barclays International | 92341 | 13275 | 1059 | 106675 | 187 | 192 | 458 | 837 | 105838 |
| Head Office | 542 | 2 | 21 | 565 |  |  | 19 | 19 | 546 |
| **Total Barclays Group wholesale<sup>1</sup>** | **128454** | **15194** | **2049** | **145697** | **340** | **235** | **588** | **1163** | **144534** |
| **Total loans and advances at amortised cost** | **318865** | **41093** | **7235** | **367193** | **1206** | **2015** | **2521** | **5742** | **361451** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 312142 | 34815 | 1298 | 348255 | 217 | 302 | 23 | 542 | 347713 |
| **Total<sup>3</sup>** | **631007** | **75908** | **8533** | **715448** | **1423** | **2317** | **2544** | **6284** | **709164** |
|  | **As at 31.12.21** | **As at 31.12.21** | **As at 31.12.21** | **As at 31.12.21** | **Year ended 31.12.21** | **Year ended 31.12.21** | **Year ended 31.12.21** | **Year ended 31.12.21** |  |
|  | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** | **Loan impairment charge/(release) and loan loss rate** |  |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Loan impairment charge/(release)** | **Loan impairment charge/(release)** | **Loan loss rate** | **Loan loss rate** |  |
|  | % | % | % | % | £m | £m | bps | bps |  |
| Barclays UK | 0.2 | 4.2 | 25.0 | 1.0 |  | (227) |  |  |  |
| Barclays International | 2.3 | 29.5 | 54.8 | 7.5 |  | 181 |  | 60 |  |
| Head Office | 0.1 | 8.4 | 49.2 | 7.9 |  |  |  |  |  |
| **Total Barclays Group retail** | **0.5** | **6.9** | **37.3** | **2.1** |  | **(46)** |  | **—** |  |
| Barclays UK | 0.4 | 2.2 | 11.5 | 0.8 |  | 122 |  | 32 |  |
| Barclays International | 0.2 | 1.4 | 43.2 | 0.8 |  | (197) |  |  |  |
| Head Office |  |  | 90.5 | 3.4 |  |  |  |  |  |
| **Total Barclays Group wholesale<sup>1</sup>** | **0.3** | **1.5** | **28.7** | **0.8** |  | **(75)** |  | **—** |  |
| **Total loans and advances at amortised cost** | **0.4** | **4.9** | **34.8** | **1.6** |  | **(121)** |  | **—** |  |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 0.1 | 0.9 | 1.8 | 0.2 |  | (514) |  |  |  |
| Other financial assets subject to impairment<sup>3</sup> |  |  |  |  |  | (18) |  |  |  |
| **Total** | **0.2** | **3.1** | **29.8** | **0.9** |  | **(653)** |  |  |  |

---

---

| | |
|:---|:---|
| *1* | *Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLS of £9.4bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £6.0bn of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure.* |
| *2* | *Excludes loan commitments and financial guarantees of £18.8bn carried at fair value.* |
| *3* | *Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157m Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances and £107m on £110m Stage 3 other assets.* |

---

 **Loans and advances at amortised cost by product**

The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Stage 2** | **Stage 2** | **Stage 2** | **Stage 2** |  |  |
| **As at 31.12.22** | **Stage 1** | **Not past due** | **<=30 days past due** | **>30 days past due** | **Total** | **Stage 3** | **Total** |
| **Gross exposure** | £m | £m | £m | £m | £m | £m | £m |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 153672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15990 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1684 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18200 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2414 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 174286 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44175 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 576 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8099 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2122 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 54396 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 152698 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2550 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175689 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **350545** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **43310** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2231** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1199** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **46740** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7086** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **404371** |
| **Impairment allowance** |  |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 53 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 73 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 414 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 516 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 582 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1483 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 129 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 220 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1832 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3692 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 403 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 527 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1384 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1057** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1939** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **146** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **231** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2316** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2219** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5592** |
| **Net exposure** |  |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 153643 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15937 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 517 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18127 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173770 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 43593 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5643 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 268 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 356 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6267 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 844 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50704 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 152252 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19791 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20030 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 174305 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **349488** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **41371** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2085** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **968** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **44424** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4867** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **398779** |
| **Coverage ratio** | % | % | % | % | % | % | % |
| Home loans |  | 0.3 | 0.7 | 1.7 | 0.4 | 17.1 | 0.3 |
| Credit cards, unsecured loans and other retail lending | 1.3 | 20.8 | 32.5 | 38.2 | 22.6 | 60.2 | 6.8 |
| Wholesale loans | 0.3 | 2.0 | 4.0 | 2.1 | 2.0 | 20.7 | 0.8 |
| **Total** | **0.3** | **4.5** | **6.5** | **19.3** | **5.0** | **31.3** | **1.4** |
| **As at 31.12.21** |  |  |  |  |  |  |  |
| **Gross exposure** | £m | £m | £m | £m | £m | £m | £m |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 148058 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1660 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 707 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2122 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 169680 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37840 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5102 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5650 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45822 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 132967 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15246 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 306 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 391 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15943 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2781 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 151691 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **318865** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **37481** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2266** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1346** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **41093** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7235** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **367193** |
| **Impairment allowance** |  |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 475 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 824 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 85 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 123 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1504 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4029 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 363 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 620 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1238 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1206** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1787** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **95** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **133** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2015** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2521** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5742** |
| **Net exposure** |  |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 148039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17087 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1654 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 700 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1725 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 169205 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37016 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3609 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 215 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 125 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3949 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 828 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41793 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 132604 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14998 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 388 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15688 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150453 |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **317659** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **35694** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2171** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1213** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **39078** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4714** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **361451** |
| **Coverage ratio** | % | % | % | % | % | % | % |
| Home loans |  | 0.3 | 0.4 | 1.0 | 0.3 | 18.7 | 0.3 |
| Credit cards, unsecured loans and other retail lending | 2.2 | 29.3 | 28.3 | 49.6 | 30.1 | 64.5 | 8.8 |
| Wholesale loans | 0.3 | 1.6 | 1.3 | 0.8 | 1.6 | 22.3 | 0.8 |
| **Total** | **0.4** | **4.8** | **4.2** | **9.9** | **4.9** | **34.8** | **1.6** |

---

 **Loans and advances at amortised cost by selected sectors**

The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised cost with stage allocation for selected industry sectors within the wholesale loans portfolio. As the nature of macroeconomic uncertainty has evolved from the COVID-19 pandemic towards high inflation, supply chain constraints and consumer demand headwinds, so has the selected population under management focus. The credit risk industry concentration disclosure in the analysis of the concentration of credit risk section represents all the industry categories and the below only covers a subset of that table.

The gross loans and advances to selected sectors has decreased during the year. The increased provision is informed by the current macroeconomic outlook and underlying portfolio performance. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against credit losses. An additional £115m (December 2021: £123m) impairment allowance has been applied to the undrawn exposures not included in the table below.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** |
| **As at 31.12.22** | £m | £m | £m | £m | £m | £m | £m | £m |
| Autos | 881 | 194 | 31 | 1106 | 6 | 5 | 6 | 17 |
| Consumer manufacture | 3845 | 1729 | 199 | 5773 | 45 | 41 | 46 | 132 |
| Discretionary retail and wholesale | 5143 | 1711 | 249 | 7103 | 41 | 37 | 51 | 129 |
| Hospitality and leisure | 3902 | 1316 | 429 | 5647 | 40 | 31 | 70 | 141 |
| Passenger travel | 744 | 267 | 51 | 1062 | 9 | 7 | 13 | 29 |
| Real estate | 13042 | 3049 | 499 | 16590 | 91 | 66 | 123 | 280 |
| Steel and aluminium manufacturers | 486 | 85 | 18 | 589 | 7 | 1 | 8 | 16 |
| **Total** | **28043** | **8351** | **1476** | **37870** | **239** | **188** | **317** | **744** |
| Total of wholesale exposures (%) | 18% | 41% | 58% | 22% | 54% | 46% | 60% | 54% |
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** |
| **As at 31.12.21** | £m | £m | £m | £m | £m | £m | £m | £m |
| Autos | 656 | 295 | 2 | 953 | 3 | 3 |  | 6 |
| Consumer manufacture | 3904 | 1304 | 211 | 5419 | 18 | 22 | 43 | 83 |
| Discretionary retail and wholesale | 5413 | 1197 | 230 | 6840 | 47 | 20 | 54 | 121 |
| Hospitality and leisure | 4348 | 1613 | 384 | 6345 | 28 | 33 | 44 | 105 |
| Passenger travel | 856 | 285 | 143 | 1284 | 30 | 8 | 40 | 78 |
| Real estate | 13620 | 3314 | 518 | 17452 | 65 | 53 | 93 | 211 |
| Steel and aluminium manufacturers | 415 | 75 | 6 | 496 | 2 | 3 | 1 | 6 |
| **Total** | **29212** | **8083** | **1494** | **38789** | **193** | **142** | **275** | **610** |
| Total of wholesale exposures (%) | 22% | 51% | 54% | 26% | 53% | 56% | 44% | 49% |

---

Exposure to UK Commercial Real Estate (CRE) of £9.7bn (2021: £10bn<sup>1</sup>) remained stable and was predominantly in Stage 1 at 81% (2021: 78%). The loan portfolio was well collateralised, hence a low coverage of 1.1% (ECL: £0.1bn). Exposure at Stage 3 was 2% (2021: 3%) with a coverage ratio of 12% (2021: 18%).

However, UK CRE has been included within selected sector scoping as the broader real estate sector remains under pressure due to pricing and affordability concerns, as well as construction input costs and supply chain issues adding to the uncertainty, in particular across non-investment grade exposures.

The coverage ratio for selected sectors has increased from 1.6% as at 31 December 2021 to 2.0% as at 31 December 2022. Non-default coverage ratio has increased from 0.9% as at 31 December 2021 to 1.2% as at 31 December 2022.

 *1* *From 2022, Barclays has enhanced the process of identifying UK CRE exposures.*

 **Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees**

The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays PLC Annual Report 2022. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 12-month period.

 **Loans and advances at amortised cost**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Stage 1** | **Stage 1** | **Stage 2** | **Stage 2** | **Stage 3** | **Stage 3** | **Total** | **Total** |
|  | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** |
| **Home loans** | £m | £m | £m | £m | £m | £m | £m | £m |
| **As at 1 January 2022** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 148058 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2122 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 169680 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 475 |
| Transfers from Stage 1 to Stage 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8747) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8747 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers from Stage 2 to Stage 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7489) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (24) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers to Stage 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (400) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (725) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (6) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1125 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers from Stage 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 229 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (261) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Business activity in the period<sup>1</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30028 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1142 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31176 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17 |
| Refinements to models used for calculation | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8846) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (22) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1081) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (125) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 52 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (10052) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 66 |
| Final repayments<sup>2</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (13942) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2123) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (426) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (9) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (16491) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (15) |
| Disposals | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Write-offs<sup>3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (27) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (27) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (27) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (27) |
| **As at 31 December 2022<sup>4</sup>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **153672** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **29** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **18200** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **73** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2414** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **414** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **174286** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **516** |
| **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** |
| **As at 1 January 2022** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37840 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 824 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5650 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1504 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45822 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4029 |
| Transfers from Stage 1 to Stage 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3474) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (80) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3474 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers from Stage 2 to Stage 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1941 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1941) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (489) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers to Stage 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (649) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (20) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (707) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (307) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1356 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 327 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Transfers from Stage 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (112) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (46) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Business activity in the period<sup>1</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 177 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 769 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 157 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12265 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 489 |
| Refinements to models used for calculation<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (45) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137 |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1246 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (887) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1199 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 179 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 787 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 636 |
| Final repayments<sup>2</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3996) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (36) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (341) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (32) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (228) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (60) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4565) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (128) |
| Disposals<sup>6</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (159) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (29) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (11) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (275) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (169) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (463) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (184) |
| Write-offs<sup>3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1287) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1287) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1287) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1287) |
| **As at 31 December 2022<sup>4</sup>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **44175** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **582** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8099** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1832** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2122** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1278** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **54396** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3692** |

---

---

| | |
|:---|:---|
| *1* | *Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'. Business activity reported within Credit cards, unsecured loans and other retail lending portfolio includes Gap portfolio acquisition in US cards of £2.7bn.* |
| *2* | *Final repayments include repayment from the facility closed during the year whereas partial repayments from existing facility are reported under 'Net drawdowns, repayments, net remeasurement and movements due to exposure and risk parameter changes'.* |
| *3* | *In 2022, gross write-offs amounted to £1,620m (2021: £1,836m). In Q422, £329m of balances with de minimis recovery expectations were written-off in line with policy in UK Cards and Unsecured Loans. Post write-off recoveries amounted to £64m (2021: £66m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,556m (2021: £1,770m).* |
| *4* | *Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn (December 21: £155.2bn) and an impairment allowance of £163m (December 21: £114m). This comprises £10m ECL (December 21: £6m) on £178.4bn Stage 1 assets (December 21: £154.9bn), £9m (December 21: £1m) on £1.5bn Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157m) and £144m (December 21: £107m) on £149m Stage 3 other assets (December 21: £110m).* |
| *5* | *Refinements to models used for calculation reported within Credit cards, unsecured loans and other retail lending portfolio include a £0.3bn movement in US Cards and £(0.2)bn movement in UK Cards. These reflect model enhancements made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.* |
| *6* | *The £0.5bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £0.2bn sale of NFL portfolio within US Cards and £0.3bn of debt sales undertaken during the year.* |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Loans and advances at amortised cost** | **Loans and advances at amortised cost** | **Loans and advances at amortised cost** |  |  |  |  |  |  |
|  | **Stage 1** | **Stage 1** | **Stage 2** | **Stage 2** | **Stage 3** | **Stage 3** | **Total** | **Total** |
|  | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** | **Gross exposure** | **ECL** |
| **Wholesale loans** | £m | £m | £m | £m | £m | £m | £m | £m |
| **As at 1 January 2022** | 132967 | 363 | 15943 | 255 | 2781 | 620 | 151691 | 1238 |
| Transfers from Stage 1 to Stage 2 | (9488) | (67) | 9488 | 67 |  |  |  |  |
| Transfers from Stage 2 to Stage 1 | 5258 | 55 | (5258) | (55) |  |  |  |  |
| Transfers to Stage 3 | (1480) | (6) | (684) | (11) | 2164 | 17 |  |  |
| Transfers from Stage 3 | 204 | 21 | 339 | 28 | (543) | (49) |  |  |
| Business activity in the period<sup>1</sup> | 40490 | 83 | 4104 | 86 | 239 | 30 | 44833 | 199 |
| Refinements to models used for calculation<sup>2</sup> |  | (64) |  | (66) |  | (374) |  | (504) |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes<sup>3</sup> | 12799 | 103 | 352 | 154 | (1504) | 693 | 11647 | 950 |
| Final repayments<sup>4</sup> | (26540) | (42) | (3812) | (47) | (232) | (57) | (30584) | (146) |
| Disposals<sup>5</sup> | (1512) |  | (31) |  | (49) | (47) | (1592) | (47) |
| Write-offs<sup>6</sup> |  |  |  |  | (306) | (306) | (306) | (306) |
| **As at 31 December 2022<sup>7</sup>** | **152698** | **446** | **20441** | **411** | **2550** | **527** | **175689** | **1384** |
| **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** | **Reconciliation of ECL movement to impairment charge/(release) for the period** |  |
|  |  |  |  |  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** |
|  |  |  |  |  | £m | £m | £m | £m |
| *Home loans* | *Home loans* | *Home loans* | *Home loans* | *Home loans* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44 | 68 |
| *Credit cards, unsecured loans and other retail lending* | *Credit cards, unsecured loans and other retail lending* | *Credit cards, unsecured loans and other retail lending* | *Credit cards, unsecured loans and other retail lending* | *Credit cards, unsecured loans and other retail lending* | (238) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 142 | 1230 | 1134 |
| *Wholesale loans* | *Wholesale loans* | *Wholesale loans* | *Wholesale loans* | *Wholesale loans* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 156 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260 | 499 |
| **ECL movement excluding assets derecognised due to disposals and write-offs** | **ECL movement excluding assets derecognised due to disposals and write-offs** | **ECL movement excluding assets derecognised due to disposals and write-offs** | **ECL movement excluding assets derecognised due to disposals and write-offs** | **ECL movement excluding assets derecognised due to disposals and write-offs** | (145) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 312 | 1534 | 1701 |
| ECL movement on loan commitments and other financial guarantees | ECL movement on loan commitments and other financial guarantees | ECL movement on loan commitments and other financial guarantees | ECL movement on loan commitments and other financial guarantees | ECL movement on loan commitments and other financial guarantees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13 |  | 41 |
| ECL movement on other financial assets<sup>7</sup> | ECL movement on other financial assets<sup>7</sup> | ECL movement on other financial assets<sup>7</sup> | ECL movement on other financial assets<sup>7</sup> | ECL movement on other financial assets<sup>7</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37 | 49 |
| Recoveries and reimbursements<sup>8</sup> | Recoveries and reimbursements<sup>8</sup> | Recoveries and reimbursements<sup>8</sup> | Recoveries and reimbursements<sup>8</sup> | Recoveries and reimbursements<sup>8</sup> | (122) | (63) | (78) | (263) |
| Total exchange and other adjustments<sup>9</sup> | Total exchange and other adjustments<sup>9</sup> | Total exchange and other adjustments<sup>9</sup> | Total exchange and other adjustments<sup>9</sup> | Total exchange and other adjustments<sup>9</sup> |  |  |  | (308) |
| **Total income statement charge for the period** | **Total income statement charge for the period** | **Total income statement charge for the period** | **Total income statement charge for the period** | **Total income statement charge for the period** |  |  |  | **1220** |

---

---

| | |
|:---|:---|
| *1* | *Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'.* |
| *2* | *Refinements to models used for calculation reported within Wholesale loans include a £(0.5)bn movement in Business Banking. This relates to an update in the underlying ECL model that now fully recognises the 100% government guarantee against Barclays Bounce Back Loans exposure.* |
| *3* | *'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes' reported within Wholesale loans also include assets of £1.3bn de-recognised due to payment received on defaulted loans from government guarantees issued under government's Bounce Back Loans Scheme.* |
| *4* | *Final repayments include repayment from the facilities closed during the year whereas partial repayments from existing facility are reported under 'Net drawdowns, repayments, net remeasurement and movements due to exposure and risk parameter changes'.* |
| *5* | *The £1.6bn disposals reported within Wholesale loans includes sale of debt securities as part of Group Treasury Operations.* |
| *6* | *In 2022, gross write-offs amounted to £1,620m (2021: £1,836m). In Q422, £329m of balances with de minimis recovery expectations were written-off in line with policy in UK Cards and Unsecured Loans. Post write-off recoveries amounted to £64m (2021: £66m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,556m (2021: £1,770m).* |
| *7* | *Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn (December 21: £155.2bn) and impairment allowance of £163m (December 21: £114m). This comprises £10m ECL (December 21: £6m) on £178.4bn stage 1 assets (December 21: £154.9bn), £9m (December 21: £1m) on £1.5bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157m) and £144m (December 21: £107m) on £149m stage 3 other assets (December 21: £110m).* |
| *8* | *Recoveries and reimbursements includes £199m (2021 loss: £306m) for reimbursements expected to be received under the arrangement where Group has entered into financial guarantee contracts which provide credit protection over certain loan assets with third parties and cash recoveries of previously written off amounts of £64m (FY21: £66m).* |
| *9* | *Exchange and other adjustments includes foreign exchange and interest and fees in suspense.* |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** | **Loan commitments and financial guarantees** |
|  | **Stage 1** | **Stage 1** | **Stage 2** | **Stage 2** | **Stage 3** | **Stage 3** | **Total** | **Total** |
|  | **Gross**<br> **exposure** | **ECL** | **Gross**<br> **exposure** | **ECL** | **Gross**<br> **exposure** | **ECL** | **Gross**<br> **exposure** | **ECL** |
| **Home loans** | £m | £m | £m | £m | £m | £m | £m | £m |
| **As at 1 January 2022** | 10833 |  | 532 |  | 3 |  | 11368 |  |
| Net transfers between stages | 8 |  | (17) |  | 9 |  |  |  |
| Business activity in the period | 8034 |  |  |  |  |  | 8034 |  |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6793) |  | (21) |  | (6) |  | (6820) |  |
| Limit management and final repayments | (368) |  | (44) |  |  |  | (412) |  |
| **As at 31 December 2022** | **11714** | **—** | **450** | **—** | **6** | **—** | **12170** | **—** |
| **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** | **Credit cards, unsecured loans and other retail lending** |
| **As at 1 January 2022** | 122819 | 50 | 5718 | 61 | 218 | 20 | 128755 | 131 |
| Net transfers between stages | (3390) | 47 | 3050 | (42) | 340 | (5) |  |  |
| Business activity in the period | 38204 | 25 | 451 | 27 | 14 | 2 | 38669 | 54 |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 9633 | (54) | (1949) | 67 | (151) | 5 | 7533 | 18 |
| Limit management and final repayments | (8212) | (7) | (503) | (23) | (89) | (2) | (8804) | (32) |
| **As at 31 December 2022** | **159054** | **61** | **6767** | **90** | **332** | **20** | **166153** | **171** |
| **Wholesale loans** |  |  |  |  |  |  |  |  |
| **As at 1 January 2022** | 178490 | 167 | 28565 | 241 | 1077 | 3 | 208132 | 411 |
| Net transfers between stages | 5826 | 60 | (5759) | (64) | (67) | 4 |  |  |
| Business activity in the period | 43683 | 28 | 4233 | 54 | 15 |  | 47931 | 82 |
| Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 28353 | (42) | 5953 | 59 | 138 | (2) | 34444 | 15 |
| Limit management and final repayments | (54175) | (29) | (9515) | (65) | (321) | (2) | (64011) | (96) |
| **As at 31 December 2022** | **202177** | **184** | **23477** | **225** | **842** | **3** | **226496** | **412** |

---

 **Management adjustments to models for impairment**

Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable.

Management adjustments are captured through "Economic uncertainty" and "Other" adjustments presented by product below:

 **Management adjustments to models for impairment allowance presented by product**<sup>1</sup>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Impairment allowance pre management adjustments<sup>2</sup>** | **Economic uncertainty adjustments** | **Other adjustments** | **Management adjustments** | **Total impairment allowance<sup>3</sup>** | **Proportion of Management adjustments to total impairment allowance** |
|  |  | (a) | (b) | (a+b) |  |  |
| **As at 31 December 2022** | £m | £m | £m | £m | £m | **%** |
| Home loans | 427 | 4 | 85 | 89 | 516 | 17.2 |
| Credit cards, unsecured loans and other retail lending | 3543 | 118 | 202 | 320 | 3863 | 8.3 |
| Wholesale loans | 1680 | 195 | (79) | 116 | 1796 | 6.5 |
| **Total** | **5650** | **317** | **208** | **525** | **6175** | **8.5** |
| **As at 31 December 2021** | £m | £m | £m | £m | £m | **%** |
| Home loans | 372 | 72 | 31 | 103 | 475 | 21.7 |
| Credit cards, unsecured loans and other retail lending | 2798 | 1217 | 145 | 1362 | 4160 | 32.7 |
| Wholesale loans | 1628 | 403 | (382) | 21 | 1649 | 1.3 |
| **Total** | **4798** | **1692** | **(206)** | **1486** | **6284** | **23.6** |

---

 **Economic uncertainty adjustments presented by stage**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** |
| **As at 31 December 2022** | £m | £m | £m | £m |
| Home loans | 1 | 3 |  | 4 |
| Credit cards, unsecured loans and other retail lending | 24 | 93 | 1 | 118 |
| Wholesale loans | 181 | 14 |  | 195 |
| **Total** | **206** | **110** | **1** | **317** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **As at 31 December 2021** | £m | £m | £m | £m |
| Home loans | 5 | 35 | 32 | 72 |
| Credit cards, unsecured loans and other retail lending | 403 | 803 | 11 | 1217 |
| Wholesale loans | 333 | 70 |  | 403 |
| **Total** | **741** | **908** | **43** | **1692** |

---

---

| | |
|:---|:---|
| *1* | *Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.* |
| *2* | *Includes £4.8bn (December 2021: £4.2bn) of modelled ECL, £0.4bn (December 2021: £0.5bn) of individually assessed impairments and £0.5bn (December 2021: £0.1bn) ECL from non-modelled exposures.* |
| *3* | *Total impairment allowance consists of ECL stock on drawn and undrawn exposure.* |

---

 **Economic uncertainty adjustments**

Models have been developed with data from non-inflationary periods establishing a relationship between input variables and customer delinquency based on past behaviour. Additionally, models are trying to interpret significant rates of change in macroeconomic variables and applying these to stable probability of default (PD) levels. As such there is a risk that the modelled output fails to capture the appropriate response to changes in macroeconomic variables and rising costs with modelled impairment provisions impacted by uncertainty.

This uncertainty continues to be captured in two ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to economic instability; and secondly, model uncertainty: to capture the impact from model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level.

In 2022, previously established economic uncertainty adjustments have been partially released, informed by some normalisation of customer behaviour, refreshed scenarios and a rebuild of certain models to better capture the macroeconomic outlook.

---

| | |
|:---|:---|
| The balance as at 31 December 2022 is £317m (December 2021: £1,692m) and includes: | The balance as at 31 December 2022 is £317m (December 2021: £1,692m) and includes: |
| **Customer and client uncertainty provisions of £423m (December 2021: £1,508m) includes:** | **Customer and client uncertainty provisions of £423m (December 2021: £1,508m) includes:** |
| ●  | **Credit cards, unsecured loans and other retail lending** includes an adjustment of £118m (December 2021: £1,203m) which has been applied to customers and clients considered most vulnerable to affordability pressures. This adjustment is predominantly held in Stage 2 in line with customer risk profiles.<br>The reduction is informed by the release of COVID-19 related adjustments as credit performance stabilises at or below pre-pandemic levels which is reflected in the models, and a rebuild of certain models to better capture the macroeconomic outlook. |
| ●  | **Wholesale loans:** £301m (FY21: £305m) includes an adjustment of £205m for exposures considered most at risk from inflationary concerns, supply chain constraints and consumer demand headwinds. The adjustment involves applying Stage 2 coverage rates to Stage 1 exposures assessed as most vulnerable. Sectors in scope are presented in the selected sectors disclosure on page 32. The remaining adjustment includes £92m to reflect possible cross default risk on Barclays' lending in respect of clients who have taken bounce back loans. |
| **Model uncertainty provisions of £(106)m (December 2021: £184m) includes:** | **Model uncertainty provisions of £(106)m (December 2021: £184m) includes:** |
| ●  | **Wholesale loans:** £(106)m (December 2021: £98m) includes an adjustment to correct for the deterioration in wholesale PDs impacted by model over-sensitivity to certain macroeconomic variables. In 2021, this adjustment was held at £98m driven by an unintuitive model output from certain Q421 macroeconomic variables. |
| ●  | Management adjustments of £72m within **home loans** in 2021 primarily comprised of a now retired adjustment, reflecting the non-linearity of the UK mortgages portfolio in order to generate a more appropriate level of predicted results. |

---

 **Other adjustments**

Other adjustments are operational in nature and are expected to remain in place until they can be reflected in the underlying models. These adjustments result from data limitations and model performance related issues identified through model monitoring and other established governance processes.

---

| | |
|:---|:---|
| Other adjustments of £208m (December 2021: £(206)m) includes: | Other adjustments of £208m (December 2021: £(206)m) includes: |
| ●  | **Home loans:** £85m (December 2021: £31m) primarily includes adjustments for model performance informed by model monitoring and an adjustment for the adoption of the new definition of default under the Capital Requirements Regulation. |
| ●  | **Credit cards, unsecured loans and other retail lending:** £202m (December 2021: £145m) primarily includes an adjustment for adoption of the new definition of default under the Capital Requirements Regulation and an adjustment to the qualitative measures used in identification of high-risk account management (HRAM) accounts for US cards, partially offset by a recalibration of Loss Given Default (LGD) to reflect revised recovery expectations.<br>The £145m adjustments held in December 2021 primarily included adjustments for model performance informed by model monitoring, partially offset by an adjustment for reclassification of loans and advances from Stage 2 to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of origination probability of default characteristics require management adjustment. These adjustments are no longer required due to model enhancements made during the year. |
| ●  | **Wholesale loans:** £(79)m (December 2021: £(382)m): includes adjustments for model performance informed by model monitoring.<br>Management adjustments of £(382)m within wholesale loans in 2021 consisted of an adjustment of £(380)m applied on bounce back loans to reverse out the modelled charge which did not consider the government guarantee. This adjustment is no longer needed due to model enhancements made during the year. |

---

 **Measurement uncertainty**

Scenarios used to calculate the Group's ECL charge were refreshed in Q422 with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh. In the Baseline scenario, further deterioration in major economies, as inflation pressures continue to squeeze household income, along with significant monetary policy tightening contribute to lower growth prospects. UK GDP is expected to continue falling into 2023 and the US economy dips into mild recession in 2023. Slight increases in the UK and US unemployment rates are expected, peaking at 4.9% in Q423 and 4.7% in Q124 respectively. Central banks continue raising interest rates, peaking during 2023, and consumer price inflation eases over 2023.

In the Downside 2 scenario, inflation continues to accelerate amid increasing gas and oil prices and persistent supply-chain pressures as a result of the Russia-Ukraine conflict. Central banks are forced to raise interest rates sharply with the UK bank rate reaching 8% and the US federal funds rate peaking at 7%. Unemployment peaks at 8.5% in the UK and 8.6% in the US. Given already stretched valuations, the sharp increase in borrowing costs sees house prices decrease significantly. In the Upside 2 scenario, lower energy prices add downward pressure on prices globally, while recovering labour force participation limits wage growth. As a result of easing inflation, central banks lower interest rates to support the economic recovery.

The methodology for estimating scenario probability weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The median is centred around the Baseline with scenarios further from the Baseline attracting a lower weighting before the five weights are normalised to total 100%. The increase in the Downside weightings and the decrease in the Upside weightings reflected the deteriorating economic outlook which moved the Baseline UK/US GDP paths closer to the Downside scenarios. For further details see page 41.

The economic uncertainty adjustments of £0.3bn (2021: £1.7bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £0.4bn (2021: £1.5bn) which has been applied to customers and clients considered most vulnerable to affordability pressures, and a model uncertainty adjustment of £(0.1)bn (2021: £0.2bn). For further details see page 36.

The tables below show the key macroeconomic variables used in the five scenarios (5 year annual paths), the probability weights applied to each scenario.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Baseline average macroeconomic variables used in the calculation of ECL** | **Baseline average macroeconomic variables used in the calculation of ECL** | **Baseline average macroeconomic variables used in the calculation of ECL** | **Baseline average macroeconomic variables used in the calculation of ECL** | **Baseline average macroeconomic variables used in the calculation of ECL** | **Baseline average macroeconomic variables used in the calculation of ECL** |
|  | **2022** | **2023** | **2024** | **2025** | **2026** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>1</sup> | **3.3** | **(0.8)** | **0.9** | **1.8** | **1.9** |
| UK unemployment<sup>2</sup> | **3.7** | **4.5** | **4.4** | **4.1** | **4.2** |
| UK HPI<sup>3</sup> | **8.4** | **(4.7)** | **(1.7)** | **2.2** | **2.2** |
| UK bank rate | **1.8** | **4.4** | **4.1** | **3.8** | **3.4** |
| US GDP<sup>1</sup> | **1.8** | **0.5** | **1.2** | **1.5** | **1.5** |
| US unemployment<sup>4</sup> | **3.7** | **4.3** | **4.7** | **4.7** | **4.7** |
| US HPI<sup>5</sup> | **11.2** | **1.8** | **1.5** | **2.3** | **2.4** |
| US federal funds rate | **2.1** | **4.8** | **3.6** | **3.1** | **3.0** |
|  | **2021** | **2022** | **2023** | **2024** | **2025** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>1</sup> | 6.2 | 4.9 | 2.3 | 1.9 | 1.7 |
| UK unemployment<sup>2</sup> | 4.8 | 4.7 | 4.5 | 4.3 | 4.2 |
| UK HPI<sup>3</sup> | 4.7 | 1.0 | 1.9 | 1.9 | 2.3 |
| UK bank rate | 0.1 | 0.8 | 1.0 | 1.0 | 0.8 |
| US GDP<sup>1</sup> | 5.5 | 3.9 | 2.6 | 2.4 | 2.4 |
| US unemployment<sup>4</sup> | 5.5 | 4.2 | 3.6 | 3.6 | 3.6 |
| US HPI<sup>5</sup> | 11.8 | 4.5 | 5.2 | 4.9 | 5.0 |
| US federal funds rate | 0.2 | 0.3 | 0.9 | 1.2 | 1.3 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Downside 2 average economic variables used in the calculation of ECL** | **Downside 2 average economic variables used in the calculation of ECL** | **Downside 2 average economic variables used in the calculation of ECL** | **Downside 2 average economic variables used in the calculation of ECL** | **Downside 2 average economic variables used in the calculation of ECL** | **Downside 2 average economic variables used in the calculation of ECL** |
|  | **2022** | **2023** | **2024** | **2025** | **2026** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>1</sup> | **3.3** | **(3.4)** | **(3.8)** | **2.0** | **2.3** |
| UK unemployment<sup>2</sup> | **3.7** | **6.0** | **8.4** | **8.0** | **7.4** |
| UK HPI<sup>3</sup> | **8.4** | **(18.3)** | **(18.8)** | **(7.7)** | **8.2** |
| UK bank rate | **1.8** | **7.3** | **7.9** | **6.6** | **5.5** |
| US GDP<sup>1</sup> | **1.8** | **(2.7)** | **(3.4)** | **2.0** | **2.6** |
| US unemployment<sup>4</sup> | **3.7** | **6.0** | **8.5** | **8.1** | **7.1** |
| US HPI<sup>5</sup> | **11.2** | **(3.1)** | **(4.0)** | **(1.9)** | **4.8** |
| US federal funds rate | **2.1** | **6.6** | **6.9** | **5.8** | **4.6** |
|  | **2021** | **2022** | **2023** | **2024** | **2025** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>1</sup> | 6.2 | 0.2 | (4.0) | 2.8 | 4.3 |
| UK unemployment<sup>2</sup> | 4.8 | 7.2 | 9.0 | 7.6 | 6.3 |
| UK HPI<sup>3</sup> | 4.7 | (14.3) | (21.8) | 11.9 | 15.2 |
| UK bank rate | 0.1 | 2.2 | 3.9 | 3.1 | 2.2 |
| US GDP<sup>1</sup> | 5.5 | (0.8) | (3.5) | 2.5 | 3.2 |
| US unemployment<sup>4</sup> | 5.5 | 6.4 | 9.1 | 8.1 | 6.4 |
| US HPI<sup>5</sup> | 11.8 | (6.6) | (9.0) | 5.9 | 6.7 |
| US federal funds rate | 0.2 | 2.1 | 3.4 | 2.6 | 2.0 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Downside 1 average economic variables used in the calculation of ECL** | **Downside 1 average economic variables used in the calculation of ECL** | **Downside 1 average economic variables used in the calculation of ECL** | **Downside 1 average economic variables used in the calculation of ECL** | **Downside 1 average economic variables used in the calculation of ECL** | **Downside 1 average economic variables used in the calculation of ECL** |
|  | **2022** | **2023** | **2024** | **2025** | **2026** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>1</sup> | **3.3** | **(2.1)** | **(1.5)** | **1.9** | **2.1** |
| UK unemployment<sup>2</sup> | **3.7** | **5.2** | **6.4** | **6.0** | **5.8** |
| UK HPI<sup>3</sup> | **8.4** | **(11.7)** | **(10.6)** | **(2.8)** | **5.2** |
| UK bank rate | **1.8** | **5.9** | **6.1** | **5.3** | **4.6** |
| US GDP<sup>1</sup> | **1.8** | **(1.1)** | **(1.1)** | **1.7** | **2.1** |
| US unemployment<sup>4</sup> | **3.7** | **5.1** | **6.6** | **6.4** | **5.9** |
| US HPI<sup>5</sup> | **11.2** | **(0.7)** | **(1.3)** | **0.2** | **3.6** |
| US federal funds rate | **2.1** | **5.8** | **5.4** | **4.4** | **3.9** |
|  | **2021** | **2022** | **2023** | **2024** | **2025** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>1</sup> | 6.2 | 2.8 | (0.7) | 2.3 | 2.9 |
| UK unemployment<sup>2</sup> | 4.8 | 6.2 | 6.8 | 6.0 | 5.3 |
| UK HPI<sup>3</sup> | 4.7 | (6.8) | (10.5) | 6.9 | 8.6 |
| UK bank rate | 0.1 | 1.6 | 2.7 | 2.3 | 1.6 |
| US GDP<sup>1</sup> | 5.5 | 1.6 | (0.4) | 2.4 | 2.7 |
| US unemployment<sup>4</sup> | 5.5 | 5.4 | 6.6 | 6.1 | 5.2 |
| US HPI<sup>5</sup> | 11.8 | (1.2) | (2.1) | 4.8 | 5.2 |
| US federal funds rate | 0.2 | 1.3 | 2.3 | 2.1 | 1.8 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Upside 2 average economic variables used in the calculation of ECL** | **Upside 2 average economic variables used in the calculation of ECL** | **Upside 2 average economic variables used in the calculation of ECL** | **Upside 2 average economic variables used in the calculation of ECL** | **Upside 2 average economic variables used in the calculation of ECL** | **Upside 2 average economic variables used in the calculation of ECL** |
|  | **2022** | **2023** | **2024** | **2025** | **2026** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>1</sup> | **3.3** | **2.8** | **3.7** | **2.9** | **2.4** |
| UK unemployment<sup>2</sup> | **3.7** | **3.5** | **3.4** | **3.4** | **3.4** |
| UK HPI<sup>3</sup> | **8.4** | **8.7** | **7.5** | **4.4** | **4.2** |
| UK bank rate | **1.8** | **3.1** | **2.6** | **2.5** | **2.5** |
| US GDP<sup>1</sup> | **1.8** | **3.3** | **3.5** | **2.8** | **2.8** |
| US unemployment<sup>4</sup> | **3.7** | **3.3** | **3.3** | **3.3** | **3.3** |
| US HPI<sup>5</sup> | **11.2** | **5.8** | **5.1** | **4.5** | **4.5** |
| US federal funds rate | **2.1** | **3.6** | **2.9** | **2.8** | **2.8** |
|  | **2021** | **2022** | **2023** | **2024** | **2025** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>1</sup> | 6.2 | 7.2 | 4.0 | 2.7 | 2.1 |
| UK unemployment<sup>2</sup> | 4.8 | 4.5 | 4.1 | 4.0 | 4.0 |
| UK HPI<sup>3</sup> | 4.7 | 8.5 | 9.0 | 5.2 | 4.2 |
| UK bank rate | 0.1 | 0.2 | 0.5 | 0.5 | 0.3 |
| US GDP<sup>1</sup> | 5.5 | 5.3 | 4.1 | 3.5 | 3.4 |
| US unemployment<sup>4</sup> | 5.5 | 3.9 | 3.4 | 3.3 | 3.3 |
| US HPI<sup>5</sup> | 11.8 | 10.6 | 8.5 | 7.2 | 6.6 |
| US federal funds rate | 0.2 | 0.3 | 0.4 | 0.7 | 1.0 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Upside 1 average economic variables used in the calculation of ECL** | **Upside 1 average economic variables used in the calculation of ECL** | **Upside 1 average economic variables used in the calculation of ECL** | **Upside 1 average economic variables used in the calculation of ECL** | **Upside 1 average economic variables used in the calculation of ECL** | **Upside 1 average economic variables used in the calculation of ECL** |
|  | **2022** | **2023** | **2024** | **2025** | **2026** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>1</sup> | **3.3** | **1.0** | **2.3** | **2.4** | **2.1** |
| UK unemployment<sup>2</sup> | **3.7** | **4.0** | **3.9** | **3.8** | **3.8** |
| UK HPI<sup>3</sup> | **8.4** | **1.8** | **2.9** | **3.3** | **3.2** |
| UK bank rate | **1.8** | **3.5** | **3.3** | **3.0** | **2.8** |
| US GDP<sup>1</sup> | **1.8** | **1.9** | **2.3** | **2.2** | **2.2** |
| US unemployment<sup>4</sup> | **3.7** | **3.8** | **4.0** | **4.0** | **4.0** |
| US HPI<sup>5</sup> | **11.2** | **3.8** | **3.3** | **3.4** | **3.4** |
| US federal funds rate | **2.1** | **3.9** | **3.4** | **3.0** | **3.0** |
|  | **2021** | **2022** | **2023** | **2024** | **2025** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>1</sup> | 6.2 | 6.0 | 3.1 | 2.3 | 1.9 |
| UK unemployment<sup>2</sup> | 4.8 | 4.6 | 4.3 | 4.2 | 4.1 |
| UK HPI<sup>3</sup> | 4.7 | 5.0 | 5.0 | 3.9 | 3.3 |
| UK bank rate | 0.1 | 0.6 | 0.8 | 0.8 | 0.5 |
| US GDP<sup>1</sup> | 5.5 | 4.6 | 3.4 | 2.9 | 2.9 |
| US unemployment<sup>4</sup> | 5.5 | 4.0 | 3.5 | 3.5 | 3.5 |
| US HPI<sup>5</sup> | 11.8 | 8.3 | 7.0 | 6.0 | 5.7 |
| US federal funds rate | 0.2 | 0.3 | 0.6 | 1.0 | 1.1 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Scenario probability weighting<sup>1</sup>** | **Scenario probability weighting<sup>1</sup>** | **Scenario probability weighting<sup>1</sup>** | **Scenario probability weighting<sup>1</sup>** | **Scenario probability weighting<sup>1</sup>** | **Scenario probability weighting<sup>1</sup>** |
|  | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
|  | % | % | % | % | % |
| **As at 31.12.22** |  |  |  |  |  |
| Scenario probability weighting | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9.0 |
| **As at 31.12.21** |  |  |  |  |  |
| Scenario probability weighting | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.0 |

---

 *1* *For further details on changes to scenario weights please see page 38.*

Specific bases show the most extreme position of each variable in the context of the downside/upside scenarios, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest cumulative position relative to the start point, in the 20 quarter period.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Macroeconomic variables (specific bases)<sup>1</sup>** | **Macroeconomic variables (specific bases)<sup>1</sup>** | **Macroeconomic variables (specific bases)<sup>1</sup>** | **Macroeconomic variables (specific bases)<sup>1</sup>** | **Macroeconomic variables (specific bases)<sup>1</sup>** | **Macroeconomic variables (specific bases)<sup>1</sup>** |
|  | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>2</sup> | **13.9** | **9.4** | **1.4** | **(3.2)** | **(6.8)** |
| UK unemployment<sup>3</sup> | **3.4** | **3.6** | **4.2** | **6.6** | **8.5** |
| UK HPI<sup>4</sup> | **37.8** | **21.0** | **1.2** | **(17.9)** | **(35.0)** |
| UK bank rate | **0.5** | **0.5** | **3.5** | **6.3** | **8.0** |
| US GDP<sup>2</sup> | **14.1** | **9.6** | **1.3** | **(2.5)** | **(6.3)** |
| US unemployment<sup>3</sup> | **3.3** | **3.6** | **4.4** | **6.7** | **8.6** |
| US HPI<sup>4</sup> | **35.0** | **27.5** | **3.8** | **3.7** | **0.2** |
| US federal funds rate | **0.1** | **0.1** | **3.3** | **6.0** | **7.0** |
|  | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>2</sup> | 21.4 | 18.3 | 3.4 | (1.6) | (1.6) |
| UK unemployment<sup>3</sup> | 4.0 | 4.1 | 4.5 | 7.0 | 9.2 |
| UK HPI<sup>4</sup> | 35.7 | 23.8 | 2.4 | (12.7) | (29.9) |
| UK bank rate | 0.1 | 0.1 | 0.7 | 2.8 | 4.0 |
| US GDP<sup>2</sup> | 22.8 | 19.6 | 3.4 | 1.5 | (1.3) |
| US unemployment<sup>3</sup> | 3.3 | 3.5 | 4.1 | 6.8 | 9.5 |
| US HPI<sup>4</sup> | 53.3 | 45.2 | 6.2 | 2.2 | (5.0) |
| US federal funds rate | 0.1 | 0.1 | 0.8 | 2.3 | 3.5 |

---

---

| | |
|:---|:---|
| *1* | *UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q122 (2021: Q121).* |
| *2* | *Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.* |
| *3* | *Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.* |
| *4* | *Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.* |

---

Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Macroeconomic variables (5-year averages)<sup>1</sup>** | **Macroeconomic variables (5-year averages)<sup>1</sup>** | **Macroeconomic variables (5-year averages)<sup>1</sup>** | **Macroeconomic variables (5-year averages)<sup>1</sup>** | **Macroeconomic variables (5-year averages)<sup>1</sup>** | **Macroeconomic variables (5-year averages)<sup>1</sup>** |
|  | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **As at 31.12.22** | % | % | % | % | % |
| UK GDP<sup>2</sup> | **3.0** | **2.2** | **1.4** | **0.7** | **—** |
| UK unemployment<sup>3</sup> | **3.5** | **3.8** | **4.2** | **5.4** | **6.7** |
| UK HPI<sup>4</sup> | **6.6** | **3.9** | **1.2** | **(2.6)** | **(6.4)** |
| UK bank rate | **2.5** | **2.9** | **3.5** | **4.7** | **5.8** |
| US GDP<sup>2</sup> | **2.9** | **2.1** | **1.3** | **0.7** | **—** |
| US unemployment<sup>3</sup> | **3.4** | **3.9** | **4.4** | **5.5** | **6.7** |
| US HPI<sup>4</sup> | **6.2** | **5.0** | **3.8** | **2.5** | **1.2** |
| US federal funds rate | **2.8** | **3.1** | **3.3** | **4.3** | **5.2** |
|  | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **As at 31.12.21** | % | % | % | % | % |
| UK GDP<sup>2</sup> | 4.4 | 3.9 | 3.4 | 2.7 | 1.8 |
| UK unemployment<sup>3</sup> | 4.3 | 4.4 | 4.5 | 5.8 | 7.0 |
| UK HPI<sup>4</sup> | 6.3 | 4.4 | 2.4 | 0.3 | (2.0) |
| UK bank rate | 0.3 | 0.5 | 0.7 | 1.7 | 2.3 |
| US GDP<sup>2</sup> | 4.4 | 3.9 | 3.4 | 2.4 | 1.3 |
| US unemployment<sup>3</sup> | 3.9 | 4.0 | 4.1 | 5.7 | 7.1 |
| US HPI<sup>4</sup> | 8.9 | 7.7 | 6.2 | 3.6 | 1.4 |
| US federal funds rate | 0.5 | 0.6 | 0.8 | 1.5 | 2.1 |

---

---

| | |
|:---|:---|
| *1* | *UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index.* |
| *2* | *5-year yearly average CAGR, starting 2021 (2021: 2020).* |
| *3* | *5-year average. Period based on 20 quarters from Q122 (2021: Q121).* |
| *4* | *5-year quarter end CAGR, starting Q421 (2021: Q420).* |

---

 **ECL under 100% weighted scenarios for modelled portfolios**

The table below shows the modelled ECL assuming each of the five modelled scenarios are 100% weighted with the dispersion of results around the Baseline, highlighting the impact on exposure and ECL across the scenarios. Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** |
| <br> **As at 31 December 2022** | **Weighted<sup>1</sup>** | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **Stage 1 Model Exposure (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 144701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 147754 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 146873 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 145322 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 142599 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 138619 |
| Credit cards, unsecured loans and other retail lending<sup>2, 3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81457 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81171 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80921 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80529 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 186838 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 194970 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 192218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 188746 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 181247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 167848 |
| **Stage 1 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 562 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 579 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 594 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 604 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 610 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 245 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 382 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 431 |
| **Stage 1 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.8 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.3 |
| **Stage 2 Model Exposure (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18723 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15670 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16551 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18102 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20825 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24805 |
| Credit cards, unsecured loans and other retail lending<sup>2, 3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9414 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8131 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8817 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9535 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10377 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11456 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25634 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17503 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23726 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31226 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44624 |
| **Stage 2 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 151 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1786 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1487 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1629 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1785 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2004 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2274 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 603 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 392 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 463 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 562 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 809 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1288 |
| **Stage 2 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19.8 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.9 |
| **Stage 3 Model Exposure (£m)<sup>4</sup>** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1553 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1606 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2855 |
| **Stage 3 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 311 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 317 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 405 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1033 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1034 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1048 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1059 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64 |
| **Stage 3 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26.1 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 63.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 63.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65.9 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.2 |
| **Total Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 372 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 338 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 350 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 401 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 586 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3411 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3060 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3231 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3413 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3656 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3943 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 977 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 682 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 784 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 919 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1783 |
| **Total Model ECL** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4760** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4071** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4353** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4682** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5305** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **6312** |

---

---

| | |
|:---|:---|
| **Reconciliation to total ECL** | **£m** |
| Total weighted model ECL | 4760 |
| ECL from individually assessed impairments<sup>5</sup> | 434 |
| ECL from non-modelled exposures and others | 456 |
| ECL from post model management adjustments | 525 |
| *Of which: ECL from economic uncertainty adjustments* | 317 |
| **Total ECL** | **6175** |

---

---

| | |
|:---|:---|
| *1* | *Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach as required for Barclays reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned to a different stage dependent on the scenario.* |
| *2* | *For Credit cards, unsecured loans and other retail lending, the model exposure movement between stages 1 and 2 across scenarios differs due to additional impacts from the undrawn exposure.* |
| *3* | *For Credit cards, unsecured loans and other retail lending, the dispersion of results around Baseline has narrowed following model enhancements made during the year.* |
| *4* | *Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at 31 December 2022 and not on macroeconomic scenario.* |
| *5* | *Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £434m is reported as an individually assessed impairment in the reconciliation table.* |

---

The use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 1.7%.

 **Home loans:** Total weighted ECL of £372m represents a 6.3% increase over the Baseline ECL (£350m) with coverage ratios remaining steady across the Upside scenarios, Baseline and Downside 1 scenario. Under the Downside 2 scenario, total ECL increases to £586m driven by a significant fall in UK HPI to (18.3)% in 2023 reflecting the non-linearity of the UK portfolio.

 **Credit cards, unsecured loans and other retail lending:** Total weighted ECL of £3,411m is aligned to the Baseline ECL (£3,413m). The impact of the deteriorated Baseline scenario relative to the severity of the downside scenarios is greater than the impact of the higher weights applied to the Downside scenarios when compared to 2021. This results in a convergence between Baseline and Weighted ECL in 2022. Total ECL increases to £3,943m under the Downside 2 scenario, driven by the significant increase in UK unemployment rate to 6.0% and US unemployment rate to 6.0% in 2023.

 **Wholesale loans:** Total weighted ECL of £977m represents an 6.3% increase over the Baseline ECL (£919m). Total ECL increases to £1,783m under Downside 2 scenario, driven by a significant decrease in UK GDP to (3.4)% and US GDP to (2.7)% in 2023.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** | **Scenarios** |
| <br> **As at 31 December 2021** | **Weighted<sup>1</sup>** | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
| **Stage 1 Model Exposure (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137279 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 139117 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 138424 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 135544 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 133042 |
| Credit cards, unsecured loans and other retail lending<sup>2, 3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56783 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 54758 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 55771 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56821 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57698 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 55315 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 174249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 177453 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 176774 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175451 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 169814 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 161998 |
| **Stage 1 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 324 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 266 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 272 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 279 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 350 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 418 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 240 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 262 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 286 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 327 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 350 |
| **Stage 1 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.8 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 |
| **Stage 2 Model Exposure (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22915 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21076 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21769 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22631 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24649 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27151 |
| Credit cards, unsecured loans and other retail lending<sup>2, 3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6447 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6757 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7084 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10689 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18452 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32256 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29052 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29732 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31054 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36692 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44507 |
| **Stage 2 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 925 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 988 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1058 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1497 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3295 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 572 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 431 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 467 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 528 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 851 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1510 |
| **Stage 2 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.9 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.4 |
| **Stage 3 Model Exposure (£m)<sup>4</sup>** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1724 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1922 |
| Wholesale loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1811 |
| **Stage 3 Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 303 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 292 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 299 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 320 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 346 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1236 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1245 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1277 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1297 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 321 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 322 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 326 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 332 |
| **Stage 3 Coverage (%)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.6 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.1 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65.3 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 66.4 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67.5 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.8 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.3 |
| **Total Model ECL (£m)** |  |  |  |  |  |  |
| Home loans | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 322 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 304 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 314 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 348 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 407 |
| Credit cards, unsecured loans and other retail lending | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2693 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2427 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3124 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5010 |
| Wholesale loans<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1185 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 992 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1051 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1504 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2192 |
| **Total Model ECL** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4200** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3723** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3864** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4043** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4976** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7609** |

---

---

| | |
|:---|:---|
| **Reconciliation to total ECL** | **£m** |
| Total model ECL | 4200 |
| ECL from individually assessed impairments<sup>5</sup> | 524 |
| ECL from non-modelled exposures and others | 74 |
| ECL from post model management adjustments<sup>6</sup> | 1486 |
| *Of which: ECL from economic uncertainty adjustments* | *1692* |
| **Total ECL** | **6284** |

---

---

| | |
|:---|:---|
| *1* | *Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach, as required for Barclays reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned to a different stage dependent on the scenario.* |
| *2* | *For Credit cards, unsecured loans and other retail lending, the model exposure movement between stages 1 and 2 across scenarios differs due to additional impacts from the undrawn exposure.* |
| *3* | *In 2021, Loans & Advances at amortised cost were used as model exposure for the International Consumer Bank within this disclosure. The process was revised in 2022 to incorporate Exposure at Default (EAD) with no impact to ECL. This has been represented in prior year comparatives.* |
| *4* | *Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at 31 December 2021 and not on macroeconomic scenario.* |
| *5* | *Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as an individually assessed impairment in the reconciliation table.* |
| *6* | *Post Model Adjustments include negative adjustments reflecting operational post model adjustments.* |

---

 **Analysis of specific portfolios and asset types**

 **Secured home loans**

The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2021: 93%) of the Group's total home loans balance.

---

| | | |
|:---|:---|:---|
| | **Barclays UK** | **Barclays UK** |
| <br> **Home loans principal portfolios** | **As at 31.12.22** | **As at 31.12.21** |
| Gross loans and advances (£m) | **162380** | 158192 |
| 90 day arrears rate, excluding recovery book (%) | **0.1** | 0.1 |
| Annualised gross charge-off rates - 180 days past due (%) | **0.5** | 0.5 |
| Recovery book proportion of outstanding balances (%) | **0.5** | 0.6 |
| Recovery book impairment coverage ratio (%) | **5.2** | 4.2 |
| **Average marked to market LTV** |  |  |
| Balance weighted % | **50.4** | 50.7 |
| Valuation weighted % | **37.3** | 37.5 |
| **New lending** | **Year ended 31.12.22** | **Year ended 31.12.21** |
| New home loan bookings (£m) | **30307** | 33945 |
| New home loan proportion > 90% LTV (%) | **2.8** | 1.9 |
| Average LTV on new home loans: balance weighted (%) | **68.1** | 69.5 |
| Average LTV on new home loans: valuation weighted (%) | **59.6** | 61.9 |

---

 **Home loans principal portfolios – distribution of balances by LTV<sup>1</sup>**

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Distribution of balances** | **Distribution of balances** | **Distribution of balances** | **Distribution of balances** | **Distribution of impairment allowance** | **Distribution of impairment allowance** | **Distribution of impairment allowance** | **Distribution of impairment allowance** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** |
|  | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** | **Stage 1** | **Stage 2** | **Stage 3** | **Total** |
| **Barclays UK** | % | % | % | % | % | % | % | % | % | % | % | % |
| **As at 31.12.22** |  |  |  |  |  |  |  |  |  |  |  |  |
| <=75% | **78.8** | **10.5** | **0.8** | **90.1** | **10.2** | **30.8** | **33.2** | **74.2** | **—** | **0.2** | **2.9** | **0.1** |
| >75% and <=90% | **8.8** | **0.5** | **—** | **9.3** | **3.9** | **9.7** | **5.2** | **18.8** | **—** | **1.4** | **30.8** | **0.1** |
| >90% and <=100% | **0.6** | **—** | **—** | **0.6** | **0.3** | **0.3** | **2.4** | **3.0** | **—** | **1.5** | **85.0** | **0.4** |
| >100% | **—** | **—** | **—** | **—** | **0.1** | **0.6** | **3.3** | **4.0** | **0.4** | **21.4** | **64.9** | **13.1** |
| **As at 31.12.21** |  |  |  |  |  |  |  |  |  |  |  |  |
| <=75% | 77.2 | 11.3 | 0.7 | 89.2 | 8.3 | 17.7 | 31.9 | 57.9 |  | 0.1 | 2.4 |  |
| >75% and <=90% | 9.3 | 0.6 |  | 9.9 | 4.8 | 10.7 | 11.7 | 27.2 |  | 1.0 | 22.6 | 0.1 |
| >90% and <=100% | 0.9 |  |  | 0.9 | 0.9 | 1.0 | 2.9 | 4.8 | 0.1 | 1.9 | 87.5 | 0.3 |
| >100% |  |  |  |  | 0.2 | 1.0 | 8.9 | 10.1 | 0.4 | 6.4 | 100.0 | 14.1 |

---

 *1* *Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 31 December 2022.*

 **New lending** in 2022 was £30.3bn, a reduction of 11% on 2021. This was mainly driven by economic conditions that resulted in general mortgage market suppression, including higher mortgage payments as rates continued to rise and increased cost of living factors in line with inflation.

 **Head Office**: Italian home loans and advances at amortised cost reduced to £4.5bn (2021: £4.7bn) and continue to run-off since new bookings ceased in 2016. The portfolio is secured on residential property with an average balance weighted mark to market LTV of 58.8% (2021: 60.4%). 90 day arrears decreased to 1.2% (2021: 1.3%), gross charge-off rates increased to 0.6% (2021: 0.3%) due to a combination of affordability stress related to rising inflation and interest rates, and the particularly low rate observed in 2021 due to the COVID portfolio improvements.

 **Credit cards, unsecured loans and other retail lending**

The principal portfolios listed below accounted for 85% (December 2021: 82%) of the Group's total credit cards, unsecured loans and other retail lending.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Principal portfolios**<br>**As at 31.12.22** | **Gross exposure**<br>**£m** | **30 day arrears rate, excluding recovery book %**<br> | **90 day arrears rate, excluding recovery book %**<br> | **Annualised gross write-off rate %**<br> | **Annualised net write-off rate %**<br> |
| **Barclays UK** |  |  |  |  |  |
| UK cards | 9939 | 0.9 | 0.2 | 3.7 | 3.6 |
| UK personal loans | 4023 | 1.4 | 0.6 | 4.1 | 3.8 |
| Barclays Partner Finance | 2612 | 0.5 | 0.2 | 0.7 | 0.7 |
| **Barclays International** |  |  |  |  |  |
| US cards | 25554 | 2.2 | 1.2 | 2.4 | 2.3 |
| Germany consumer lending | 4269 | 1.7 | 0.7 | 0.7 | 0.6 |
| **As at 31.12.21** |  |  |  |  |  |
| **Barclays UK** |  |  |  |  |  |
| UK cards | 9933 | 1.0 | 0.2 | 4.1 | 4.0 |
| UK personal loans | 4011 | 1.5 | 0.7 | 3.5 | 3.2 |
| Barclays Partner Finance | 2471 | 0.4 | 0.2 | 1.4 | 1.4 |
| **Barclays International** |  |  |  |  |  |
| US cards | 17779 | 1.6 | 0.8 | 4.3 | 4.2 |
| Germany consumer lending | 3559 | 1.5 | 0.7 | 0.9 | 0.8 |

---

 **UK cards:** 30 day arrears rate reduced marginally to 0.9% (Q421: 1.0%) and 90 day arrears rate remained stable at 0.2% (Q421: 0.2%), whilst total exposure was stable at £9.9bn. Both the gross and net write off rates decreased by 0.4% due to reduced debt sales and monthly delinquency flows.

 **UK personal loans:** 30 and 90 day arrears rates have reduced marginally to 1.4% (Q421: 1.5%) and 0.6% (Q421: 0.7%) respectively, whilst total exposure was stable at £4.0bn. Both the annualised gross and net write off rates increased by 0.6% due to increased regular debt sales.

 **Barclays Partner Finance:** 30 day arrears rate increased slightly to 0.5% (Q421: 0.4%) and 90 day arrears rate remained stable at 0.2% (Q421: 0.2%), reflecting marginally higher entry rates with stable flows through the delinquency cycles. Total exposure grew by £0.1bn to £2.6bn (December 2021: £2.5bn) as a result of increased sales. Both the annualised gross and net write off rates decreased by 0.7% as a result of the reducing delinquent stock and subsequent flow into recoveries.

 **US cards:** Balances increased due to the acquisition of the Gap portfolio in June 2022, movement in the USD/GBP exchange rate and core portfolio growth. 30 and 90 day arrears rates increased to 2.2% (Q421: 1.6%) and 1.2% (Q421: 0.8%) due to the partial normalisation of customer behaviour and the acquisition of the Gap portfolio, though rates remain below pre-pandemic levels. Write-off rates decreased reflecting portfolio growth and the impact of lower charge offs in 2021 due to the benefit of government support schemes.

 **Germany consumer lending:** 30 day arrears rate increased to 1.7% (Q421: 1.5%) due to increased macroeconomic uncertainty in Europe, though the rate was consistent with pre-pandemic levels.

 **Market Risk**

 **Analysis of management value at risk (VaR)**

The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material businesses and trading desks.

 **Management VaR (95%) by asset class**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.21** | **Year ended 31.12.21** | **Year ended 31.12.21** |
|  | **Average**<br>£m | **High**<br>£m | **Low**<br>£m | **Average**<br>£m | **High**<br>£m | **Low**<br>£m |
| Credit risk | 25 | 71 | 8 | 14 | 30 | 7 |
| Interest rate risk | 13 | 23 | 4 | 7 | 15 | 4 |
| Equity risk | 10 | 29 | 4 | 9 | 29 | 4 |
| Basis risk | 12 | 24 | 4 | 6 | 10 | 3 |
| Spread risk | 7 | 11 | 3 | 4 | 6 | 3 |
| Foreign exchange risk | 8 | 25 | 2 | 4 | 16 | 1 |
| Commodity risk |  | 1 |  |  | 1 |  |
| Inflation risk | 6 | 17 | 3 | 3 | 5 | 2 |
| Diversification effect<sup>1</sup> | (45) | n/a | n/a | (28) | n/a | n/a |
| **Total management VaR** | **36** | **73** | **13** | **19** | **36** | **6** |

---

---

| | |
|:---|:---|
| *1* | *Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.* |

---

Average management VaR increased 89% to £36m (2021: £19m) driven by higher market volatility. The Russia-Ukraine conflict and elevated inflation increased volatility across all asset classes as central banks increased base rates, equity markets declined, and credit spreads widened during this period. The Global Markets business maintained a generally short and defensive risk profile (i.e. positioned to gain as the market sells off) for most of 2022. VaR increased in Q4 2022 from an increase in funded, fair-value leverage loan exposure in Investment Banking. Risk taking remained within agreed risk appetite limits at all times in 2022.

 **Treasury and Capital Risk**

The Group has established a comprehensive set of policies, standards and controls for managing its liquidity risk; together these set out the requirements for Barclays' liquidity risk framework. The liquidity risk framework meets the PRA standards and enables Barclays to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group's Liquidity Risk Appetite. The liquidity risk framework is delivered via a combination of policy formation, review and challenge, governance, analysis, stress testing, limit setting and monitoring.

Liquidity risk stress testing

The internal liquidity stress test measures the potential contractual and contingent stress outflows under a range of scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-wide scenario

The LCR requirement takes into account the relative stability of different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank's liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.

As at 31 December 2022, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external regulatory requirements.

---

| | | |
|:---|:---|:---|
| **Liquidity coverage ratio** |  |  |
|  | **As at 31.12.22** | **As at 31.12.21** |
|  | £bn | £bn |
| Eligible liquidity buffer | 295 | 285 |
| Net stress outflows | (178) | (169) |
| **Surplus** | **117** | **116** |
| **Liquidity coverage ratio** | **165%** | **168%** |

---

 **Net Stable Funding Ratio**

The external NSFR metric requires banks to maintain a stable funding profile taking into account both on and certain off balance sheet exposures over a medium to long term period. The ratio is defined as the Available Stable Funding (capital and certain liabilities which are treated as stable sources of funding) relative to the Required Stable Funding (assets on balance sheet and certain off balance sheet exposures). The NSFR (average of last four quarter ends) as at 31 December 2022 was 137%, which was a surplus above requirements of £155bn.

---

| | |
|:---|:---|
| **Net Stable Funding Ratio<sup>1</sup>** | **As at31.12.22** |
|  | £bn |
| Total Available Stable Funding | 576 |
| Total Required Stable Funding | 421 |
| **Surplus** | **155** |
| **Net Stable Funding Ratio** | **137%** |

---

 *1* *Represents average of the last four spot quarter end positions.*

As part of the liquidity risk appetite, Barclays establishes minimum LCR, NSFR and internal liquidity stress test limits. The Group plans to maintain its surplus to the internal and regulatory requirements at an efficient level. Risks to market funding conditions, the Group's liquidity position and funding profile are assessed continuously, and actions are taken to manage the size of the liquidity pool and the funding profile as appropriate.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Composition of the Group liquidity pool** | **Composition of the Group liquidity pool** |  |  |  |  |  |  |
|  | **LCR eligible<sup>1</sup> High Quality Liquid Assets (HQLA)** | **LCR eligible<sup>1</sup> High Quality Liquid Assets (HQLA)** | **LCR eligible<sup>1</sup> High Quality Liquid Assets (HQLA)** | **LCR eligible<sup>1</sup> High Quality Liquid Assets (HQLA)** | **LCR eligible<sup>1</sup> High Quality Liquid Assets (HQLA)** | **Liquidity pool** | **Liquidity pool** |
|  | **Cash** | **Level 1** | **Level 2A** | **Level 2B** | **Total** | **2022** | **2021** |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| **Cash and deposits with central banks<sup>2</sup>** | **248** | **—** | **—** | **—** | **248** | **263** | **245** |
| **Government bonds<sup>3</sup>** |  |  |  |  |  |  |  |
| AAA to AA- |  | 21 | 10 |  | 31 | 39 | 26 |
| A+ to A- |  | 1 | 2 |  | 3 | 3 | 2 |
| BBB+ to BBB- |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
| **Total government bonds** | **—** | **22** | **12** | **—** | **34** | **42** | **28** |
| **Other** |  |  |  |  |  |  |  |
| Government Guaranteed Issuers, PSEs and GSEs |  | 5 | 1 |  | 6 | 6 | 6 |
| International Organisations and MDBs |  | 2 |  |  | 2 | 2 | 5 |
| Covered bonds |  | 2 | 2 |  | 4 | 5 | 6 |
| Other |  |  |  | 1 | 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 |
| **Total other** | **—** | **9** | **3** | **1** | **13** | **13** | **18** |
| **Total as at 31 December 2022** | **248** | **31** | **15** | **1** | **295** | **318** |  |
| **Total as at 31 December 2021** | **243** | **37** | **3** | **2** | **285** |  | **291** |

---

---

| | |
|:---|:---|
| *1* | *The LCR eligible HQLA is adjusted for operational restrictions upon consolidation under Article 8 of the Liquidity Coverage Ratio section of the PRA rulebook (CRR) such as trapped liquidity within Barclays subsidiaries. It also reflects differences in eligibility of assets between the LCR and Barclays' Liquidity Pool.* |
| *2* | *Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99% (December 2021: over 99%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.* |
| *3* | *Of which over 79% (December 2021: over 82%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.* |

---

The Group liquidity pool increased to £318bn as at December 2022 (December 2021: £291bn) driven by continued deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption and trapped liquidity within Barclays' subsidiaries. During 2022, the month-end liquidity pool ranged from £309bn to £359bn (2021: £290bn to £337bn), and the month-end average balance was £331bn (2021: £303bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.

As at 31 December 2022, 60% (December 2021: 58%) of the liquidity pool was located in Barclays Bank PLC, 25% (December 2021: 30%) in Barclays Bank UK PLC and 9% (December 2021: 7%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements or operational restrictions, it is assumed to be unavailable to the rest of the Group in calculating the LCR.

The composition of the pool is subject to limits and controls set by the respective entity Boards and independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.

 **Deposit funding**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As at 31.12..22** | **As at 31.12..22** | **As at 31.12..22** | **As at 31.12.21** |
|  | **Loans and advances at amortised cost** | **Deposits at amortised cost** | **Loan: deposit ratio<sup>1</sup>** | **Loan: deposit ratio<sup>1</sup>** |
| **Funding of loans and advances** | £bn | £bn | % | % |
| Barclays UK | 225 | 258 | 87 | 85 |
| Barclays International | 170 | 288 | 59 | 52 |
| Head Office | 4 |  |  |  |
| **Barclays Group** | **399** | **546** | **73** | **70** |

---

 *1* *The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.*

 **Funding structure and funding relationships**

The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due. The Group's overall funding strategy is to develop a diversified funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection against unexpected fluctuations, while minimising the cost of funding.

Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets.

These funding relationships as at 31 December 2022 are summarised below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | **Restated<sup>1</sup>** |
|  | **As at 31.12.22** | **As at 31.12.21** |  | **As at 31.12.22** | **As at 31.12.21** |
| **Assets** | £bn | £bn | **Liabilities and equity** | £bn | £bn |
| Loans and advances at amortised cost<sup>2</sup> | 385 | 358 | Deposits at amortised cost | 546 | 519 |
| Group liquidity pool | 318 | 291 | <1 Year wholesale funding | 73 | 67 |
|  |  |  | >1 Year wholesale funding | 111 | 101 |
| Reverse repurchase agreements, trading portfolio assets, cash collateral and settlement balances | 412 | 388 | Repurchase agreements, trading portfolio liabilities, cash collateral and settlement balances | 370 | 330 |
| Derivative financial instruments | 302 | 263 | Derivative financial instruments | 290 | 257 |
| Other assets<sup>3</sup> | 97 | 84 | Other liabilities | 55 | 40 |
|  |  |  | Equity | 69 | 70 |
| **Total assets** | **1514** | **1384** | **Total liabilities and equity** | **1514** | **1384** |

---

---

| | |
|:---|:---|
| *1* | *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information. The contractual maturity profile of Senior unsecured (privately placed) has been restated to reflect the impact of the Over-issuance of Securities.* |
| *2* | *Adjusted for liquidity pool debt securities reported at amortised cost of £14bn (December 2021: £3bn).* |
| *3* | *Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.* |

---

 **Composition of wholesale funding**

Wholesale funding outstanding (excluding repurchase agreements) was £184.0bn (December 2021: £167.5bn). In 2022, the Group issued £15.3bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies.

Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK PLC continued to issue in the shorter-term markets and maintains active secured funding programmes.

Wholesale funding of £72.5bn (December 2021: £66.7bn<sup>1</sup>) matures in less than one year, representing 39% (December 2021: 40%<sup>1</sup>) of total wholesale funding outstanding. This includes £15.0bn (December 2021: £24.9bn<sup>1</sup>) related to term funding<sup>2</sup>.

 **Maturity profile of wholesale funding<sup>2,3</sup>**

---

| | | | |
|:---|:---|:---|:---|
|  | **<1**<br>**month**<br>£bn | **<1**<br>**year**<br>£bn | <br> **Total**<br>£bn |
| **Barclays PLC (the Parent company)** |  |  |  |
| Senior unsecured (public benchmark) |  | 1.9 | 44.1 |
| Senior unsecured (privately placed) |  | 0.2 | 1.3 |
| Subordinated liabilities |  |  | 9.6 |
| **Barclays Bank PLC (including subsidiaries)** |  |  |  |
| Certificates of deposit and commercial paper | 0.3 | 41.8 | 44.0 |
| Asset backed commercial paper | 3.6 | 11.0 | 11.0 |
| Senior unsecured (public benchmark) |  |  | 1.0 |
| Senior unsecured (privately placed)<sup>4</sup> | 1.2 | 10.5 | 58.4 |
| Asset backed securities |  | 0.3 | 5.0 |
| Subordinated liabilities |  | 0.3 | 1.6 |
| **Barclays Bank UK PLC (including subsidiaries)** |  |  |  |
| Certificates of deposit and commercial paper | 4.7 | 4.7 | 4.7 |
| Senior unsecured (public benchmark) |  |  | 0.1 |
| Covered Bonds | 1.3 | 1.8 | 3.2 |
| **Total as at 31 December 2022** | **11.1** | **72.5** | **184.0** |
| Of which secured | 4.9 | 13.1 | 19.2 |
| Of which unsecured | 6.2 | 59.4 | 164.8 |
| **Total as at 31 December 2021<sup>1</sup>** | **14.1** | **66.7** | **167.5** |
| Of which secured | 2.4 | 9.9 | 16.6 |
| Of which unsecured | 11.7 | 56.8 | 150.9 |

---

---

| | |
|:---|:---|
| *1* | *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information. The contractual maturity profile of financial liabilities designated at fair value has been restated to reflect the impact of the Over-issuance of Securities. Securities issued by BBPLC in excess of the maximum aggregate offering price registered under Barclays Bank PLC's 2019 F-3 and Barclays Bank PLC's predecessor shelf registration statement on Form F-3 filed in 2018 (Predecessor Shelf) with a value of £6,997m have been classified as "on demand".* |
| *2* | *The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.* |
| *3* | *Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year.* |
| *4* | *Includes structured notes of £48.4bn, of which £9.4bn matures within one year.* |

---

 **Regulatory minimum requirements**

 **Capital**

The Group's Overall Capital Requirement for CET1 is 11.3% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0.4% Countercyclical Capital Buffer (CCyB).

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 13 December 2021, the Financial Policy Committee (FPC) announced the re-introduction of a CCyB rate of 1% for UK exposures with effect from 13 December 2022. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.4% CCyB for the Group. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% with effect from 5 July 2023.

The Group's updated Pillar 2A requirement as per the PRA's Individual Capital requirement is 4.3% of which at least 56.25% needs to be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

The Group's CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.

 **Leverage**

The Group is subject to a UK leverage ratio requirement of 4.0%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.2%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £5.9bn and against the 0.2% CCLB was £2.3bn.

The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

 **MREL**

The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.5% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.

 **Significant regulatory updates in the period**

 **Capital and RWAs**

On 1 January 2022, the PRA's implementation of Basel III standards took effect including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and the introduction of the Standardised Approach for Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method for Standardised derivative exposures as a more risk sensitive approach. In addition, the PRA also implemented IRB roadmap changes which includes revisions to the criteria for definition of default, probability of default and loss given default estimation to ensure supervisory consistency and increase transparency of IRB models.

On 30 November 2022, the PRA published its consultation paper 'Implementation of the Basel 3.1 standards', which covers the remaining parts of the Basel III standards to be implemented in the UK. Changes are expected to come in to force from 1 January 2025, other than those areas subject to transitional provisions. Barclays currently expects the impact on RWAs on 1 January 2025 to be at the lower end of the prior 5-10% RWA inflation guidance. The PRA is currently consulting on the rule changes, and there will be a review of the Pillar 2A framework in 2024 which may offset some of the impact.

 **Leverage**

From 1 January 2022, UK banks became subject to a single UK leverage ratio requirement meaning that the CRR leverage ratio no longer applies. Under the revised UK leverage ratio framework, central bank claims have been excluded from the UK leverage exposure measure where they are matched by qualifying liabilities (rather than deposits).

In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 **Impact of Over-issuance of Securities in the US**

 **Basis of preparation**

In March 2022, the Group became aware that Barclays Bank PLC had issued securities materially in excess of the amount it had registered with the SEC under Barclays Bank PLC's 2019 F-3. Subsequently, the Group became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities issued in excess of the registered amount included structured products and exchange traded notes. As these securities were not issued in compliance with the Securities Act, a right of rescission arose for certain purchasers of the securities. A portion of the costs associated with the right of rescission was attributable to the financial statements for the year ended 31 December 2021, resulting in the restatement of the 2021 figures in the disclosures below.

Prior to the restatement, litigation and conduct charges in the income statement in relation to 2021 were underreported by £220m (pre-tax). This resulted in a CET1 capital decrease of £170m from £47,497m to £47,327m. Both the transitional and fully loaded CET1 ratios remained unchanged at 15.1% and 14.7% respectively. The T1 ratio moved from 19.2% to 19.1% and the total capital ratio moved from 22.3% to 22.2%.

The leverage exposure increased £1.9bn to recognise on a regulatory basis, the potential commitment relating to the rescission offer. This resulted in the UK leverage ratio moving from 5.3% to 5.2% whilst the average UK leverage ratio remained unchanged at 4.9%.

Total own funds and eligible liabilities decreased £0.2bn to £108bn, which was in excess of a restated requirement to hold £94bn of own funds and eligible liabilities.

---

| | | | |
|:---|:---|:---|:---|
| <br> **Capital ratios<sup>2,3</sup>** | <br> **As at 31.12.22** | <br> **As at 30.09.22** | **Restated<sup>1</sup>**<br>**As at 31.12.21** |
| CET1 | 13.9% | 13.8% | 15.1% |
| T1 | 17.9% | 17.6% | 19.1% |
| Total regulatory capital | 20.8% | 20.3% | 22.2% |
| **Capital resources** | **£m** | **£m** | **£m** |
| **Total equity excluding non-controlling interests per the balance sheet** | **68292** | **67034** | **69052** |
| Less: other equity instruments (recognised as AT1 capital) | (13284) | (13270) | (12259) |
| Adjustment to retained earnings for foreseeable ordinary share dividends | (787) | (494) | (666) |
| Adjustment to retained earnings for foreseeable repurchase of shares |  | (9) |  |
| Adjustment to retained earnings for foreseeable other equity coupons | (37) | (82) | (32) |
| **Other regulatory adjustments and deductions** |  |  |  |
| Additional value adjustments (PVA) | (1726) | (1850) | (1585) |
| Goodwill and intangible assets | (8224) | (8356) | (6804) |
| Deferred tax assets that rely on future profitability excluding temporary differences | (1500) | (1034) | (1028) |
| Fair value reserves related to gains or losses on cash flow hedges | 7237 | 9451 | 852 |
| Excess of expected losses over impairment | (119) | (7) |  |
| Gains or losses on liabilities at fair value resulting from own credit | (620) | (773) | 892 |
| Defined benefit pension fund assets | (3430) | (3162) | (2619) |
| Direct and indirect holdings by an institution of own CET1 instruments | (20) | (20) | (50) |
| Adjustment under IFRS 9 transitional arrangements | 700 | 759 | 1229 |
| Other regulatory adjustments | 396 | 387 | 345 |
| **CET1 capital** | **46878** | **48574** | **47327** |
| **AT1 capital** |  |  |  |
| Capital instruments and related share premium accounts | 13284 | 13270 | 12259 |
| Qualifying AT1 capital (including minority interests) issued by subsidiaries |  |  | 637 |
| Other regulatory adjustments and deductions | (60) | (60) | (80) |
| **AT1 capital** | **13224** | **13210** | **12816** |
| **T1 capital** | **60102** | **61784** | **60143** |
| **T2 capital** |  |  |  |
| Capital instruments and related share premium accounts | 9000 | 8524 | 8713 |
| Qualifying T2 capital (including minority interests) issued by subsidiaries | 1095 | 1176 | 1113 |
| Credit risk adjustments (excess of impairment over expected losses) | 35 |  | 73 |
| Other regulatory adjustments and deductions | (160) | (160) | (160) |
| **Total regulatory capital** | **70072** | **71324** | **69882** |
| **Total RWAs** | **336518** | **350774** | **314136** |

---

---

| | |
|:---|:---|
| *1* | *Capital metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for more information. The transitional CET1 ratio remains unchanged at 15.1%.* |
| *2* | *CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments. December 2021 comparatives include the grandfathering of CRR non-compliant capital instruments.* |
| *3* | *The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.7%, with £46.2bn of CET1 capital and £336.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.* |

---

---

| | | |
|:---|:---|:---|
| **Movement in CET1 capital** | **Three months ended 31.12.22** | **Twelve months ended 31.12.22** |
|  | £m | £m |
| **Opening CET1 capital<sup>1</sup>** | **48574** | **47327** |
| Profit for the period attributable to equity holders | 1321 | 5928 |
| Own credit relating to derivative liabilities | 90 | (85) |
| Ordinary share dividends paid and foreseen | (293) | (1149) |
| Purchased and foreseeable share repurchase |  | (1500) |
| Other equity coupons paid and foreseen | (240) | (910) |
| **Increase in retained regulatory capital generated from earnings** | **878** | **2284** |
| Net impact of share schemes | 99 | 108 |
| Fair value through other comprehensive income reserve | (26) | (1277) |
| Currency translation reserve | (1401) | 2032 |
| Other reserves | (4) | 138 |
| **(Decrease)/increase in other qualifying reserves** | **(1332)** | **1001** |
| Pension remeasurements within reserves | (606) | (281) |
| Defined benefit pension fund asset deduction | (268) | (811) |
| **Net impact of pensions** | **(874)** | **(1092)** |
| Additional value adjustments (PVA) | 124 | (141) |
| Goodwill and intangible assets | 132 | (1420) |
| Deferred tax assets that rely on future profitability excluding those arising from temporary differences | (466) | (472) |
| Excess of expected loss over impairment | (112) | (119) |
| Direct and indirect holdings by an institution of own CET1 instruments |  | 30 |
| Adjustment under IFRS 9 transitional arrangements | (59) | (529) |
| Other regulatory adjustments | 13 | 9 |
| **(Decrease) in regulatory capital due to adjustments and deductions** | **(368)** | **(2642)** |
| **Closing CET1 capital** | **46878** | **46878** |

---

1 *Opening balance as at 1 January 2022 has been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for more information*

CET1 capital decreased £0.4bn to £46.9bn (December 2021: £47.3bn).

CET1 capital decreased by £1.7bn as a result of regulatory changes that took effect from 1 January 2022 including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and a reduction in IFRS9 transitional relief due to the relief applied to the pre-2020 impairment charge reducing to 25% in 2022 from 50% in 2021 and the relief applied to the post-2020 impairment charge reducing to 75% in 2022 from 100% in 2021.

---

| | |
|:---|:---|
| £5.9bn of capital generated from profit, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities, was partially offset by distributions of £3.5bn comprising: | £5.9bn of capital generated from profit, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities, was partially offset by distributions of £3.5bn comprising: |
| ●  | £1.5bn of total buybacks including the £1bn buyback announced with FY21 results and the £0.5bn buyback announced with H122 results |
| ●  | £1.1bn of ordinary share dividends paid and foreseen reflecting the £0.4bn half year 2022 dividend paid and a £0.8bn accrual towards a full year 2022 dividend |
| ●  | £0.9bn of equity coupons paid and foreseen |
| Other significant movements in the period were: | Other significant movements in the period were: |
| ●  | £1.3bn reduction from decreases in the fair value of the bond portfolio through other comprehensive income |
| ●  | £2.0bn increase in the currency translation reserve driven by the appreciation of period end USD against GBP |
| ●  | £1.1bn decrease due to the net impact of pensions primarily as a result of the accelerated cash settlement to the UKRF of earlier deficit reduction contributions as well as deficit reduction payments made in 2022 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** |
|  | **Credit risk** | **Credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Market Risk** | **Market Risk** | **Operational risk** | **Total RWAs** |
|  | **STD** | **IRB** | **STD** | **IRB** | **Settlement Risk** | **CVA** | **STD** | **IMA** |  |  |
| **As at 31.12.22** | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| **Barclays UK** | **6836** | **54752** | **167** | **—** | **—** | **72** | **233** | **—** | **11023** | **73083** |
| Corporate and Investment Bank | 35738 | 75413 | 16814 | 21449 | 80 | 3093 | 13716 | 22497 | 27064 | 215864 |
| Consumer, Cards and Payments | 27882 | 3773 | 214 | 46 |  | 61 |  | 388 | 6559 | 38923 |
| **Barclays International** | **63620** | **79186** | **17028** | **21495** | **80** | **3154** | **13716** | **22885** | **33623** | **254787** |
| **Head Office** | **2636** | **6843** | **—** | **—** | **—** | **—** | **—** | **—** | **(831)** | **8648** |
| **Barclays Group** | **73092** | **140781** | **17195** | **21495** | **80** | **3226** | **13949** | **22885** | **43815** | **336518** |
| **As at 30.09.22** |  |  |  |  |  |  |  |  |  |  |
| **Barclays UK** | **6487** | **55121** | **246** | **—** | **—** | **84** | **256** | **—** | **11047** | **73241** |
| Corporate and Investment Bank | &nbsp;&nbsp;&nbsp; 38886 | &nbsp;&nbsp;&nbsp; 75561 | 20115 | 24735 | 446 | 3111 | 15596 | 26879 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25296 | &nbsp;&nbsp;&nbsp; 230625 |
| Consumer, Cards and Payments | &nbsp;&nbsp;&nbsp; 28180 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3597 | 279 | 35 |  | 69 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6424 | &nbsp;&nbsp;&nbsp; 38688 |
| **Barclays International** | **67066** | **79158** | **20394** | **24770** | **446** | **3180** | **15596** | **26983** | **31720** | **269313** |
| **Head Office** | **2785** | **6431** | **—** | **—** | **—** | **—** | **—** | **—** | **(996)** | **8220** |
| **Barclays Group** | **76338** | **140710** | **20640** | **24770** | **446** | **3264** | **15852** | **26983** | **41771** | **350774** |
| **As at 31.12.21** |  |  |  |  |  |  |  |  |  |  |
| **Barclays UK** | **7195** | **53408** | **426** | **—** | **—** | **138** | **100** | **—** | **11022** | **72289** |
| Corporate and Investment Bank | 29420 | 64416 | 15223 | 19238 | 105 | 2289 | 17306 | 27308 | 25359 | 200664 |
| Consumer, Cards and Payments | 20770 | 2749 | 215 | 18 |  | 21 |  | 57 | 6391 | 30221 |
| **Barclays International** | **50190** | **67165** | **15438** | **19256** | **105** | **2310** | **17306** | **27365** | **31750** | **230885** |
| **Head Office** | **4733** | **7254** | **—** | **—** | **—** | **—** | **—** | **—** | **(1025)** | **10962** |
| **Barclays Group** | **62118** | **127827** | **15864** | **19256** | **105** | **2448** | **17406** | **27365** | **41747** | **314136** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Movement analysis of RWAs** | **Credit risk** | **Counterparty credit risk** | **Market risk** | **Operational risk** | **Total RWAs** |
|  | £m | £m | £m | £m | £m |
| **Opening RWAs (as at 31.12.21)** | **189945** | **37673** | **44771** | **41747** | **314136** |
| Book size | 15371 | (3254) | (9707) | 2068 | 4478 |
| Acquisitions and disposals | (1187) |  |  |  | (1187) |
| Book quality | (2236) | 1320 |  |  | (916) |
| Model updates |  |  |  |  |  |
| Methodology and policy | 2961 | 2952 |  |  | 5913 |
| Foreign exchange movements<sup>1</sup> | 9019 | 3305 | 1770 |  | 14094 |
| **Total RWA movements** | **23928** | **4323** | **(7937)** | **2068** | **22382** |
| **Closing RWAs (as at 31.12.22)** | **213873** | **41996** | **36834** | **43815** | **336518** |

---

 *1* *Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.*

Overall RWAs increased £22.4bn to £336.5bn (December 2021: £314.1bn)

---

| | |
|:---|:---|
| Credit risk RWAs increased £23.9bn: | Credit risk RWAs increased £23.9bn: |
| ●  | A £15.4bn increase in book size primarily driven by an increase in lending activities across CIB, CC&P and growth in mortgages within Barclays UK |
| ●  | A £1.2bn decrease in acquisitions and disposals primarily driven by the disposal of Barclays' equity stake in Absa, offset by Gap portfolio acquisition |
| ●  | A £2.2bn decrease in RWAs due to book quality primarily driven by the benefit in mortgages from an increase in the HPI, partially offset by movements in risk parameters primarily within Barclays UK |
| ●  | A £3.0bn increase in methodology and policy primarily as a result of regulatory changes relating to implementation of IRB roadmap changes, partially offset by the reversal of the software intangibles benefit |
| ●  | A £9.0bn increase in FX primarily due to appreciation of USD against GBP |
| Counterparty Credit risk RWAs increased £4.3bn: | Counterparty Credit risk RWAs increased £4.3bn: |
| ●  | A £3.3bn decrease in book size primarily driven by derivative mark-to-market movements |
| ●  | A £1.3bn increase in RWAs due to book quality primarily driven by movements in risk parameters within CIB |
| ●  | A £3.0bn increase in methodology and policy as a result of regulatory changes relating to the introduction of SA-CCR |
| ●  | A £3.3bn increase in FX primarily due to appreciation of USD against GBP |
| Market risk RWAs decreased £7.9bn: | Market risk RWAs decreased £7.9bn: |
| ●  | A £9.7bn decrease in book size primarily driven by a £6.7bn in Stressed Value at Risk (SVaR) model adjustment as a result of changes in portfolio composition, a £2.3bn decrease due to client and trading activities and a £0.7bn reduction in Structural FX |
| ●  | A £1.8bn increase in FX primarily due to appreciation of USD against GBP |
| Operational risk RWAs increased £2.1bn: | Operational risk RWAs increased £2.1bn: |
| ●  | A £2.1bn increase in book size primarily driven by the inclusion of higher 2022 CIB income compared to 2019 |

---

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **Restated<sup>1</sup>** |
| **Leverage ratios<sup>2,3</sup>** | **As at 31.12.22** | **As at 30.09.22** | **As at 31.12.21** |
| **Leverage ratios<sup>2,3</sup>** | £m | £m | £m |
| **Average UK leverage ratio** | **4.8%** | **4.8%** | **4.9%** |
| Average T1 capital | 60865 | 60651 | 59739 |
| Average UK leverage exposure | 1280972 | 1259648 | 1229041 |
| **UK leverage ratio** | **5.3%** | **5.0%** | **5.2%** |
| CET1 capital | 46878 | 48574 | 47327 |
| AT1 capital | 13224 | 13210 | 12179 |
| **T1 capital** | **60102** | **61784** | **59506** |
| **UK leverage exposure** | **1129973** | **1232105** | **1137904** |
| **UK leverage exposure** |  |  |  |
| **Accounting assets** |  |  |  |
| Derivative financial instruments | 302380 | 416908 | 262572 |
| Derivative cash collateral | 69048 | 90948 | 58177 |
| Securities financing transactions (SFTs) | 189637 | 224978 | 170853 |
| Loans and advances and other assets | 952634 | 994065 | 892683 |
| **Total IFRS assets** | **1513699** | **1726899** | **1384285** |
| **Regulatory consolidation adjustments** | **(8278)** | **(6598)** | **(3665)** |
| **Derivatives adjustments** |  |  |  |
| Derivatives netting | (256309) | (347999) | (236881) |
| Adjustments to collateral | (52715) | (76083) | (50929) |
| Net written credit protection | 16190 | 26838 | 15509 |
| Potential future exposure (PFE) on derivatives | 84168 | 84597 | 137291 |
| **Total derivatives adjustments** | **(208666)** | **(312647)** | **(135010)** |
| **SFTs adjustments** | **24203** | **30477** | **24544** |
| **Regulatory deductions and other adjustments** | **(21447)** | **(21582)** | **(20219)** |
| **Weighted off-balance sheet commitments** | **124169** | **135222** | **115047** |
| **Qualifying central bank claims** | **(272321)** | **(267792)** | **(210134)** |
| **Settlement netting** | **(21386)** | **(51874)** | **(16944)** |
| **UK leverage exposure** | **1129973** | **1232105** | **1137904** |

---

---

| | |
|:---|:---|
| *1* | *Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for further details.* |
| *2* | *Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.* |
| *3* | *Fully loaded average UK leverage ratio was 4.7%, with £60.1bn of T1 capital and £1,280.2bn of leverage exposure. Fully loaded UK leverage ratio was 5.3%, with £59.4bn of T1 capital and £1,129.3bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.* |

---

The UK leverage ratio increased to 5.3% (December 2021: 5.2%) primarily due to a £7.9bn decrease in the leverage exposure and a £0.6bn increase in Tier 1 capital. The UK leverage exposure decreased to £1,130.0bn (December 2021: £1,137.9bn) largely due to the following movements:

● £53.1bn decrease in PFE on derivatives largely driven by
increased netting eligibility due to the introduction of
SA-CCR

● £42.0bn decrease in cash at central banks net of the
qualifying central bank claims exemption primarily due to the
matching of allowable liabilities rather than deposits introduced
under the UK leverage ratio framework and a decrease in Swiss Franc
cash assets

● £33.0bn increase in loans and advances and other assets
(excluding cash and settlement balances which are subject to
regulatory exemptions) primarily due to increased
lending

● £29.5bn increase in derivative financial instruments post
additional regulatory netting and adjustments for cash collateral
primarily driven by market volatility, increased activity in CIB
and the application of a 1.4 multiplier introduced under
SA-CCR

● £18.4bn increase in SFTs primarily driven by increased reverse
repurchase activity in CIB

The average UK leverage ratio decreased to 4.8% (December 2021: 4.9%) due to a £51.9bn increase in average leverage exposure partially offset by a £1.1bn increase in average T1 capital. The average UK leverage exposure increased to £1,281.0bn (December 2021: £1,229.0bn) mainly driven by increased activity during the year that was partially offset by the impact of regulatory changes that came into effect from 1 January 2022 under the UK leverage ratio framework.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Total requirement (£m) based on** | **Total requirement (£m) based on** | **Total requirement (£m) based on** | **Requirement as a percentage of:** | **Requirement as a percentage of:** | **Requirement as a percentage of:** |
| **MREL**<br>**MREL requirements including buffers<sup>1,2,3,4</sup>**<br>| <br> **As at 31.12.22** | <br> **As at 30.09.22** | **Restated<sup>1</sup>**<br>**As at 31.12.21** | <br> **As at 31.12.22** | <br> **As at 30.09.22** | **Restated<sup>1</sup>**<br>**As at 31.12.21** |
| **Requirement based on RWAs (minimum requirement)** | **97387** | 99596 | 77302 | **28.9%** | 28.4% | 24.6% |
| Requirement based on UK leverage exposure<sup>4</sup> | 91213 | 97243 | 93975 | 8.1% | 7.9% | 6.9% |
|  |  |  |  |  |  | **Restated<sup>1</sup>** |
| **Own funds and eligible liabilities<sup>1,3</sup>** |  |  |  | **As at 31.12.22** | **As at 30.09.22** | **As at 31.12.21** |
|  |  |  |  | £m | £m | £m |
| CET1 capital |  |  |  | 46878 | 48574 | 47327 |
| AT1 capital instruments and related share premium accounts<sup>5</sup> |  |  |  | 13224 | 13210 | 12179 |
| T2 capital instruments and related share premium accounts<sup>5</sup> |  |  |  | 8875 | 8364 | 8626 |
| Eligible liabilities |  |  |  | 43851 | 41744 | 39889 |
| **Total Barclays PLC (the Parent company) own funds and eligible liabilities** | **Total Barclays PLC (the Parent company) own funds and eligible liabilities** | **Total Barclays PLC (the Parent company) own funds and eligible liabilities** |  | **112828** | **111892** | **108021** |
| **Total RWAs** |  |  |  | **336518** | **350774** | **314136** |
| **Total UK leverage exposure<sup>4</sup>** |  |  |  | **1129973** | **1232105** | **1356191** |
|  |  |  |  |  |  | **Restated<sup>1</sup>** |
| **Own funds and eligible liabilities ratios as a percentage of:<sup>1</sup>** |  |  |  | **As at 31.12.22** | **As at 30.09.22** | **As at 31.12.21** |
| Total RWAs |  |  |  | 33.5% | 31.9% | 34.4% |
| Total UK leverage exposure<sup>4</sup> |  |  |  | 10.0% | 9.1% | 8.0% |

---

As at 31 December 2022, Barclays PLC (the Parent company) held £112.8bn of own funds and eligible liabilities equating to 33.5% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £97.4bn of own funds and eligible liabilities equating to 28.9% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.

---

| | |
|:---|:---|
| *1* | *Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for further details.* |
| *2* | *Minimum requirement excludes the confidential institution-specific PRA buffer.* |
| *3* | *CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II including IFRS 9 transitional arrangements.* |
| *4* | *As at 31 December 2021, MREL requirements were on a CRR leverage basis which, from 1 January 2022, was no longer applicable for UK banks.* |
| *5* | *Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2021: £80m), and other T2 credit risk adjustments and deductions of £125m (December 2021: £87m).* |

---

 **Statement of Directors' Responsibilities**

Each of the Directors (the names of whom are set out below) confirm that:

● to the
best of their knowledge, the condensed consolidated financial
statements (set out on pages 64 to 68), which have been
prepared in accordance with (a) UK-adopted international accounting
standards; and (b) International Financial Reporting Standards
(IFRS) as issued by the International Accounting Standards Board
(IASB), including interpretations issued by the IFRS
Interpretations Committee, give a true and fair view of the assets,
liabilities, financial position and profit or loss of the Company
and the undertakings included in the consolidation taken as a
whole. The condensed consolidated financial statements should be
read in conjunction with the annual financial statements as
included in the Annual Report for the year ended 31 December 2022;
and

● to the
best of their knowledge, the management information (set out on
pages 1 to 62) includes a fair review of the development and
performance of the business and the position of the Company and the
undertakings included in the consolidation taken as a whole,
together with a description of the principal risks and
uncertainties that they face. This management information should be
read in conjunction with the principal risks and uncertainties
included in the Annual Report for the year ended 31 December
2022. Signed on 14 February 2023 on behalf of the Board by

---

| | |
|:---|:---|
| **C.S. Venkatakrishnan** | **Anna Cross** |
| Group Chief Executive | Group Finance Director |

---

Barclays PLC Board of Directors

---

| | | |
|:---|:---|:---|
| **Chairman** | **Executive Directors** | **Non-Executive Directors** |
| *Nigel Higgins* | *C.S. Venkatakrishnan* | *Mike Ashley* |
|  | *Anna Cross* | *Robert Berry* |
|  |  | *Tim Breedon CBE* |
|  |  | *Mohamed A. El-Erian* |
|  |  | *Dawn Fitzpatrick* |
|  |  | *Mary Francis CBE* |
|  |  | *Crawford Gillies* |
|  |  | *Brian Gilvary* |
|  |  | *Marc Moses* |
|  |  | *Diane Schueneman* |
|  |  | *Julia Wilson* |

---

 **Condensed Consolidated Financial Statements**

---

| | | | |
|:---|:---|:---|:---|
| **Condensed consolidated income statement** | **Condensed consolidated income statement** | **Condensed consolidated income statement** | **Condensed consolidated income statement** |
|  |  |  | **Restated<sup>2</sup>** |
|  | **Notes<sup>1</sup>** | **Year ended 31.12.22** | **Year ended 31.12.21** |
|  |  | £m | £m |
| Interest and similar income |  | 19096 | 11240 |
| Interest and similar expense |  | (8524) | (3167) |
| **Net interest income** |  | **10572** | **8073** |
| Fee and commission income |  | 9637 | 9880 |
| Fee and commission expense |  | (3038) | (2206) |
| **Net fee and commission income** |  | **6599** | **7674** |
| Net trading income |  | 8049 | 5794 |
| Net investment income |  | (434) | 311 |
| Other income |  | 170 | 88 |
| **Total income** |  | **24956** | **21940** |
| Staff costs |  | (9252) | (8511) |
| Infrastructure, administration and general expenses |  | (5881) | (5751) |
| Litigation and conduct |  | (1597) | (397) |
| **Operating expenses** |  | **(16730)** | **(14659)** |
| Share of post-tax results of associates and joint ventures |  | 6 | 260 |
| **Profit before impairment** |  | **8232** | **7541** |
| Credit impairment (charges)/releases |  | (1220) | 653 |
| **Profit before tax** |  | **7012** | **8194** |
| Tax charge | 2 | (1039) | (1138) |
| **Profit after tax** |  | **5973** | **7056** |
| **Attributable to:** |  |  |  |
| Equity holders of the parent |  | 5023 | 6205 |
| Other equity instrument holders |  | 905 | 804 |
| **Total equity holders of the parent** |  | **5928** | **7009** |
| Non-controlling interests | 3 | 45 | 47 |
| **Profit after tax** |  | **5973** | **7056** |
| **Earnings per share** |  | p | p |
| Basic earnings per ordinary share | 4 | 30.8 | 36.5 |
| Diluted earnings per ordinary share | 4 | 29.8 | 35.6 |

---

---

| | |
|:---|:---|
| *1* | *For Notes to the Financial Statements see pages 69 to 76**.*** |
| *2* | *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.* |

---

---

| | | | |
|:---|:---|:---|:---|
| **Condensed consolidated statement of comprehensive income** | **Condensed consolidated statement of comprehensive income** | **Condensed consolidated statement of comprehensive income** | **Condensed consolidated statement of comprehensive income** |
|  |  |  | **Restated<sup>2</sup>** |
|  |  | **Year ended 31.12.22** | **Year ended 31.12.21** |
|  | **Notes<sup>1</sup>** | £m | £m |
| **Profit after tax** |  | **5973** | **7056** |
| **Other comprehensive income/(loss) that may be recycled to profit or loss:<sup>3</sup>** | **Other comprehensive income/(loss) that may be recycled to profit or loss:<sup>3</sup>** |  |  |
| Currency translation reserve | 12 | 2032 | (131) |
| Fair value through other comprehensive income reserve | 12 | (1421) | (429) |
| Cash flow hedging reserve | 12 | (6382) | (2428) |
| **Other comprehensive loss that may be recycled to profit** |  | **(5771)** | **(2988)** |
| **Other comprehensive income/(loss) not recycled to profit or loss:<sup>3</sup>** | **Other comprehensive income/(loss) not recycled to profit or loss:<sup>3</sup>** |  |  |
| Retirement benefit remeasurements | 9 | (281) | 643 |
| Fair value through other comprehensive income reserve | 12 | 228 | 141 |
| Own credit | 12 | 1463 | (14) |
| **Other comprehensive income not recycled to profit** |  | **1410** | **770** |
| **Other comprehensive loss for the period** |  | **(4361)** | **(2218)** |
| **Total comprehensive income for the period** |  | **1612** | **4838** |
| **Attributable to:** |  |  |  |
| Equity holders of the parent |  | 1567 | 4791 |
| Non-controlling interests |  | 45 | 47 |
| **Total comprehensive income for the period** |  | **1612** | **4838** |

---

---

| | |
|:---|:---|
| *1* | *For Notes to the Financial Statements see pages 69 to 76**.*** |
| *2* | *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.* |
| *3* | *Reported net of tax.* |

---

---

| | | | |
|:---|:---|:---|:---|
| **Condensed consolidated balance sheet** | **Condensed consolidated balance sheet** | **Condensed consolidated balance sheet** | **Condensed consolidated balance sheet** |
|  |  |  | **Restated<sup>2</sup>** |
|  |  | **As at 31.12.22** | **As at 31.12.21** |
| **Assets** | **Notes<sup>1</sup>** | £m | £m |
| Cash and balances at central banks |  | 256351 | 238574 |
| Cash collateral and settlement balances |  | 112597 | 92542 |
| Loans and advances at amortised cost |  | 398779 | 361451 |
| Reverse repurchase agreements and other similar secured lending |  | 776 | 3227 |
| Trading portfolio assets |  | 133813 | 147035 |
| Financial assets at fair value through the income statement |  | 213568 | 191972 |
| Derivative financial instruments |  | 302380 | 262572 |
| Financial assets at fair value through other comprehensive income |  | 65062 | 61753 |
| Investments in associates and joint ventures |  | 922 | 999 |
| Goodwill and intangible assets |  | 8239 | 8061 |
| Property, plant and equipment |  | 3616 | 3555 |
| Current tax assets |  | 385 | 261 |
| Deferred tax assets | 2 | 6991 | 4619 |
| Retirement benefit assets | 9 | 4743 | 3879 |
| Other assets |  | 5477 | 3785 |
| **Total assets** |  | **1513699** | **1384285** |
| **Liabilities** |  |  |  |
| Deposits at amortised cost |  | 545782 | 519433 |
| Cash collateral and settlement balances |  | 96927 | 79371 |
| Repurchase agreements and other similar secured borrowing |  | 27052 | 28352 |
| Debt securities in issue |  | 112881 | 98867 |
| Subordinated Liabilities | 7 | 11423 | 12759 |
| Trading portfolio liabilities |  | 72924 | 54169 |
| Financial liabilities designated at fair value |  | 271637 | 250960 |
| Derivative financial instruments |  | 289620 | 256883 |
| Current tax liabilities |  | 580 | 689 |
| Deferred tax liabilities | 2 | 16 | 37 |
| Retirement benefit liabilities | 9 | 264 | 311 |
| Other liabilities |  | 13789 | 10505 |
| Provisions | 8 | 1544 | 1908 |
| **Total liabilities** |  | **1444439** | **1314244** |
| **Equity** |  |  |  |
| Called up share capital and share premium | 10 | 4373 | 4536 |
| Other reserves | 12 | (2192) | 1770 |
| Retained earnings |  | 52827 | 50487 |
| **Shareholders' equity attributable to ordinary shareholders of the parent** |  | **55008** | **56793** |
| Other equity instruments | 11 | 13284 | 12259 |
| **Total equity excluding non-controlling interests** |  | **68292** | **69052** |
| Non-controlling interests | 3 | 968 | 989 |
| **Total equity** |  | **69260** | **70041** |
| **Total liabilities and equity** |  | **1513699** | **1384285** |

---

---

| | |
|:---|:---|
| *1* | *For Notes to the Financial Statements see pages 69 to 76.* |
| *2* | *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.* |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** | **Condensed consolidated statement of changes in equity** |
|  | **Called up share capital and share premium** | **Other equity instruments** | **Other reserves** | **Restated<sup>1</sup>**<br> **Retained earnings** | **Restated<sup>1</sup>**<br> **Total** | **Non-controlling interests** | **Restated<sup>1</sup>**<br> **Total equity** |
| **Year ended 31.12.2022** | £m | £m | £m | £m | £m | £m | £m |
| **Balance as at 1 January 2022** | **4536** | **12259** | **1770** | **50487** | **69052** | **989** | **70041** |
| Profit after tax |  | 905 |  | 5023 | 5928 | 45 | 5973 |
| Retirement benefit remeasurements |  |  |  | (281) | (281) |  | (281) |
| Other comprehensive profit after tax for the year |  |  | (4080) |  | (4080) |  | (4080) |
| **Total comprehensive income for the period** | **—** | **905** | **(4080)** | **4742** | **1567** | **45** | **1612** |
| Employee share schemes and hedging thereof | 70 |  |  | 476 | 546 |  | 546 |
| Issue and redemption of other equity instruments |  | 1032 |  | 28 | 1060 | (20) | 1040 |
| Other equity instruments coupon paid |  | (905) |  |  | (905) |  | (905) |
| Disposal of Absa holding |  |  | (84) | 84 |  |  |  |
| Vesting of employee share schemes |  |  | 5 | (485) | (480) |  | (480) |
| Dividends paid |  |  |  | (1028) | (1028) | (45) | (1073) |
| Repurchase of shares | (233) |  | 233 | (1508) | (1508) |  | (1508) |
| Own credit realisation |  |  | (36) | 36 |  |  |  |
| Other movements |  | (7) |  | (5) | (12) | (1) | (13) |
| **Balance as at 31 December 2022** | **4373** | **13284** | **(2192)** | **52827** | **68292** | **968** | **69260** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year ended 31.12.2021** |  |  |  |  |  |  |  |
| **Balance as at 1 January 2021** | **4637** | **11172** | **4461** | **45527** | **65797** | **1085** | **66882** |
| Profit after tax |  | 804 |  | 6205 | 7009 | 47 | 7056 |
| Retirement benefit remeasurements |  |  |  | 643 | 643 |  | 643 |
| Other comprehensive profit after tax for the year |  |  | (2861) |  | (2861) |  | (2861) |
| **Total comprehensive income for the period** | **—** | **804** | **(2861)** | **6848** | **4791** | **47** | **4838** |
| Employee share schemes and hedging thereof | 60 |  |  | 235 | 295 |  | 295 |
| Issue and redemption of other equity instruments |  | 1078 |  | 6 | 1084 | (75) | 1009 |
| Other equity instruments coupon paid |  | (804) |  |  | (804) |  | (804) |
| Vesting of employee share schemes |  |  | 1 | (410) | (409) |  | (409) |
| Dividends paid |  |  |  | (512) | (512) | (44) | (556) |
| Repurchase of shares | (161) |  | 161 | (1200) | (1200) |  | (1200) |
| Other movements |  | 9 | 8 | (7) | 10 | (24) | (14) |
| **Balance as at 31 December 2021** | **4536** | **12259** | **1770** | **50487** | **69052** | **989** | **70041** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | |
|:---|:---|:---|
| **Condensed consolidated cash flow statement** | **Condensed consolidated cash flow statement** | **Condensed consolidated cash flow statement** |
|  |  | **Restated<sup>1</sup>** |
|  | **Year ended 31.12.22** | **Year ended 31.12.21** |
|  | £m | £m |
| Profit before tax | 7012 | 8194 |
| Adjustment for non-cash items | (8514) | 5023 |
| Net increase in loans and advances at amortised cost | (24949) | (10728) |
| Net increase in deposits at amortised cost | 26349 | 38397 |
| Net increase in debt securities in issue | 9210 | 18131 |
| Changes in other operating assets and liabilities | 21811 | (8763) |
| Corporate income tax paid | (688) | (1335) |
| **Net cash from operating activities** | **30231** | **48919** |
| **Net cash from investing activities** | **(21673)** | **4270** |
| **Net cash from financing activities** | **696** | **107** |
| Effect of exchange rates on cash and cash equivalents | 10330 | (4232) |
| **Net increase in cash and cash equivalents** | **19584** | **49064** |
| Cash and cash equivalents at beginning of the period | 259206 | 210142 |
| **Cash and cash equivalents at end of the period** | **278790** | **259206** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.*

 **Financial Statement Notes**

 **1. Basis of preparation**

 **Restatement of financial statements**

The comparatives in these condensed consolidated financial statements for the year ended 31 December 2022 (the financial statements) have been restated to reflect both a provision and contingent liability disclosure in respect of the impact of an over-issuance of securities (the Over-issuance of Securities) in excess of the maximum aggregate offering price registered under Barclays Bank PLC's shelf registration statement on Form F-3, as declared effective by the SEC in August 2019 (2019 F-3) and Barclays Bank PLC's Predecessor Shelf.

Due to an SEC settlement order in 2017, at the time the 2019 F-3 was filed and the Predecessor Shelf was amended, Barclays Bank PLC had ceased to be a "well-known seasoned issuer" (or WKSI) and had become an "ineligible issuer", as defined in Rule 405 under the Securities Act of 1933, as amended (Securities Act), thus being required to register upfront a fixed amount of securities with the SEC.

In March 2022, Barclays Bank PLC became aware that it had issued securities in the US materially in excess of the amount it had registered with the SEC under the 2019 F-3. Subsequently, Barclays Bank PLC became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities that were issued in this period included structured notes and exchange traded notes (ETNs). Certain offers and sales of these securities were not made in compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the securities. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser sold the securities at a loss (the Rescission Price). As a result, Barclays Bank PLC made a rescission offer to eligible purchasers of the relevant affected securities at the Rescission Price (the Rescission Offer).

A portion of the costs associated with the rights of rescission of certain investors was attributable to Barclays PLC's financial statements for the year ended 31 December 2021. Accordingly, the comparatives in these financial statements have been restated. The restatement impacts the consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet, the consolidated statement of changes in equity, and the consolidated cash flow statement for the year ended 31 December 2021, as well as quarterly financial information that is presented within this document.

The table below reflects each of the consolidated financial statement line items that were affected by the restatement:

---

| | | | |
|:---|:---|:---|:---|
| **Impact on the condensed consolidated income statement** | **As reported** | **Restatement** | **As restated** |
| **Year ended 31.12.21** | £m | £m | £m |
| Litigation and conduct | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (177) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (220) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (397) |
| **Operating expenses** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(14439)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(220)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(14659)** |
| **Profit before tax** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8414** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(220)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8194** |
| Taxation | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1188) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1138) |
| **Profit after tax** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7226** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(170)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7056** |
| **Impact on the condensed consolidated statement of comprehensive income** |  |  |  |
| **Year ended 31.12.21** | £m | £m | £m |
| **Profit after tax** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7226** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(170)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7056** |
| **Total comprehensive income for the period** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5008** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(170)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4838** |
| **Impact on the condensed consolidated cash flow statement** |  |  |  |
| **Year ended 31.12.21** | £m | £m | £m |
| **Profit before tax** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8414** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(220)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8194** |
| Adjustment for non-cash items | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4803 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 220 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5023 |
| **Impact on the condensed consolidated balance sheet** |  |  |  |
| **As at 31.12.21** | £m | £m | £m |
| Current tax liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 739 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (50) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 689 |
| Provisions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1688 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 220 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1908 |
| **Total liabilities** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1314074** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **170** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1314244** |
| Retained earnings | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50657 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (170) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50487 |
| **Total equity** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **70211** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **(170)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **70041** |

---

 **2. Tax**

The tax charge for 2022 was £1,039m (restated<sup>1</sup> 2021: £1,138m), representing an effective tax rate (ETR) of 14.8% (restated<sup>1</sup> 2021: 13.9%). The ETR for 2022 includes a charge recognised for the re-measurement of the Group's UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 to reduce the UK banking surcharge rate being from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 9.9%, reflecting the impact of tax benefits arising in the current year, primarily arising from tax relief related to government bonds linked to the high prevailing rate of inflation in 2022, as well as beneficial adjustments in respect of prior years. Included in the 2022 tax charge is a credit of £244m (2021: £212m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes. The 2021 ETR included a benefit recognised for the re-measurement of the Group's UK DTAs as a result of the enactment of legislation to increase the UK Corporation Tax rate to 25% effective from 1 April 2023.

The re-measurement of UK DTAs has resulted in the Group's DTAs decreasing by £318m with a tax charge in the income statement of £346m and a tax credit within other comprehensive income of £28m.

In its Autumn Statement held in November 2022, the UK Government confirmed that, as currently enacted, the banking surcharge rate will be reduced from 8% to 3% from 1 April 2023. UK deferred tax assets as at 31 December 2022 are measured at this rate, having been remeasured when the 3% rate was substantively enacted in 2022. The statutory tax rate applicable to banks' UK profits will therefore be 28% (comprising a rate of 25% for Corporation Tax and of 3% for banking surcharge)from 1 April 2023.

The OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce a global minimum tax rate of 15% and the OECD issued model rules in 2021. During 2022 further OECD guidance has been released and draft legislation to implement the global minimum tax regime has been published by the UK Government. The UK Government has stated that it intends to enact legislation in 2023 to apply for accounting periods beginning on or after 31 December 2023. The Group has reviewed the published OECD model rules and further guidance along with the draft UK legislation and has been assessing the expected impact ahead of the implementation of the new regime. The Group will review further guidance as well as new legislation expected to be released by governments implementing this new tax regime and continue to assess the potential impact.

In the USA, the Inflation Reduction Act was enacted in August 2022. The Act does not include changes to the US corporate income tax rate or to US international tax provisions included in the previously proposed Build Back Better Act but does introduce a corporate alternative minimum tax on adjusted financial statements income, effective from 1 January 2023. Further regulations and guidance are expected to be published in 2023, however the Group's preliminary view is that the alternative minimum tax is not expected to materially increase the Group's effective tax rate. The Group will review future guidance when it is published and continue to monitor other legislative developments and assess the potential impact.

1 *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | |
|:---|:---|:---|
|  | **As at 31.12.22** | **As at 31.12.21** |
| **Deferred tax assets and liabilities** | £m | £m |
| UK | 4925 | 2183 |
| USA | 1576 | 2006 |
| Other territories | 490 | 430 |
| **Deferred tax assets** | **6991** | **4619** |
| Deferred tax liabilities | (16) | (37) |
| **Analysis of deferred tax assets** |  |  |
| Temporary differences | 5345 | 3399 |
| Tax losses | 1646 | 1220 |
| **Deferred tax assets** | **6991** | **4619** |

---

 **3. Non-controlling interests**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Profit attributable to**<br> **non-controlling interests** | **Profit attributable to**<br> **non-controlling interests** | **Equity attributable to**<br> **non-controlling interests** | **Equity attributable to**<br> **non-controlling interests** |
|  | | | **As at 31.12.22** | **As at 31.12.21** |
|  | **Year ended 31.12.22**<br>£m | **Year ended 31.12.21**<br>£m | £m | £m |
| **Barclays Bank PLC issued:** |  |  |  |  |
| - Preference shares | 31 | 27 | 529 | 529 |
| - Upper T2 instruments | 14 | 17 | 438 | 458 |
| Other non-controlling interests |  | 3 | 1 | 2 |
| **Total** | **45** | **47** | **968** | **989** |

---

 **4. Earnings per share**

---

| | | |
|:---|:---|:---|
|  | <br> **Year ended 31.12.22**<br>£m | **Restated<sup>1</sup>**<br>**Year ended 31.12.21**<br>£m |
| Profit attributable to ordinary equity holders of the parent | 5023 | 6205 |
|  | m | m |
| Basic weighted average number of shares in issue | 16333 | 16985 |
| Number of potential ordinary shares | 534 | 435 |
| **Diluted weighted average number of shares** | **16867** | **17420** |
|  | p | p |
| Basic earnings per ordinary share | 30.8 | 36.5 |
| Diluted earnings per ordinary share | 29.8 | 35.6 |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.*

 **5.**

 **Dividends on ordinary shares**

It is Barclays' policy to declare and pay dividends on a semi-annual basis. The 2022 full year dividend of 5.0p per ordinary share will be paid on 31 March 2023 to the shareholders on the Share Registrar on 24 February 2023. A half year dividend for 2022 of 2.25p (H121: 2.0p) per ordinary share was paid on 16 September 2022.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.21** | **Year ended 31.12.21** |
|  | **Per share** | **Total** | **Per share** | **Total** |
| **Dividends paid during the period** | p | £m | p | £m |
| Full year dividend paid during period | 4.00 | 664 | 1.00 | 173 |
| Interim dividend paid during the period | 2.25 | 364 | 2.00 | 339 |
| **Total dividend** | **6.25** | **1028** | **3.00** | **512** |

---

The Directors have confirmed their intention initiate a share buyback of up to £0.5bn after the balance sheet date. The share buyback is expected to commence in the first quarter of 2023. The financial statements for the year ended 31 December 2022 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company.

 **6.**

 **Fair value of financial instruments**

This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2022 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used.

 **Valuation**

The following table shows the Group's assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Valuation technique using** | **Valuation technique using** | **Valuation technique using** |  |
|  | **Quoted market prices** | **Observable inputs** | **Significant unobservable inputs** |  |
|  | **(Level 1)** | **(Level 2)** | **(Level 3)** | **Total** |
| **As at 31.12.22** | £m | £m | £m | £m |
| Trading portfolio assets | 62478 | 64855 | 6480 | 133813 |
| Financial assets at fair value through the income statement | 5720 | 198723 | 9125 | 213568 |
| Derivative financial instruments | 10054 | 287152 | 5174 | 302380 |
| Financial assets at fair value through other comprehensive income | 20704 | 44347 | 11 | 65062 |
| Investment property |  |  | 5 | 5 |
| **Total assets** | **98956** | **595077** | **20795** | **714828** |
| Trading portfolio liabilities | (44128) | (28740) | (56) | (72924) |
| Financial liabilities designated at fair value | (133) | (270454) | (1050) | (271637) |
| Derivative financial instruments | (10823) | (272434) | (6363) | (289620) |
| **Total liabilities** | **(55084)** | **(571628)** | **(7469)** | **(634181)** |
| **As at 31.12.21** |  |  |  |  |
| Trading portfolio assets | 80926 | 63828 | 2281 | 147035 |
| Financial assets at fair value through the income statement | 5093 | 177167 | 9712 | 191972 |
| Derivative financial instruments | 6150 | 252412 | 4010 | 262572 |
| Financial assets at fair value through other comprehensive income | 22009 | 39706 | 38 | 61753 |
| Investment property |  |  | 7 | 7 |
| **Total assets** | **114178** | **533113** | **16048** | **663339** |
| Trading portfolio liabilities | (27529) | (26613) | (27) | (54169) |
| Financial liabilities designated at fair value | (174) | (250376) | (410) | (250960) |
| Derivative financial instruments | (6571) | (244253) | (6059) | (256883) |
| **Total liabilities** | **(34274)** | **(521242)** | **(6496)** | **(562012)** |

---

 **7.**

 **Subordinated liabilities**

---

| | | |
|:---|:---|:---|
|  | **Year ended 31.12.22**<br>£m | **Year ended 31.12.21**<br>£m |
| Opening balance as at 1 January | 12759 | 16341 |
| Issuances | 1477 | 1890 |
| Redemptions | (2679) | (4807) |
| Other | (134) | (665) |
| **Closing balance** | **11423** | **12759** |

---

Issuances of £1,477m comprise £1,000m GBP 8.407% Fixed Rate Resetting Subordinated Callable Notes issued externally by Barclays PLC and £317m USD Floating Rate Notes, £89m ZAR Floating Rate Notes, £42m EUR Floating Rate Notes and £29m JPY Floating Rate Notes issued externally by Barclays subsidiaries.

Redemptions of £2,679m comprise £2,349m notes issued externally by Barclays Bank PLC, £175m USD Floating Rate Notes, £88m USD Fixed Rate Notes issued externally by Barclays subsidiaries and £67m GBP Undated Subordinated Loan Notes (secured) issued externally by a Barclays securitisation special purpose vehicle (SPV). £2,349m notes issued externally by Barclays Bank PLC comprise £1,275m USD 7.625% Fixed Rate Contingent Capital Notes, £838m EUR 6.625% Fixed Rate Subordinated Notes, £147m USD 6.86% Callable Perpetual Core Tier One Notes, £42m EUR Subordinated Floating Rate Notes, £35m GBP 5.330% Step-up Callable Perpetual Reserve Capital Instruments and £12m GBP 6% Callable Perpetual Core Tier One Notes.

Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.

 **8.**

 **Provisions**

---

| | | |
|:---|:---|:---|
|  | <br> **As at 31.12.22**<br>£m | **Restated<sup>1</sup>**<br>**As at 31.12.21**<br>£m |
| Customer redress | 378 | 530 |
| Legal, competition and regulatory matters | 159 | 226 |
| Redundancy and restructuring | 136 | 326 |
| Undrawn contractually committed facilities and guarantees | 583 | 542 |
| Onerous contracts |  | 5 |
| Sundry provisions | 288 | 279 |
| **Total** | **1544** | **1908** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.*

 **9.**

 **Retirement benefits**

As at 31 December 2022, the Group's IAS 19 net pension surplus across all schemes was £4.5bn (December 2021: £3.6bn). The UK Retirement Fund (UKRF), which is the Group's main scheme, had an IAS 19 net pension surplus of £4.7bn (December 2021: £3.8bn). The movement for the UKRF was driven by payment of £294m deficit reduction contributions and the unwind of senior fixed rate notes (covered below), partially offset by higher than expected inflation.

 **UKRF funding valuations**

The latest triennial actuarial valuation of the UKRF with an effective date of 30 September 2022 has been completed. The valuation showed a funding surplus of £2bn and a funding level of 108% (2021 update: £0.6bn surplus, funding level 102%). The improvement was mainly due to £294m deficit reduction contributions, changes to views on life expectancy, and inflationary returns on assets relative to liabilities being better than expected.

As the UKRF has a funding surplus the 2023 deficit reduction contribution (£286m), agreed as part of the 2019 triennial actuarial valuation, is no longer required, and no recovery plan is needed.

During 2019 and 2020, the UKRF subscribed for non-transferable listed senior fixed rate notes for £1.25bn issued by entities consolidated within the Group under IFRS 10. As a result of these transactions, the CET1 impact of the 2019 and 2020 deficit contributions was deferred until 2023, 2024 and 2025 upon maturity of the notes. Barclays unwound these transactions in December 2022. This resulted in a c.30bps reduction to the CET1 ratio being accelerated to Q4 2022 from 2023, 2024 and 2025.

 **10.**

 **Called up share capital**

---

| | | | |
|:---|:---|:---|:---|
|  | **Ordinary share capital** | **Share premium** | **Total share capital and share premium** |
| **Year ended 31.12.22** | £m | £m | £m |
| Opening balance as at 1 January | 4188 | 348 | 4536 |
| Issue of shares under employee share schemes | 13 | 57 | 70 |
| Repurchase of shares | (233) |  | (233) |
| **Closing balance** | **3968** | **405** | **4373** |

---

Called up share capital comprises 15,871m (December 2021: 16,752m) ordinary shares of 25p each. The decrease is mainly due to the repurchase of 931m shares as part of the share buybacks conducted in 2022, partially offset by an increase due to the issuance of shares under employee share schemes.

 **11.**

 **Other equity instruments**

---

| | | |
|:---|:---|:---|
|  | **Year ended 31.12.22**<br>£m | **Year ended 31.12.21**<br>£m |
| Opening balance as at 1 January | 12259 | 11172 |
| Issuances | 3158 | 1078 |
| Redemptions | (2126) |  |
| Securities held by the Group | (7) | 9 |
| **Closing balance** | **13284** | **12259** |

---

Other equity instruments of £13,284m (December 2021: £12,259m) comprise AT1 securities issued by Barclays PLC. There were three issuances and two redemptions in the period.

The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.

All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%.

 **12.**

 **Other reserves**

---

| | | |
|:---|:---|:---|
|  | **As at 31.12.22**<br>£m | **As at 31.12.21**<br>£m |
| Currency translation reserve | 4772 | 2740 |
| Fair value through other comprehensive income reserve | (1560) | (283) |
| Cash flow hedging reserve | (7235) | (853) |
| Own credit reserve | 467 | (960) |
| Other reserves and treasury shares | 1364 | 1126 |
| **Total** | **(2192)** | **1770** |

---

 **Currency translation reserve**

The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group's net investment in foreign operations, net of the effects of hedging.

As at 31 December 2022, there was a credit balance of £4,772m (December 2021: £2,740m credit) in the currency translation reserve. The £2,032m credit movement principally reflects the weakening of GBP against USD during the period.

 **Fair value through other comprehensive income reserve**

The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through other comprehensive income investments since initial recognition.

As at 31 December 2022, there was a debit balance of £1,560m (December 2021: £283m debit) in the reserve. The movement in the year of £1,277m is principally driven by a loss of £1,836m from the decrease in fair value of bonds(net of hedges) due to increasing bond yields, a net loss of £111m transferred to the income statement, gains of £84m transferred to retained earnings on sale of 14.90% equity stake in Absa Group Limited offset by a tax credit of £523m.

 **Cash flow hedging reserve**

The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.

As at 31 December 2022, there was a debit balance of £7,235m (December 2021: £853m debit) in the cash flow hedging reserve. The decrease of £6,382m principally reflects a £9,052m decrease in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves increased. This is partially offset by a tax credit of £2,331m and £339m of losses transferred to the income statement.

 **Own credit reserve**

The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods.

As at 31 December 2022, there was a credit balance of £467m (December 2021: £960m debit) in the own credit reserve. The movement of £1,427m principally reflects a £2,091m gain from the widening of Barclays' funding spreads partially offset by a tax charge of £616m.

 **Other reserves and treasury shares**

Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group's various share schemes.

As at 31 December 2022, there was a credit balance of £1,364m (December 2021: £1,126m credit) in other reserves and treasury shares. This is driven by an increase of £233m due to the repurchase of 931m shares as part of the share buybacks conducted in 2022 and a £5m movement in the treasury shares balance held in relation to employee share schemes.

 **Appendix: Non-IFRS Performance Measures**

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 **Non-IFRS performance measures glossary**

---

| | |
|:---|:---|
| **Measure** | **Definition** |
| Loan: deposit ratio | Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on page 52. |
| Period end allocated tangible equity | Allocated tangible equity is calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses. |
| Average tangible shareholders' equity | Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period. |
| Average allocated tangible equity | Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
| Return on average tangible shareholders' equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 78 to 80. |
| Return on average allocated tangible equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 78 to 81. |
| Operating expenses excluding litigation and conduct | A measure of total operating expenses excluding litigation and conduct charges. |
| Operating costs | A measure of total operating expenses excluding litigation and conduct charges and UK bank levy. |
| Cost: income ratio | Total operating expenses divided by total income. |
| Loan loss rate | Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 29. |
| Net interest margin | Net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 24. |
| Tangible net asset value per share | Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 82. |
| Performance measures excluding the impact of the Over-issuance of Securities | Calculated by excluding the impact of the Over-issuance of Securities from performance measures. The components of the calculations have been included on page 79. |
| Profit before impairment | Calculated by excluding credit impairment charges or releases from profit before tax. |

---

 **Returns**

Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.

---

| | | | |
|:---|:---|:---|:---|
|  | **Profit/(loss) attributable to ordinary equity holders of the parent** | **Average tangible equity** | **Return on average tangible equity** |
| **For the year ended 31.12.22** | £m | £bn | % |
| Barclays UK | 1877 | 10.0 | 18.7 |
| Corporate and Investment Bank | 3364 | 32.8 | 10.2 |
| Consumer, Cards and Payments | 480 | 4.8 | 10.0 |
| Barclays International | 3844 | 37.6 | 10.2 |
| Head Office | (698) | 0.7 | n/m |
| **Barclays Group** | **5023** | **48.3** | **10.4** |
| **For the year ended 31.12.21<sup>1</sup>** |  |  |  |
| Barclays UK | 1756 | 10.0 | 17.6 |
| Corporate and Investment Bank | 4032 | 28.3 | 14.3 |
| Consumer, Cards and Payments | 615 | 4.1 | 15.0 |
| Barclays International | 4647 | 32.4 | 14.4 |
| Head Office | (198) | 5.0 | n/m |
| **Barclays Group** | **6205** | **47.3** | **13.1** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Year ended 31.12.22** |
|  | **Barclays UK** | **Corporate and Investment Bank** | **Consumer, Cards and Payments** | **Barclays International** | **Head Office** | **Barclays Group** |
| **Return on average tangible shareholders' equity** | £m | £m | £m | £m | £m | £m |
| Attributable profit/(loss) | 1877 | 3364 | 480 | 3844 | (698) | 5023 |
|  | £bn | £bn | £bn | £bn | £bn | £bn |
| Average shareholders' equity | 13.6 | 32.8 | 5.7 | 38.5 | 4.3 | 56.4 |
| Average goodwill and intangibles | (3.6) |  | (0.9) | (0.9) | (3.6) | (8.1) |
| **Average tangible shareholders' equity** | **10.0** | **32.8** | **4.8** | **37.6** | **0.7** | **48.3** |
| **Return on average tangible shareholders' equity** | **18.7%** | **10.2%** | **10.0%** | **10.2%** | **n/m** | **10.4%** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Year ended 31.12.21<sup>1</sup>** | **Year ended 31.12.21<sup>1</sup>** | **Year ended 31.12.21<sup>1</sup>** | **Year ended 31.12.21<sup>1</sup>** | **Year ended 31.12.21<sup>1</sup>** | **Year ended 31.12.21<sup>1</sup>** |
|  | **Barclays UK** | **Corporate and Investment Bank** | **Consumer, Cards and Payments** | **Barclays International** | **Head Office** | **Barclays Group** |
| **Return on average tangible shareholders' equity** | £m | £m | £m | £m | £m | £m |
| Attributable profit/(loss) | 1756 | 4032 | 615 | 4647 | (198) | 6205 |
|  | £bn | £bn | £bn | £bn | £bn | £bn |
| Average shareholders' equity | 13.6 | 28.3 | 4.8 | 33.1 | 8.7 | 55.4 |
| Average goodwill and intangibles | (3.6) |  | (0.7) | (0.7) | (3.7) | (8.1) |
| **Average tangible shareholders' equity** | **10.0** | **28.3** | **4.1** | **32.4** | **5.0** | **47.3** |
| **Return on average tangible shareholders' equity** | **17.6%** | **14.3%** | **15.0%** | **14.4%** | **n/m** | **13.1%** |

---

 **Performance measures excluding the impact of the Over-issuance of Securities**

---

| | |
|:---|:---|
| **Corporate and Investment Bank**<br> **Attributable profit excluding the impact of the Over-issuance of Securities** | <br> **Year ended**<br> **31.12.22**<br> **£m** |
| Attributable profit | 3364 |
| Post-tax impact of the Over-issuance of Securities | (552) |
| **Attributable profit excluding the impact of the Over-issuance of Securities** | **3916** |
| **Return on average allocated tangible equity** | £bn |
| Average allocated tangible equity | 32.8 |
| The impact of the Over-issuance of Securities | 0.3 |
| **Average allocated tangible equity adjusted for the impact of the Over-issuance of Securities** | **32.5** |
| Return on average allocated tangible equity | 10.2% |
| The impact of the Over-issuance of Securities | (1.8)% |
| **Return on average allocated tangible equity excluding the impact of the Over-issuance of Securities** | **12.0%** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group** |  |  |  |  |  |  |  |  |
| **Return on average tangible shareholders' equity** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Return on average tangible shareholders' equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 1036 | 1512 | 1071 | 1404 | 1079 | 1374 | 2048 | 1704 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average shareholders' equity | 54.9 | 56.8 | 57.1 | 56.9 | 56.1 | 56.5 | 54.4 | 54.4 |
| Average goodwill and intangibles | (8.2) | (8.2) | (8.1) | (8.1) | (8.1) | (8.2) | (7.9) | (7.9) |
| **Average tangible shareholders' equity** | **46.7** | **48.6** | **49.0** | **48.8** | **48.0** | **48.3** | **46.5** | **46.5** |
| **Return on average tangible shareholders' equity** | **8.9%** | **12.5%** | **8.7%** | **11.5%** | **9.0%** | **11.4%** | **17.6%** | **14.7%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 474 | 549 | 458 | 396 | 420 | 317 | 721 | 298 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 13.7 | 13.5 | 13.6 | 13.7 | 13.6 | 13.6 | 13.5 | 13.5 |
| Average goodwill and intangibles | (3.5) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) |
| **Average allocated tangible equity** | **10.2** | **9.9** | **10.0** | **10.1** | **10.0** | **10.0** | **9.9** | **9.9** |
| **Return on average allocated tangible equity** | **18.7%** | **22.1%** | **18.4%** | **15.6%** | **16.8%** | **12.7%** | **29.1%** | **12.0%** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays International** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 625 | 1136 | 783 | 1300 | 818 | 1191 | 1207 | 1431 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 39.9 | 40.1 | 38.2 | 36.0 | 33.8 | 32.7 | 33.0 | 32.8 |
| Average goodwill and intangibles | (1.0) | (1.0) | (0.9) | (0.9) | (0.9) | (0.9) | (0.6) | (0.5) |
| **Average allocated tangible equity** | **38.9** | **39.1** | **37.3** | **35.1** | **32.9** | **31.8** | **32.4** | **32.3** |
| **Return on average allocated tangible equity** | **6.4%** | **11.6%** | **8.4%** | **14.8%** | **9.9%** | **14.9%** | **14.9%** | **17.7%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Corporate and Investment Bank** | **Corporate and Investment Bank** |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421<sup>1</sup>** | **Q321<sup>1</sup>** | **Q221<sup>1</sup>** | **Q121** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 454 | 1015 | 579 | 1316 | 695 | 1085 | 989 | 1263 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 33.7 | 34.0 | 32.7 | 30.8 | 28.7 | 27.8 | 28.4 | 28.2 |
| Average goodwill and intangibles |  |  |  |  |  |  |  |  |
| **Average allocated tangible equity** | **33.7** | **34.0** | **32.7** | **30.8** | **28.7** | **27.8** | **28.4** | **28.2** |
| **Return on average allocated tangible equity** | **5.4%** | **11.9%** | **7.1%** | **17.1%** | **9.7%** | **15.6%** | **14.0%** | **17.9%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Consumer, Cards and Payments** | **Consumer, Cards and Payments** |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q422** | **Q322** | **Q222** | **Q122** | **Q421** | **Q321** | **Q221** | **Q121** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit/(loss) | 171 | 121 | 204 | (16) | 123 | 106 | 218 | 168 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 6.2 | 6.1 | 5.5 | 5.2 | 5.1 | 4.9 | 4.6 | 4.6 |
| Average goodwill and intangibles | (1.0) | (1.0) | (0.9) | (0.9) | (0.9) | (0.9) | (0.6) | (0.5) |
| **Average allocated tangible equity** | **5.2** | **5.1** | **4.6** | **4.3** | **4.2** | **4.0** | **4.0** | **4.1** |
| **Return on average allocated tangible equity** | **13.0%** | **9.5%** | **17.8%** | **(1.5)%** | **11.7%** | **10.5%** | **21.8%** | **16.5%** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | |
|:---|:---|:---|
| **Tangible net asset value per share** | **As at 31.12.22** | **Restated<sup>1</sup>**<br> **As at 31.12.21** |
|  | £m | £m |
| Total equity excluding non-controlling interests | 68292 | 69052 |
| Other equity instruments | (13284) | (12259) |
| Goodwill and intangibles | (8239) | (8061) |
| **Tangible shareholders' equity attributable to ordinary shareholders of the parent** | **46769** | **48732** |
|  | m | m |
| Shares in issue | 15871 | 16752 |
|  | p | p |
| **Tangible net asset value per share** | **295** | **291** |

---

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Notable Items** |  |  |  |  |
| **Notable Items** | **Year ended 31.12.22** | **Year ended 31.12.22** | **Three months ended 31.12.22** | **Three months ended 31.12.22** |
| **£m** | **Profit before tax** | **Attributable profit** | **Profit before tax** | **Attributable profit** |
| **Statutory** | **7012** | **5023** | **1310** | **1036** |
| Net impact from the Over-issuance of Securities | (674) | (552) |  |  |
| Customer remediation costs on legacy loan portfolio | (282) | (228) |  |  |
| Settlements in principle in respect of industry-wide devices investigations by SEC and CFTC | (165) | (165) |  |  |
| Other litigation and conduct | (184) | (167) | (79) | (70) |
| Re-measurement of UK DTAs |  | (346) |  |  |
| **Excluding the impact of notable items** | **8317** | **6481** | **1389** | **1106** |
|  | **Year ended 31.12.21** | **Year ended 31.12.21** | **Three months ended 31.12.21** | **Three months ended 31.12.21** |
| **£m** | **Profit before tax** | **Attributable profit** | **Profit before tax** | **Attributable profit** |
| **Statutory<sup>1</sup>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8194** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **6205** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1428** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1079** |
| Net impact from the Over-issuance of Securities | (220) | (170) | (46) | (38) |
| Structural cost action - June 2021 real estate review | (266) | (203) |  |  |
| Other litigation and conduct | (177) | (136) | (46) | (29) |
| Re-measurement of UK DTAs |  | 462 |  | 60 |
| **Excluding the impact of notable items** | **8857** | **6252** | **1520** | **1086** |

---

The Group's management believes that the non-IFRS financial measures excluding notable items, included in the table above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The notable items are separately identified within the Group's results disclosures which, when excluded from Barclays' statutory financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of performance from one period to another.

These non-IFRS financial measures excluding notable items are included as a reference point only and are not incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.

 *1* *2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.*

 **Shareholder Information**

---

| | | | |
|:---|:---|:---|:---|
| **Results timetable<sup>1</sup>** |  |  | **Date** |
| Ex-dividend date |  |  | 23 February 2023 |
| Dividend record date |  |  | 24 February 2023 |
| Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-investment Programme (DRIP) Application Form Mandate | Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-investment Programme (DRIP) Application Form Mandate |  | 10 March 2023 |
| Dividend payment date |  |  | 31 March 2023 |
| Q1 2023 Results Announcement |  |  | 27 April 2023 |
| For qualifying US and Canadian resident ADR holders, the 2022 full year dividend of 5.0p per ordinary share becomes 20.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above | For qualifying US and Canadian resident ADR holders, the 2022 full year dividend of 5.0p per ordinary share becomes 20.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above | For qualifying US and Canadian resident ADR holders, the 2022 full year dividend of 5.0p per ordinary share becomes 20.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above | For qualifying US and Canadian resident ADR holders, the 2022 full year dividend of 5.0p per ordinary share becomes 20.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above |
|  | **Year ended** | **Year ended** |  |
| **Exchange rates<sup>2</sup>** | **31.12.22** | **31.12.21** | **% Change<sup>3</sup>** |
| Period end - USD/GBP | 1.21 | 1.35 | (10)% |
| YTD average - USD/GBP | 1.24 | 1.38 | (10)% |
| 3 month average - USD/GBP | 1.17 | 1.35 | (13)% |
| Period end - EUR/GBP | 1.13 | 1.19 | (5)% |
| YTD average - EUR/GBP | 1.17 | 1.16 | 1% |
| 3 month average - EUR/GBP | 1.15 | 1.18 | (3)% |
| **Share price data** |  |  |  |
| Barclays PLC (p) | 158.52 | 187.00 |  |
| Barclays PLC number of shares (m) | 15871 | 16752 |  |
| **For further information please contact** |  |  |  |
| **Investor relations** | **Media relations** | **Media relations** | **Media relations** |
| Chris Manners +44 (0) 20 7773 2136 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 |
| More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays |  |
| **Registered office** |  |  |  |
| 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. |
| **Registrar** |  |  |  |
| Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. |
| Tel: 0371 384 2055<sup>4</sup> from the UK or +44 121 415 7004 from overseas. | Tel: 0371 384 2055<sup>4</sup> from the UK or +44 121 415 7004 from overseas. | Tel: 0371 384 2055<sup>4</sup> from the UK or +44 121 415 7004 from overseas. | Tel: 0371 384 2055<sup>4</sup> from the UK or +44 121 415 7004 from overseas. |
| **American Depositary Receipts (ADRs)** |  |  |  |
| EQ Shareowner Services | EQ Shareowner Services | EQ Shareowner Services | EQ Shareowner Services |
| P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 |
| St. Paul, MN 55164-0854 | St. Paul, MN 55164-0854 | St. Paul, MN 55164-0854 | St. Paul, MN 55164-0854 |
| United States of America | United States of America | United States of America | United States of America |
| shareowneronline.com | shareowneronline.com |  |  |
| Toll Free Number: +1 800-990-1135 |  |  |  |
| Outside the US +1 651-453-2128 |  |  |  |
| Delivery of ADR certificates and overnight mail |  |  |  |
| EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. |

---

---

| | |
|:---|:---|
| *1* | *Note that these dates are provisional and subject to change.* |
| *2* | *The average rates shown above are derived from daily spot rates during the year.* |
| *3* | *The change is the impact to GBP reported information.* |
| *4* | *Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.* |

---